Loading...

How to order a communication strategies presentation american asa double spaced


Best website to get writing services presentation communication strategies 35 pages / 9625 words standard american business

Double-spaced (including footnotes) Pages are numbered, from the title page to the reference page Must have a title page, which will have the full title of your paper, your name, your institution, a running head, and an approximate word count of your paper.Should include an abstract page (on the second page, right after the title page).

It should be approximately 150-200 words, in one paragraph Best websites to get presentation communication strategies American US Letter Size Standard 71 pages / 19525 words.It should be approximately 150-200 words, in one paragraph.

The text of your paper will start on the third page, starting with the title of your paper Use parenthetical citations instead of footnotes/endnotes.However, use footnotes/endnotes if your professor requires them.Parenthetical citations are inserted at the end of the information 1-01. Chapter 1. Manuscript Preparation. The American Society of Agronomy (ASA), Crop Science Society of America (CSSA),   to the manuscript number in all subsequent communications. Authors will be informed   Agronomy Journal and the Soil Science Society of America Journal use a double- blind process and also  .

Parenthetical citations are inserted at the end of the information.

Footnotes/endnotes are inserted in a separate section of your paper.References should appear on the very last page of your paper, titled "References" Your references will be in an alphabetical order, using hanging indents golge.com/paper/bullying.php.References should appear on the very last page of your paper, titled "References" Your references will be in an alphabetical order, using hanging indents.The title of your paper should be centered two lines below the date.Do not underline or quote the title Always check with your instructor to see if he or she has any different requirements or specifications for your paper.

In-text Citations Citations for Most Written Sources.

ASA Style Citation require that credit must be given for all information whether it be a direct quote or a paraphrase.Generally you are required to give the following information: author's last name, year of publication, and page number in parenthesis directly after the quote or paraphrase.Direct Quote He stated, "Apes can gesture, but do not understand the grammatical structure of American Sign Language" (Smith 1994:345).Paraphrase It has been shown that apes do not actually understand the syntax and structure of ASL (Smith 1994:345).If you include the author's name as part of the sentence, just give the year in parenthesis directly after the author's name, and put p.

for the page number in parenthesis after the quote.Direct Quote with author's name in sentence According to Jack Gannon (1988), "The protest provided a wonderful opportunity for those interpreters to assist the deaf community" (p.Paraphrase with author's name in sentence Jack Gannon (1988) explained that the DPN protest gave interpreters a chance to help Gallaudet's deaf community (p.Multiple Authors When a source has two authors, you should give both last names.Within the parenthetical citation, use and between the authors' names.

If you use their names in the sentence, just write and between their names.Both methods must be followed by the year of publication, and at the end of the sentence, put in the page number.One source with two authors The Oxford English Dictionary was written "specifically for learners of English as a foreign or second language" (Hornby and Ruse 1976:82).One source with two authors in the sentence Hornby and Ruse (1976) explain that the Oxford English Dictionary was designed to be used mostly by new English users (p.When a source has three authors, cite all the authors’ last names and the year the first time the reference occurs.For later references to the same source cite only the first author’s last name followed by et al.However, if a source has four or more authors, use et al.both in the first citation and in all subsequent citations.One source with three authors, first citation "Scientists are trying to find a cure for the common cold" (Juneston, Craig, and Carter 1993:220).

One source with three authors, later citation "There are thousands of different viruses that cause what we refer to as 'the common cold'" (Juneston et al.One source with four or more authors, both first and later citations U.Congress is too focused on getting re-elected and not focused enough on meeting their constituents' needs (Harris et al.If you are using several different works to illustrate one point, you may find it necessary to cite two or more works written by different authors with different dates.In that situation, organize the information alphabetically by the authors' last names, and separate each block of information with a semicolon.

Put all the names inside one set of parenthesis.Citing multiple works in one sentence Several studies (Burna 1980; Geraldi 1988; Kesser and Morals 1990) indicate that the cure for the common cold is just around the corner.association, organization, or government agency) you should spell out the full name.Citing source by group author "Some people have adverse reactions to the flu shot, such as vomiting, fever, and rashes" (National Institute of Health 1999).Quotes of 40 Words or More Block quotations are presented in smaller type (10pt) and are set off in a separate, indented paragraph.Block quotations should not be enclosed in quotation marks.The author, date, and/or page number, in parenthesis, follows the last period in the block quotation.

The P for page should be used and capitalized if it stands alone, without author and year.

Get an presentation communication strategies originality standard business editing british

Gallaudet University received a lot of publicity during the 1988 DPN Rallies.It was a time when deaf people learned about the strength of their community.The student protest that shut down Gallaudet University the week of March 6-13, 1988, accomplished far more than just the selection of the world's first deaf university president ASA Style Guide. Information for these guidelines is compiled from the American Sociological Association Style Guide, Second Edition. ASA is a non-profit   Margins: one inch on all sides; Double-spaced (including footnotes); 12 points type font size; Pages are numbered, from the title page to the reference page; Must have  .

The student protest that shut down Gallaudet University the week of March 6-13, 1988, accomplished far more than just the selection of the world's first deaf university president.

It proved, convincingly, that deaf people could band together effectively for a common cause and succeed.

The protest experiences taught deaf people about the needs and values of being more assertive.(Gannon 1988:15) It also reaffirmed that the deaf population has a voice worth listening to, and that they will fight to be heard by Gallaudet's Board of Trustees.Reference Format For a paper done in ASA documentation style, the reference list will appear in a separate section and will be titled "References." Here on your References page, you acknowledge your sources by listing them in an alphabetical order by author's last name.Although the References page appears at the end of your paper, you will draft this section in advance, so that you will have the appropriate information to cite your paper properly.

The general formatting rules for your References page are as follows: List your sources in an alphabetical order according to the author's last name.If no author is listed, begin with the main word of the article or book title (ignoring A, Book with two authors A Goal to a Better Health: Basic Cooking Skills.Book with three or more authors Jonessey, Vivian R.Works Cited format for Electronic Sources If you are citing from an online publication, you should include all of the information that you would include for journals or articles.After this standard information, you should include the date you found the information on the world wide web (the date of retrieval) and the web address (URL) where you found the information.The basic citing format for electronic sources is as follows: Author." Online journal article American Online newspaper article Goldstein, Amy."Dying Patients' Care Wishes Vary Widely.Retrieved January 25, 1998 ( /wp-srv/WPlate/1997-10/15/ ).Help me with an case study social media high quality cbe graduate academic american 9 Formatting Tactics That Will Double Your Readers’ Average Time on Page by Neil Patel on July 15, 2015 I’ve been through it all. From publishing posts that no one reads to posts that get thousands of views and hundreds of comments within a day.Putting in time and effort into writing a post and then getting an average time on page of 10 seconds sucks The style is supported by Cite This For Me's citation management tool; making the ASA formatting of your in-text citations and reference list a straightforward task.Include the first names for all authors rather than their initials – unless the author used their initials in the original publication; in these cases, add a space.

Putting in time and effort into writing a post and then getting an average time on page of 10 seconds sucks.When I write a post, I want readers to take 10, 20, or even 30 minutes out of their days to read it word by word.I know that not all readers will do that, but if a decent chunk of them do, I’m a typical blog, only about 2% will spend more than two minutes reading a good news is that yours doesn’t have to be a typical blog—it can be are many factors that affect how much time the average reader will spend on one of your blog posts: load speed length of content These elements are all more or less under your control, so it’s important that you take the time to understand 9 formatting tactics that will double your readers’ average time on page.I’m going to show you 9 most crucial and often missed formatting tips that can make a big difference to the average amount of time your readers spend on your page.Forget blog width, focus on this instead Imagine if a blog post was printed on a page the size of a giant movie would have a heck of a time trying to read the whole thing, having to constantly look back and forth, trying to find the next would be slow, frustrating, and hard to retain information this only that, if someone walked up to you with it and asked you to read it, it’d probably be same thing happens when you make your blog post too wide.

I am sure you noticed that the page in Microsoft Word doesn’t take up the whole width of your , let’s take it to the other extreme: imagine if you wrote one word per ’d make it harder to connect words and sentences onally, you’d be scrolling non-stop.A study of reader comprehension found that: When someone is reading slowly, lines of about 55 characters per line aresomeone is reading fast, lines of about 100 characters per line are I say “best,” I am talking in terms of reading speed and ’s important that you consider both of these reading types when you write a blog ? Because a small portion of readers will read your whole post, practically word by word.However, most Internet readers are s only read an average of 20-28% of a post, even if they like it .With the huge amount of content being published, over 2 million blog posts per day alone, skimming is skim to read the key points of an article to see if they are they are interested, they often go back and read the article more slowly.When you optimize your content for skimmers, they will be able to understand more from quickly scrolling through, which gives you a better chance of grabbing their what’s the best width? I think it’s safe to say that each line should hold somewhere between 55 to 100 letter, space, or punctuation (comma, period, claim that around 66 characters per line is ideal, but I’ve found that a bit higher works better for most blogs.

The bigger your font, the fewer characters will fit on a rly, some fonts are wider than general, somewhere between 500 and 650 pixels is ideal.Quick Sprout falls near the upper limit of this we do any testing, see if you’re doing okay a single line of one of your previous posts into a character count that there will be some variation based on which line you can check four or five lines to get a more accurate average.If you already fall within that 55 to 100 character range, it’s up to you if you’d like to change it at this ng that you’re not in this range, or are at the very low end, here’s how you can optimize your font size and blog 1: Pick a blog width Unless you are very comfortable modifying HTML and CSS, or you have a developer, it’s usually the easiest to change the font size unless your blog width falls out of that 500-650 pixel range (pretty rare).I can’t show you how to easily change the width of your blog because it depends on the exact theme you’re using.9 formatting tactics that will double your readers average time on nbsp Step 2: See what 100 characters looks like In both Chrome and Firefox, you can bring up an element/page inspector using the shortcut “Ctrl + Shift + I”.

You can use this to dig around and play with the code on your blog a bit (don’t worry, none of it will have any effect on your actual blog).Alternatively, right-click on a sentence and select “inspect element” to bring up the inspector A seasoned editor gives advice to get your work published in an international journal.By Angel Borja, PhD Posted on 2 March 2015.Share story:Again, look at the journal's Guide for Authors, but an ideal length for a manuscript is 25 to 40 pages, double spaced, including essential data atively, right-click on a sentence and select “inspect element” to bring up the inspector.

If you use the shortcut, scroll through the HTML until you find the paragraph tags that contain a sentence in your , left-click (the normal one) on any element that contains a sentence in the inspector.Then, right click that sentence and choose “Edit as Text.

Asa style guide gallaudet university

” Highlight the entire sentence, delete it, and then copy and paste this example phrase that has 100 characters (without the quotation marks): “This is a line of words that has only 100 characters in it to test font sizes on your blog.” Then press enter to see the changes reflected on your screen.If you want your blog to be 100 characters wide, it should accommodate this example phrase perfectly Authors have been uncertain about what ASA style really is. Is it the same for all ASA journals? Is it the Chicago Manual style? The American Psychological Association style? Elements of both? Copy edi- tors have noted these problems as well, and have added that many authors fail to communicate clearly in their writing..

If you want your blog to be 100 characters wide, it should accommodate this example phrase perfectly.

Adjust the phrase if you would like fewer the character count test that we did earlier, I saw that Quick Sprout was set up to fit about 100 big surprise that this sentence fit almost if the sentence did not fit as you’d like, you can also preview different font sizes using the inspector, so don’t close it that sentence highlighted in the inspector, look on the panel on the right.Scroll down, and look for a “font-size” property that doesn’t have a line through ng you have a responsive theme (which you really should), it’ll look something like “font-size:X This document has been developed by the ASA Committee on Equipment and Facilities but has not been reviewed or approved as a practice parameter or policy   Environmental impacts require quantification in order for physician anesthesiologists to begin to factor environmental impacts into clinical decision-making..Scroll down, and look for a “font-size” property that doesn’t have a line through ng you have a responsive theme (which you really should), it’ll look something like “font-size:X.” If you can’t find it, you can also click the “+” sign at the top of the CSS section to create a new property This document has been developed by the ASA Committee on Equipment and Facilities but has not been reviewed or approved as a practice parameter or policy   Environmental impacts require quantification in order for physician anesthesiologists to begin to factor environmental impacts into clinical decision-making..” If you can’t find it, you can also click the “+” sign at the top of the CSS section to create a new property.Then, click inside the new curly brackets – – and type in “font-size:1em” to change the font size, left-click the number (the “X.XX” part), and type in a different number.

A bigger number will make the text enter after each change and keep adjusting that value until you’re happy.Step 3: Make the changes Once you’ve found your ideal font size, you need to make the change in your admin panel, whether you’re using WordPress or a different check your theme options as there’s usually an easy setting to change font ise, you’ll have to add the CSS to your CSS code in the editor, ideally in a child it time to ditch the sidebar? The sidebar is such a standard feature of blogs that it’s rarely thought about, but that’s a mistake.The average sidebar is barely ever used by a highly optimized sidebar like Brian Dean’s at Backlinko only gets 1.9% of visitors clicking on the most important element: Okay, so why does this matter? The problem is that your sidebar is a distraction, especially to new time that you have to capture a visitor’s attention has become increasingly short.A new visitor may spend anywhere from 1-2 seconds looking at your sidebar, or about 25-50% of your window of opportunity to get them to do what you are a few good case studies that support the idea of removing your Harris was able to improve his email opt-in rate by 26% on blog posts by removing his: Impact Branding & Design also tested this went from this complicated sidebar: to this: What those studies confirm is that a sidebar can be a most cases, I believe it will increase the average time on page for your we saw, it might also increase your email opt-in ally, I like being able to include my bio on every blog post (in the sidebar) to help build my brand and be more that doesn’t mean that it is or isn’t going to be right for you.

Split test having a sidebar and not having a if the results indicate that you should drop the sidebar can be an asset or a distraction I’m a huge fan of images, but you need to use them in the right image selection will have a large positive impact on the amount of time your visitors spend reading your blog posts.The former Director of Product Management for PRWeb analyzed thousands of press releases to discover the impact of found that press releases with no images had an average time on page of 2:18.Guide to citations mhra format goldsmiths virtual learning nbsp However, press releases with at least one image had an average time on page of 2: if you don’t pick the best pictures, being able to break up your text is bound to have a decent effect on your time on guideline #1: Use the right type of images Based on that analysis, any picture seems better than no picture, but there is a difference between different types of pictures .Image guideline #1: Use the right type of images Based on that analysis, any picture seems better than no picture, but there is a difference between different types of pictures.I looked at 41 blogs across a variety of niches to find which types of images were shared the best were hand-drawn and animated images Help me with an social media case study Undergraduate Vancouver British double best were hand-drawn and animated ing that were graphs, infographics, and stock photos Help me with an social media case study Undergraduate Vancouver British double ing that were graphs, infographics, and stock of those image types aren’t realistic.

Are you really going to include five hand-drawn images or infographics in a post? Probably not because they’re expensive.Even if you have the skill to make them yourself, they take a lot of time to graphs? You can easily find a few useful graphs from research you are fantastic because they are not only interesting but they also force the user to take a few seconds and figure out what’s going about stock photos? I don’t recommend just using plain stock photos, but you can buy these for $1 or less if you know where to can even customize them to look better and grab more attention.Check out my guide to making inexpensive custom images if you haven’t guideline #2: Use the right number of images Imagine if I used one picture for a 5,000-word might help the time on page a bit, but I doubt it would do the same time, having 100 pictures for a 1,000-word post would be ridiculous unless you write for Pros looked at 100 most popular blog posts to find similarities.They found that the most popular articles had one picture for about every 350 words (3.Remember, that’s just an average; some had ’ll notice that on my posts, I probably go closer to one picture for every 200 y, you also need to consider page speed.

If you overload your post with pictures, it will take longer to is very important to use a high quality content delivery network (cdn) and fast hosting if you plan to use a lot of images in ve ways to break up your content Part of why images are so great at increasing your visitors’ average time on page is because they break up your matter how good you are with words, no one wants to read a wall of text because it’s boring.While images might be your primary way of spacing things out and varying your reader’s experience, there are other effective ways of doing this that give you even more 1: Lists Most find that lists are easier to read than normal onally, you have many different list options: lists like this one also break up the text numbered lists provide some extra variety you can also use custom bulletsThe guys at Authority Hacker have a solid blog design and bullets are a part of it: Changing your standard round dot bullet to something like a green checkmark will require some custom “list-style-image” property tells the browser that you’d like to use an image for your list (the HTML for lists is “li”).The “url” element designates the URL of the image you’d like to y, the “!important” tells your browser to override any other list style properties.A custom bullet image doesn’t have to be can either create your own using a tool like Canva or buy a simple icon at the Noun Project.Option 2: Embedded social media What’s better than an element that breaks up your text? An element that can also get you additional ing social media elements is becoming more and more common because it works, especially now because the web hasn’t been saturated with them easiest way is to use a plugin like ’s the latest one we’re trying out on the Crazy Egg blog, and it seems to be working pretty ’s what it looks like (box design 4 if any of you try out the plugin): It stands out, breaks up the text really well, and gets the post a few extra tweets.

What’s not to like?If you don’t want to use a plugin to embed Tweets or Facebook posts (or other social networks), most networks provide a way to embed a specific ’s a good guide that outlines the 3: Tables Although the application of tables is far more limited than the other options, they provide a nice mixture of image and text are useful when you’re writing an article that compares multiple things.The best free option for WordPress that I’ve seen is the TablePress plugin: Again though, if you are familiar with HTML and CSS, you can create your own custom layouts as well.Notes on essay writing format references nbsp university of sussex Option 4: Quotes In addition to breaking up text, quotes add credibility to your you have an opinion on a topic but aren’t an authority in that niche, you can quote an expert with a similar opinion, and it will be taken more ’s one more aspect of quotes that I love, and it’s that you can also use them as part of your promotional strategy 8 Nov 2016 - source.(c) Whenever you present specific information from a source such as statistics or case studies.(d) Whenever you refer to an idea or argument originally presentedYou should study this carefully, and haveThe MHRA advise, 'Double spaces should not be used in normal text', which means ’s one more aspect of quotes that I love, and it’s that you can also use them as part of your promotional strategy.

Contact anyone that you quote in your article (if possible) after you publish your post, and let them know.Then, politely ask for a share if they like atively, contact authorities in your niche before you publish your post, and ask for a quote on a specific topic Online Researches What Is A Double Spaced Essay top writers atively, contact authorities in your niche before you publish your post, and ask for a quote on a specific you send them the post later, they are much more likely to share your visitor through your page For most blog posts, it’s a case of: here it is, read away.That’s what starts the skimming for a lot of might’ve noticed that in my advanced guides on Quick Sprout (which are very long), I don’t leave navigation to some of my guides, I even include a dotted line in the background that takes you from section to section: Another subtle tactic I use is I include downward-facing arrows when , these direct the reader’s attention down to the next section so that they keep y, this isn’t just a tactic for blog posts; it’s used by copywriters for landing pages as well.Take a look at the initial landing page for Air Story that was written by Joanna Wiebe of Copy Hacker: Look at the person in the ’s been proven that faces in pictures attract also naturally follow their eye-line, which in this case is to the call to you’re using pictures of people in your blog posts, try not to have any that are looking up: that kills your reader’s have them looking sideways, towards the reader, or down towards the next section.Give skimmers a chance to re-engage Remember skimmers? They’re the ones hopping and scrolling through your page instead of reading every win their attention (and subsequently convince them to go back and read your post in full), you need to take advantage of the elements in your posts that stand already covered images, and that’s a great start.

But there are two other elements that are also t 1: Colored backgrounds While it takes some extra effort, I’ve found using colored backgrounds is an effective way to grab my definitive guides, I used background color changes to signify a new ’s as if it’s saying: “Hey skimmer, check out this before you keep scrolling.” Element 2: Take full advantage of your subheadlines Subheadlines (your H2s and H3s) stand out by default.They stand alone on a line and are usually bolder and bigger than the surrounding worst thing you can do is to write a really basic and plain d, take extra time and care to create powerful example, if I called this section “Backgrounds and Headlines,” very few skimmers would with a title such as“Give Skimmers a Chance to Re-Engage,” a decent portion of the readers will get curious and at least start reading.Then it’s up to me to convince them to keep reading by giving them useful users control over their visit One of the main reasons that skimmers skim is that they are unsure if they are interested in your they already know a lot about the topic you’re writing about and aren’t sure if you’re adding anything maybe they’re just interested in one or two parts of it, and not a full article.If you can show these skimmers exactly what’s in the article, they are going to find what they’re looking for stops them from entering “skimming” mode, and it also prevents them from missing what they’re looking most effective way to do this is by either explaining the article in the introduction or by having a table of contents.

Best website to purchase a custom presentation communication strategies plagiarism-free 30 pages / 8250 words chicago double spaced junior

I’m going to outline 3 different types of table of contents, but they can all work well, so pick whichever one seems appropriate for your rd Wiki-style table of contents Wikipedia isn’t pretty, but it’s brilliant from a usability point of of its articles feature the exact same simple table of can manually create it if you want to learn a bit of simple HTML and CSS, but it’s much easier to install a plugin like Table of Contents plus.A simple click of a button will automatically grab all your subheadings and create a table of contents: 2.Text- and link-based table of contents Sometimes headlines alone aren’t descriptive enough, especially if you’re creating a huge guide The American Sociological Association (ASA), founded in 1905, is a non-profit membership association dedicated to advancing sociology as a scientific discipline and profession serving the public good. With nearly 15,000 members, ASA encompasses sociologists who are faculty members at colleges and universities,  .Text- and link-based table of contents Sometimes headlines alone aren’t descriptive enough, especially if you’re creating a huge guide.

I’ve tried out a few different methods and found that one of my favorite ways to start a guide is an introductory table of contents that mixed descriptions with links.

Need to get an social media case study chicago premium us letter size american You could also do this on a much smaller scale in a single blog post with the simple HTML code I mentioned can link to any point on a page pretty do so, just add an “id” tag to any HTML element (div, span, p, a, img, H2, H3, etc Best website to write a college social media case study professional US Letter Size British Business 69 pages / 18975 do so, just add an “id” tag to any HTML element (div, span, p, a, img, H2, H3, etc Help me write my custom communication strategies presentation confidentially A4 (British/European) single spaced Writing from scratch MLA.

Need to get an social media case study chicago premium us letter size american You could also do this on a much smaller scale in a single blog post with the simple HTML code I mentioned can link to any point on a page pretty do so, just add an “id” tag to any HTML element (div, span, p, a, img, H2, H3, etc Best website to write a college social media case study professional US Letter Size British Business 69 pages / 18975 do so, just add an “id” tag to any HTML element (div, span, p, a, img, H2, H3, etc.

Give Users Control Over Their Visit Then, I could link to it from anywhere in this post by referencing that id in a link (an tag): This link will take you tip 7 Create links for all the important areas of your post, and put them together in your intro as you see -based table of contents I came across this type of table of content recently, and I love it Get a case study social media ASA 11 days Writing A4 (British/European) Help me write my custom communication strategies presentation confidentially A4 (British/European) single spaced Writing from scratch MLA.Give Users Control Over Their Visit Then, I could link to it from anywhere in this post by referencing that id in a link (an tag): This link will take you tip 7 Create links for all the important areas of your post, and put them together in your intro as you see -based table of contents I came across this type of table of content recently, and I love it Get a case study social media ASA 11 days Writing A4 (British/European).Image-based table of contents I came across this type of table of content recently, and I love it.It’s a creative way to get the attention of your readers and direct them to the sections they’ll appreciate the most Get a case study social media ASA 11 days Writing A4 (British/European).It’s a creative way to get the attention of your readers and direct them to the sections they’ll appreciate the most.Here’s what it looks like: This would take some time to put together, using the link HTML code I showed you in option 2 and some CSS to get the layout/color correct /research-paper/ ’s what it looks like: This would take some time to put together, using the link HTML code I showed you in option 2 and some CSS to get the layout/color r, you could re-use it in the future with se alternative content formats I’m a big supporter of giving the reader ( you) as much control as ’re the only one who knows what you like the most and what you’re interested in.

On top of navigation options, you can also give your readers the choice of the format they want to consume your content in.A single topic could be covered in: an article (text/images) a slideshow If you plan ahead, you can create your article in more than one format before you publish allows readers to pick their favorite like to listen; others would rather read.Keep in mind that having content in multiple formats, also known as repurposing, can help expand your promotion options as , a small infographic in an article: Infographics don’t necessarily need to be as huge as standalone posts on Quick Sprout you do have a large infographic, you can also clip the relevant part to a section in your article and just include you haven’t seen, CopyBlogger has recently adopted podcasting like madmen! Almost all of their content is hosted on their new podcasting platform.The problem for them was that many of their visitors prefer to ering that a large part of their audience are writers, there’s a huge chunk that simply prefer addition, podcasting is a fairly slow format, which often takes 10 minutes to say what you could read in team at CopyBlogger anticipated this problem and decided to offer their content in two different can listen to the podcast as the first option, or you can read a well-formatted transcript below.Finally, you can also do the opposite, like we do on Crazy the content on the blog are traditional articles, which are published once every r, at the bottom of certain posts, there’s an opportunity to download a podcast version of the post (3-4 times a month).

Think about which formats work best for the topic you’re writing about and what your audiences can try out a few different formats over the course of a few months and then stick with the ones that perform the best.Read your visitor’s mind to ramp up results The eight tips above show you what you need to do, but not exactly how to do you really want to maximize the amount of time your readers spend consuming your content, you need to , come up with a hypothesis Always have a reason for including or changing something.I’d recommend starting by trying these tips on an older post that gets fairly steady traffic.You might want to start with adding a table of theory, for example, would be: a table of contents should prevent readers from missing what they’re looking , you need to test it You could simply make the change and compare your new results to old ones, but that isn’t the best y, you would use a tool like Optimizely to create 2 different pages (1 the same, 1 with a table of contents) and split traffic to each , look at the results After you’ve had a significant amount of traffic read the post, you need to look at the metrics you’re most interested in: average time on page pages per visit That’s how you determine if your change truly helped.A winning change should result in positive improvements in at least two of the three metrics above (ideally all three).

Not every test will win, and that’s why it’s important to keep testing new theories y, determine why you got the results you did This is the trickiest part, but it is essential to maximizing your engagement only way to determine the underlying reasons of why your results changed is to use heatmap software (obviously, I’m partial to Crazy Egg).You could use the software to look at: which percentage of readers used the table of contents how much attention was given to the table relative to surrounding text and elements (e., the sidebar) which table of content links were clicked the most Once you think you understand how the new modification affected your readers’ behavior, you can come up with a new your initial experiment already won, you can develop a theory on how to improve it further (split-test the size, color, or format, g never ends! Once your traffic reaches a high level, you can then hire a conversion rate optimization expert to execute all these steps for you.Apa writing style guide the learning center Conclusion The average time that a reader spends on your pages is one of the most important metrics for an online top of that, it’s one of the most important feedback mechanisms that lets you know if people are benefiting from your you use even a few of these nine formatting tips, you can more than double the average time on page for most blogs, which is huge Spacing, Layout and Title Please use double spacing and leave wide margins (at least 1 1/2 in.) on the left and right edgesReferencing Everything you quote from a primary or secondary source (books or articles you have read to prepare your essay) should be acknowledged (referenced).If you use even a few of these nine formatting tips, you can more than double the average time on page for most blogs, which is huge.Think about the difference that kind of engagement would provide, not just for a single post, but for every post you write in the future.Then, make a list of which of these tips you’d like to try in your next post so that you don’t forget.

I’d love it if you came back and let me know how it first, one more thing: I’d be really interested to find out which of these tips is the most useful or surprising for you /thesis/ first, one more thing: I’d be really interested to find out which of these tips is the most useful or surprising for let me know in the comments below advertising thesis Academic College Freshman 3 let me know in the comments : Essay formatting guidelines#permalink Show Tags 5 KUDOS This is just general advice that comes from years of experience of preparing documents for all sorts of different reasons, so take it and apply it / ignore it however you like.And of course, any SPECIFIC school requirements should naturally override anything I say in this : I'd stick to a sans-serif font (no little tails or embellishments like you see in Times New Roman).They're clean and I think more standard now when it comes to business or Calibri are pretty universal and often only time I'd muck with these is if I was try to take care of a widowed or orphaned part of the text (i.1 (or maybe 2) lines of a paragraph stuck alone on a page or or being chopped off at the lly the most sloppy looking case is when your last page is nothing but a line at the top (the ultimate widowed line).My style for paragraphs is to NOT indent and have paragraph breaks (like this post) as opposed to indenting with no breaks (like you'd find in a book).

Doing both indenting and breaking looks sloppy t wise: again, it's usually specified, But if it's loosely defined, YOU HAVE A HUGE out on a freakin' limb and write something a little funky if you have the writing aptitude to do so.I don't mean be stupid or pointlessly weird, but DO NOT just pump out the dry bullsh*t that you think that they want to g your accolades, interests, generic 's all crap and that's all what your resume will communicate (hopefully).I'm a firm believer that if you inject a bit of personality and creativity into an essay it will be NOTICED and REMEMBERED and your chances of landing that interview are so so so much better than the dude who did 10 points better on the GMAT and had .1 better GPA but their essay was a bunch of dry carbon copy that the adcom has heard time and time again for the past 18 years they've done this.When I did my essay I spoke about goals and stuff, but I also talked about my childhood, I talked about how my relationship was an important part of my life.

I spoke about how I was more of a nerd than a cool kid in were phrases like "Even at 22 years of age, if you put me in a room with Lego I'd make something just for fun." I ended it with "Wherever I end up, I plan to make a difference and to inspire those around me to make a difference as only question is if you'll join me along my way.I got the interview, I got accepted, best choice of my er that specific instruction from a school for their essays will override any advice ng their rules won't look too good unless you do it in an awesome AND are able to explain why you did looking at my essay, I actually used Indent, No Break style.Good luck!! Kudos ? : 43 5 , given: 8 +1 Kudos What is the ASA Citation Style? The ASA format is a citation style that has been widely adopted by the community of writers, researchers, publishers, and students who contribute scholarly papers to the field of is used by sociologists to credit other people’s words, ideas and theories utilized in their written work in a systematic and consistent manner.It is a parenthetical referencing style that adopts the author-date documentation system.

Get an social media case study double spaced 2 days formatting 2017 nbsp

This is an attractive format for sociologists because the absence of distracting footnotes makes it a highly economical and efficient way of consists of: In-text citations, which are inserted near the source and encloses both the author’s surname and the year of publication in parentheses A ‘ References’ section at the end of the paper that lists all of the sources cited in your work, and includes full publication information for each In short, an ASA in-text citation is used to draw the reader’s attention to where you have quoted or paraphrased a source within the citation includes the name of the author, publication date of the source and, where needed, the page numbers, for example: (Woolf, 2007).Subsequent references to the same source are still listed parenthetically by author and in-text citation must link to a reference list entry, and its purpose is to direct your reader there.Your reference list is an alphabetized list of fully-formatted citations, which will provide all of the information needed for your reader to locate the original emphasis on dates is carried over to the reference list, where the publication date is the first piece of information after the author’s format has many similarities to both the APA (American Psychological Association) style and the Chicago citation style; both in appearance and function 20 Apr 2011 - This resource covers American Sociological Association (ASA) style and includes information about manuscript formatting, in-text citations, formatting the   and the page of references, which follows a document, the ASA Style Guide also specifies a particular style of writing for presenting sociological work..Your reference list is an alphabetized list of fully-formatted citations, which will provide all of the information needed for your reader to locate the original emphasis on dates is carried over to the reference list, where the publication date is the first piece of information after the author’s format has many similarities to both the APA (American Psychological Association) style and the Chicago citation style; both in appearance and function.

Iirp graduate school writing apa style guidelines pdf However, there are some key differences so it is essential that you follow the ASA Style guide was primarily designed by the American Sociological Association to assist authors submitting articles to their journals, but it is now used by those preparing theses, dissertations, and other research papers.The style is supported by Cite This For Me’s citation management tool; making the ASA formatting of your in-text citations and reference list a straightforward task 15 Jul 2015 - From publishing posts that no one reads to posts that get thousands of views and hundreds of comments within a day.

Putting in timeDownload this cheat sheet about 9 formatting tactics that will double your readers' average time on page.I'm going toOption 2: Embedded social media thesis.I'm going toOption 2: Embedded social media.The style is supported by Cite This For Me’s citation management tool; making the ASA formatting of your in-text citations and reference list a straightforward task.

Cite This For Me’s Citation Generator & Guide Here at Cite This For Me we are committed to educating students in excellent citing style guide has been written to support anyone who is using the ASA style to cite their essay, research paper, or journal provides clear, useful guidance that covers in-text citations, the reference list, manuscript formatting, and much more I was wondering if anyone had general guidelines on how to format the essay.

Should each essay fit to 1 page? (if so can font size across different essays be different?) Double spacing? Margins? Should I include headers with my name? Also, I'd appreciate it if anyone have specific details about formatting.It provides clear, useful guidance that covers in-text citations, the reference list, manuscript formatting, and much ing to this style sheet will ensure you achieve consistency across your work, taking you one step further to getting the result that you deserve after all your hard work.Looking for a citation tool to save you time? Our open-access citation generator does just that, leaving you more time to spend on actually writing your can format ASA citations quickly, simply and smartly in the version of the style recognized by your institution using our multi-platform you need to cite a research paper using MLA formatting? Or has your professor asked you to use the APA citation format? You may be looking to instantly cite in the Chicago citation style, or just need to read up on how to create IEEE or AMA citations… There are thousands of referencing styles in use today, and the one that you need will depend on your discipline, college, professor, or the publication you are writing ver style you need, visit Cite This For Me's website to select from 1,000+ citation styles, including college variations of sign up to Cite This For Me for free, log-in to your account, and set your institution in ‘My Profile’.Check with your institution to find out which they want and make sure you follow their requirements exactly, as it’s what you’ll be marked ue reading this guide for practical advice and examples that will help you create each citation with more information on the mechanics of the style, in-depth guidance on the required writing style and further examples, we encourage you to refer to the complete ASA Style Guide (5th Edition).How do I Create and Format an In-text Citation? The ASA citation format follows the author-date system adopted by The Chicago Manual of Style: a brief in-text citation is inserted wherever a source is cited, and a complete list of references is included at the end of the use of in-text citations enables you to integrate source material into your work with ease, allowing you to effectively link your own ideas with those of other authors without interrupting the flow of your paper.

Remember that in-text citations are included in your final word in-text citation encloses the author’s last name and the year the source was published in parentheses, and is generally placed at the end of the sentence - or as close to the source as possible - between the last word and the more about creating your in-text citations on this quick tips style is essential that you cite each reference to another publication completely and accurately within the body of your work in order to avoid you have created and formatted an ASA in-text citation, we recommend checking it against the following list of examples for guaranteed accuracy: If the author's name is mentioned in the text, insert a parenthetical citation including the year of publication at the end of the sentence contends that this is not the case (1991).If the author's name is not mentioned in the text, enclose the author’s last name and year of publication in parentheses it has been argued that this was not the case (Welch 1991).Include page numbers within the citation when quoting directly from a source or referring to specific passages; pagination is separated by a colon and no spaces As tabulated by Kuhn (1970:71) the results show… is now the preferred method; previous forms such as (Kuhn 1970, p.71) are no longer accepted The following forms should be used for multiple authors: A recent study confirmed her belief (Johnson and Smith 1995:34).This was reinforced by recent research on the topic (Johnson, Smith, and Marcus 1999) If a work has et al.

’ translates as ‘ and others’; it is widely adopted by different citation styles in order to abbreviate long lists of author names within in-text term should never be used in a reference list, and should not be a work has more than three authors, use "et al." in the first ASA in-text citation, and in all subsequent citations This was not accurate according to a recent study (Johnson et multiple sources are cited for the same statement, the author and publication year should be distinguished from other texts with a the series in alphabetical or chronological order; this should be consistent throughout the paper Some studies have refuted these arguments (Benson 1993; Nguyen 1999; Brown and Goggans 2000).If a work cited has been reprinted, list the earliest publication date in brackets, followed by the most recent publication date … affected the aged (Omran 1971 2005).For unpublished materials, use ‘ forthcoming’ to indicate material scheduled for dissertations and unpublished papers, cite the date.(no date) in place of the date Previous studies by Smith (forthcoming) and Jones (N.

) concluded… For National Archives or other archival sources, use abbreviated citations in the text … (NA, RG 381, Box 780, April 28, 1965; Meany Archives, LRF, Box 6, March 18, 1970).If you are citing an e-resource it will generally follow the preceding guidelines, but you can find specific information in this guide’s section on: ‘Guidelines and Examples for Citing Electronic Resources’.Running out of time before a deadline? Creating each in-text citation by hand can be ’t forget, Cite This For Me's intuitive ASA citation machine will automate the citing process for you.Creating My Reference List As well as inserting in-text citations within the main body of your work, you will need to provide a comprehensive reference list that details exactly which sources you have drawn upon in your research and writing tely, a full and accurate reference list is essential because it allows your reader to easily locate and verify the source material you have parenthetical citation in the text must have a corresponding reference list entry, and vice er to double-check that none of your citations are missing from your reference list.Essay formatting guidelines the b school application gmat club These ASA formatting guidelines will help you compile your reference list: A reference list follows the text and footnotes on a separate page headed ‘References’ – use the first-level head format for the heading List all citations in alphabetical order by the first author’s last name Include the first names for all authors rather than their initials – unless the author used their initials in the original publication; in these cases, add a space between the initials Citations should be double-spaced, with double line spacing between each entry Do not use the ampersand (&) for and when including two names in a citation Add a comma between two or more author names – this is an update in the 5th edition of the style guide Capitalize all words except prepositions (e.

but, and, or) – only capitalize these exceptions if they begin the title or subtitle When including more than one work by the same author, include their full name in each citation – arrange these citations in chronological order, beginning with the earliest work If an author features in both a single-authored citation and as the first author in a multi-authored citation, place all of the single-authored ASA citations first, even though this may not be chronological Example: Hoge, Dean R."A Test of Theories of Denominational Growth and Decline Get custom writing assistance case study social media Academic American 89 pages / 24475 words Premium."A Test of Theories of Denominational Growth and Decline.179-197 in Understanding Church Growth and Decline 1950-1978, edited by D.New York and Philadelphia: Pilgrim Press FREE ASA Citation Machine Format Guide Cite This For Me.

New York and Philadelphia: Pilgrim Press.Vanishing Boundaries: The Religion of Mainline Baby Boomers.Louisville, KY: Westminster John Knox multiple authors, invert only the first author’s last name ( Jones, Arthur B.Smith, and James Petersen) - list in alphabetical order by author’s last name Do not use ‘ et al.’ in the reference list, unless the work was authored by a committee Distinguish works by the same author(s) in the same year by adding letters to the year ( 2002a, 2002b, 2002c) - list such works in alphabetical order by title Example: Creating Mental Illness.

“The Measurement of Mental Health Outcomes: Where Have We Been and Where Are We Going?” Journal of Health and Social Behavior 43(2): e the state abbreviation only if city of publication is not clear.For example, New York, Chicago, and Los Angeles do not need a state r, Cambridge should be followed by an appropriate state abbreviation or country the cited material is unpublished but has been accepted for publication, use Forthcoming in place of the date and give the name of the publisher or journal Depending on the nature of your work, and the preference of your tutor or publication to whom you are submitting your work, you may need to include a bibliography as well as a reference instance, if you are preparing a book-length manuscript it will add value to include a list of every relevant source you consulted whilst researching your examples that follow demonstrate common usages of different source types; adhere to these when creating your own reference list: Book with one on of publisher, state, or province postal code (or name of country if a foreign publisher) : Publisher’s Name.” Name of Publication (italicized) Colen, Cynthia G.“Addressing Racial Disparities in Health Using Life Course Perspectives.

View by presentations asa 2017 meeting on demand

“The Origins of Legacy Admissions: A Sociological Explanation.

” Review of Religious Research 52(3):233-47.Note: These examples include the issue number after the volume number of the journal; issue numbers should be included in ASA citations to make the source easier to issue numbers are used, they should be used throughout the reference rs in Books or Other Collected 1 (last name inverted) , and Author3 Where to order a presentation communication strategies American Editing Premium A4 (British/European).Note: These examples include the issue number after the volume number of the journal; issue numbers should be included in ASA citations to make the source easier to issue numbers are used, they should be used throughout the reference rs in Books or Other Collected 1 (last name inverted) , and Author3.

(with page numbers, elided) in Name of Publication (italicized) , edited by Editor1, Editor2, and Editor3 (use editors’ initials only for first/middle names, names not inverted) .Location of publisher, state, or province postal code (or name of country if a foreign publisher) : Publisher’s Name Writing Topic ASA Reference Guide Student Academic Success nbsp.Location of publisher, state, or province postal code (or name of country if a foreign publisher) : Publisher’s Name.“Early Life Conditions and Later Life Mortality Writing Topic ASA Reference Guide Student Academic Success nbsp.

“Early Life Conditions and Later Life Mortality.

187-206 in International Handbook of Adult Mortality, edited by R.George Meany Memorial Archives, Legislature Reference Files, Box 6.Memo, Conference with Gloster Current, Director of Organization, National Association for the Advancement of Colored People.Looking to cite another source type? Check out Section 4.2 in the ASA Style Guide: ‘Other Types of Reference Material’ for guidelines and examples on how to cite other types of instance; major reference books, dissertations and theses, unpublished papers magazine articles, book reviews and other peer-reviewed material, translations, government documents and presentations.

You can read more about creating a reference list on Bucknell University’s is a common mistake to leave your reference list until the very last minute, but Cite This For Me’s ASA citation machine will accurately write your entire list in just a few reference list is then stored in the cloud, ready for you to access online and copy straight into your ines and Examples for Citing Electronic Resources The publishing industry has continuously shifted and evolved in recent years, largely due to the emergence and integration of the internet and a diverse range of electronic resources.This has created new challenges for citation styles, and basic guidelines have now emerged in order to enable writers to document these new source types in their written work.The ASA style has based its guidelines for citing e-resources on Across all sociological disciplines, writers and researchers draw from a huge variety of online source types to support their own ideas; from websites and e-zines, to blogs, electronic mailing lists, machine-readable data files (MRDF), CD-ROM, DVD, and social media are a few points to bear in mind when citing e-resources: Include all of the basic elements of source information in the citation so that the reader can access the material with ease Sources that are unlikely to change (e.those in PDF or TIFF form, those accessed through JSTOR, exact replicas of the print version) should be cited in print-form Ensure that the source you are using will be accessible to your reader (e.

, look out for subscription based databases, access time limits and legal restrictions) Whenever possible include the author’s name, document title, date of publication (or retrieval date), and an address (e.

, URL or DOI) How do I Use a URL to Cite a Source? Uniform Resource Locator) is crucial for locating an online document.Best websites to order a custom social media case study confidentially business turabian proofreading standard However, websites can be regularly modified, updated, redesigned, or even removed, so it is crucial that you follow these steps when including a URL in your ASA sure to carefully check the spelling of a URL so that the source is accurately identified Avoid citing a source with a URL that no longer exists Do not type the URL address; copy and paste it directly from your browser into your work Print and save the data obtained from a URL in case the URL is modified and the information is lost If the URL has expired and you still need to cite the source, cite it as an unpublished paper in an archived collection Keep reading for a detailed list of examples that show you how best to cite electronic sources.If an e-book was consulted online, omit page numbers and include the URL and date of access If an e-book is available in more than one format, other formats may be listed as well - end the citation with: (Also available at: insert URL ) Young, T Best website to order an case study social media original double spaced A4 (British/European) CBE an e-book was consulted online, omit page numbers and include the URL and date of access If an e-book is available in more than one format, other formats may be listed as well - end the citation with: (Also available at: insert URL ) Young, T.Crime and Social Justice: Theory and Policy for the 21st Century.Retrieved June 22, 2010 ( /Red FEATHER/crime/ ) International Studies Association Formatting Policies.

The entire document, including footnotes but excluding figures and tables, must be one-and-a-half-.Primary and secondary text(1994) Social Network Analysis: Methods and Applications.

Retrieved June 22, 2010 ( /Red FEATHER/crime/ ).Printed edition of a book accessed through an online town, IL: University of Middletown ved April 6, 2011 ( /lib/collegestudies/ ?docID=1010101010).Online periodicals available in print & online form.“Relationship of Distress and Perceived Control to Coping with Perceived Racial Discrimination among Black Youth.

” Journal of Black Psychology 31(3): l articles (e-journals) with Digital Object Identifier (DOI).A DOI is a unique alphanumeric string assigned to a publication or other unit of intellectual a digital identifier it provides a means of looking up the current location of the source on the internet When a DOI is included, it should be cut and pasted directly from the article Persell, Caroline Hodges, Kathryn M.“How Sociological Leaders Teach: Some Key a general rule, if the website contains data or evidence essential to a point being addressed in the manuscript, it should be formally cited with the URL and date of access Document retrieved from an institution with a known : (ASA 2006) Citation: American Sociological Association.” Washington, DC: American Sociological nt retrieved from a corporate website (unknown location).” Retrieved July 25, 2014 ( /annualreport/2009/2009 ibm ).

When referring to a particular social media (e., Facebook, Twitter) posting within the text, it should be accompanied by a footnote in the main body of text rather than included in the reference list The footnote must include the page’s title, date accessed, and the URL Text: The American Sociological Association mentioned the meeting directly on its Facebook an Sociological Association’s Facebook page, accessed June 6, 2014, /AmericanSociologicalAssociation/posts/ es of how to cite a web log entry (also known as “blogs”), e-mail message, items in online databases, machine-readable data files and audiovisual materials (e., CD-ROM, DVD-ROM, podcast, PowerPoint presentation and sound recordings etc.) can be found in Section 5: Guidelines for Using Electronic Resources in the 5th edition of the ASA Style ASA Style Guide outlines a rigorous set of rules for organizing and presenting content in manuscripts and is crucial that you adhere to the style requirements, so make sure that your work is formatted in line with what is expected or you could be style requires that the following pages are included when you submit your manuscript: 1.Title Page Includes the full title of your paper, the author name(s), the author’s institution(s), a running head*, the total word count (including ASA citations and footnotes), and a title footnote An asterisk (*) after the title refers the reader to a title footnote at the bottom of the title must include the name and address of the corresponding author, additional acknowledgments (usually not necessary for papers submitted in a sociology class), and grant numbers *A Running Head is simply a shortened version of the work’s title (no more than 50 characters); this gives an idea of what your paper is about and helps to identify the pages of your paper so they are kept should be titled ‘Running head’ and appear in uppercase letters at the top left of each e of title page (American Sociological Association, p.

Appendixes This is your chance to add any supplementary, supporting material to the end of your work – generally explanatory, statistical, or bibliographic Consider adding an appendix as an alternative to a footnote or endnote If you are only including one appendix, title it le appendixes should be lettered (e., Appendix A, Appendix B) to differentiate them from numbered figures and tables 7.Tables, Figures, and Graphic Materials Tables Accompany each with a descriptive title so that the reader does not need to refer to the main body of text in order to understand it Tables should be numbered consecutively throughout the text, and each should be included on a separate page at the end of the paper Left-justify title above the table Include headings for all columns and rows, and use subheadings to separate different sections or clarify categories Gather general notes on the table under Notes or Sources beneath the table – use a, b, c etc.to add explanatory footnotes to the table, and list full citations for each data source in the reference list All text and data should fit vertically across two columns Find further details on the presentation of tables, alongside some demonstrative examples, in 4.Figures, Illustrations, and Photographs Visual art should only be included when it significantly contributes to the reader’s understanding of the paper – consider how much value a figure adds before including it in your work Number them consecutively throughout, and accompany each with a title and clear label Left-justify each figure caption and place below the figure Submit high-resolution images electronically in a single file Use black-and-white figures unless it affects clarity You must secure permission to publish a copyrighted figure, illustration or photograph More information on formatting graphs, charts, images and much more, can be found in Section 6: ‘Preparing and Submitting a Manuscript to an ASA Journal’ of the ASA Style Guide.

Subheadings Use subheadings to organize the main body of text – for a full-length article, three subheadings should suffice THIS IS A FIRST-LEVEL HEAD Capitalize the whole heading, left-justify, and don’t use a bold font Some journals do not indent the paragraph immediately following a first-level head This is a Second-Level Head Italicize, left-justify, and don’t use a bold font Capitalize all words except prepositions ( of, into, between, through), articles ( a, an, the), and coordinating conjunctions ( and, but, or) This is a third-level ize, left-justify, and don’t use a bold font Indent at the beginning of the paragraph, and follow with a period The paragraph continues immediately after the period Capitalize only the first letter of the first word and proper nouns Further ASA Formatting Guidelines: All text, tables and figures should be typeset and sized to fit the journal page dimension (smaller than regular letter-sized 8.

Chapter 1 manuscript preparation the acsess digital library

5” by 11” paper) When figures are sized down to fit on the page, all text in the figure must not be smaller than 8-point Arial font Block quotes may be single-spaced Avoid using space bars or indents to align the text or create hanging indents Use a hard return after the title of the article, the running head, and every paragraph, text heading, page heading, reference, and footnote Clearly and consistently presenting your work according to the style requirements will improve its readability and add to its overall professional finish.A Brief History of the Style The American Sociological Association was founded in 1905 and remains to this day the main scholarly organization for academic sociologists in the United nonprofit membership association is committed to supporting sociologists across the world and promoting their contribution to society.The association largely disseminates sociological knowledge through its scholarly publications American Sociological Association Style Guide Brandeis University.The association largely disseminates sociological knowledge through its scholarly publications.

Best website to purchase a college social media case study single spaced apa a4 (british/european) american The official journals are the American Sociological Review (ASR), which publishes high quality original work from sociologists, and Contemporary Sociology (CS), which prints reviews and critical discussions about contemporary t a unified citation and writing style, authors submitting to ASA publications were largely uninformed about style was widespread confusion amongst authors as to what the style actually entailed; this largely stemmed from its similarities with both The Chicago Manual of Style and the American Psychological Association style International Studies Association Formatting Policies General The was widespread confusion amongst authors as to what the style actually entailed; this largely stemmed from its similarities with both The Chicago Manual of Style and the American Psychological Association style.

In 1991 it was agreed that these issues needed to be tackled by offering authors and editors a set of formal style rules that specified both writing style and formatting standards.The first American Sociological Association Style Guide was published in 1996, with the hope of aiding those authors preparing manuscripts for journals as well as those adopting the ASA citation style Formatting a Research Paper in APA Style .Double-space all reference entries with one double space separating each entry.• The first line ofIIRP Graduate School Writing & APA Style Guidelines.International Institute for Restorative Practices.APA Publication Manual section first American Sociological Association Style Guide was published in 1996, with the hope of aiding those authors preparing manuscripts for journals as well as those adopting the ASA citation guide has evolved over the years to incorporate style revisions and guidelines for citing electronic sources Formatting a Research Paper in APA Style .

Double-space all reference entries with one double space separating each entry.• The first line ofIIRP Graduate School Writing & APA Style Guidelines.International Institute for Restorative Practices.

APA Publication Manual section guide has evolved over the years to incorporate style revisions and guidelines for citing electronic extensive ASA Style Guide outlines the structure and format of in-text citations, footnotes and reference instance, the 3rd edition expanded the guidelines on citing electronic publication sources, as well as providing illustrative 4th edition covered updates on online manuscript submission and changes made to citation formatting.The latest edition of the guide, and the one on which this style sheet is based, is the 5th edition has been updated to provide further information on grammar and writing style requirements, revisions to citation formatting, and expanded details on citing new sources such as social media have been two noteworthy changes made in the 5th edition: Author citation - when a citation has two authors, a comma must now follow the first author’s last name Issue number – it is recommended that you include the issue number when citing a journal article to make it easier for your reader to locate the source The ASA Style Guide is the definitive point of reference for all those that are writing, submitting, and editing manuscripts for ASA more guidance, visit their online resource – click on ‘Research & Publications’ followed by ‘Journals’ in order to find helpful writing tips.Why is Citing Important? Cite This For Me aims to empower students by elevating their research to the next level and educating them in how to avoid plagiarism.

We know that citing can be time-consuming and confusing, but it can mean the difference between reaching your scholarly goals and damaging your reputation amongst other ASA citation format is dedicated to complete and accurate author accreditation, and sets out its ethos in the ASA Code of Ethics section 14: (a) In publications, presentations, teaching, practice, and service, sociologists explicitly identify credit, and reference the author when they take data or material verbatim from another person’s written work, whether it is published, unpublished, or electronically available.(b) In their publications, presentations, teaching, practice, and service, sociologists provide acknowledgment of and reference to the use of other's work, even if the work is not quoted verbatim or paraphrased, and they do not present others’ work as their own whether it is published, unpublished, or electronically available.(American Sociological Association, 2014, p.3) Under the pressure of fast-approaching deadlines it is easy to slip up and inadvertently plagiarize your work; even something as small as leaving a citation out of your reference list, or including an incorrect publication date for a source, could affect your grade.It is unbelievably frustrating to miss out on valuable points because of something so simple yet so integral to academic success, so it is in your own interest to ensure you cite fully and if you are using our citation generator, it is important that you get to grips with the reasons why citing is essential as this will help you to naturally integrate the process into your y, every time you use someone else’s words, data that someone else has collected, or even paraphrase another author’s ideas (regardless of whether it is published, unpublished, or available online), you must appropriately cite the bottom line is, whenever information that you have used in your work has originated from somewhere else, it needs to be cited both in the text and in a reference only exception to this rule is common knowledge – e.

‘Barack Obama is the President of the United States’.You can regard something as common knowledge if you are certain that your reader will already know it, for instance; a fact or an everyday chers and writers must acknowledge their debts to their predecessors by carefully documenting each source they use in their work.If you are going to uphold your intellectual honesty, you’ll need to accurately signpost where you have drawn on someone else’s uting your research will serve to validate your own work by demonstrating that it is built upon a combination of appropriate academic reading and original have also created a checklist to use throughout your research and writing to avoid plagiarism: Plan – create a detailed plan before you start writing that includes all relevant content, as well as an outline of how you plan on structuring the paper Time management - make use of time plans and targets, and give yourself enough time to read, write and proofread Record sources – note down publication information for each source as you go, save each quote word-for-word, and place it in inverted commas to distinguish it from your own words Use your own words – this is particularly important to remember when paraphrasing information; your work must differ from the original text Save everything – store your research and citations in a safe you follow the style guidelines, and run any questions past your institution or publisher, it is unlikely that you will plagiarize.How do I Accurately Cite My Sources with Cite This For Me’s Citation Machine? Does it constantly feel like an uphill struggle to get your citations finished on time? Remove the stress of citing by using Cite This For Me’s state-of-the-art ASA citation the final moments before an important deadline, you can’t afford to waste time searching for page numbers or publication dates to complete your This For Me’s citation management tool will transform the way you conduct your up to Cite This For Me today to access this speedy and intuitive generator that will accurately format your citations in generator will create your citation in two parts; an in-text citation and a full reference that is ready to be copied straight into your reference list.Use the web tool to add and edit citations, export full projects and individual references, utilize the add-ons, and save all of your citations in the cloud so they don’t get the refolution and exceed your academic potential by citing unlimited source types with Cite This For Me; from PDF reports and unpublished work, to podcasts, musical scores, and Instagram posts.

Categories View By Presentations The AAN Annual Meeting On Demand media player features the following session presentations from the live conference.This comprehensive digital library delivers presenters’ slides with synchronized audio and the ability to see all embedded videos and mouse movements.Watch the presentations as if you were there attending the live sessions.Patient Activity of Daily Living for Amyotrophic Lateral Sclerosis Laura Herbelin Presentation Date: 4/24/2017 1:00:00 PM Session Title: Motor Neuron Diseases: Biomarkers, Outcome Measures, and Therapeutics Phenotypic heterogeneity in Italian patients with motor neuron disease Nicola Ticozzi Presentation Date: 4/24/2017 1:00:00 PM Session Title: Motor Neuron Diseases: Biomarkers, Outcome Measures, and Therapeutics Overview of Parkinson's Disease: Part I Hubert Fernandez Presentation Date: 4/22/2017 8:00:00 AM Session Title: Parkinson's Disease Update Overview of Parkinson's Disease: Part II Melissa Nirenberg Presentation Date: 4/22/2017 8:00:00 AM Session Title: Parkinson's Disease Update Challenging Demyelinating Disease Cases Stephen Krieger Presentation Date: 4/22/2017 8:00:00 AM Session Title: Multiple Sclerosis Essentials Excessive daytime sleepiness predicts increased -amyloid accumulation in non-demented elderly: a longitudinal PiB-PET study Diego Carvalho Presentation Date: 4/24/2017 1:00:00 PM Session Title: Highlights in Sleep Science Mortality and comorbidities in narcolepsy – an Olmsted County, Minnesota community-based study Alexander Cohen Presentation Date: 4/24/2017 1:00:00 PM Session Title: Highlights in Sleep Science Nonconvulsive and Unusual Forms of Status Epilepticus Frank Drislane Presentation Date: 4/22/2017 8:05:00 AM Session Title: Status Epilepticus Presentation Date: 4/22/2017 8:05:00 AM Session Title: Status Epilepticus Presentation Date: 4/24/2017 1:00:00 PM Session Title: Highlights in Sleep Science Time course for Phenoconversion to a Defined Neurodegenerative Disease in Women with Idiopathic REM Sleep Behavior Disorder with and without Antidepressant Use Grace Tabatabai Presentation Date: 4/24/2017 1:00:00 PM Session Title: Highlights in Sleep Science Treatment of Refractory Status Epilepticus Stephan Schuele Presentation Date: 4/22/2017 8:05:00 AM Session Title: Status Epilepticus Presentation Date: 4/28/2017 1:05:00 PM Session Title: Multiple Sclerosis: A Case-based Approach Refractory and Super-refractory Status Epilepticus Jan Claassen Presentation Date: 4/26/2017 1:05:00 PM Session Title: Neurological Intensive Care II: From the Brain to the Muscles Transforming Ideas and Problems into Researchable Questions Stuart Lubarsky Presentation Date: 4/26/2017 1:10:00 PM Session Title: An Introduction to Research in Medical Education A Pilot Study of Cognition in Veterans with Traumatic Brain Injury and Obstructive Sleep Apnea Lynn Kataria Presentation Date: 4/24/2017 1:00:00 PM Session Title: Highlights in Sleep Science Network Anatomy of Behavior William Seeley Presentation Date: 4/24/2017 1:05:00 PM Session Title: Behavioral Neurology I: Network Anatomy of Behavior and Language Research Methods 1: Qualitative Methodologies Aliki Thomas Presentation Date: 4/26/2017 1:10:00 PM Session Title: An Introduction to Research in Medical Education Research Methods 2: Quantitative Methodologies Meredith Young Presentation Date: 4/26/2017 1:10:00 PM Session Title: An Introduction to Research in Medical Education The Brain Sashank Prasad Session Title: Resident Basic Science I: Neuroanatomy: All the Lesions The Brainstem Raymond Price Session Title: Resident Basic Science I: Neuroanatomy: All the Lesions The Cerebellum and Spinal Cord Praveen Dayalu Presentation Date: 4/22/2017 8:05:00 AM Session Title: Resident Basic Science I: Neuroanatomy: All the Lesions Network Anatomy of Speech and Language Maria Gorno Tempini Presentation Date: 4/24/2017 1:05:00 PM Session Title: Behavioral Neurology I: Network Anatomy of Behavior and Language Understanding Your Revenues, Expenses, and Benchmarks to Increase Your Income Gregory Esper Presentation Date: 4/24/2017 1:05:00 PM Session Title: How to Run a Practice: Business Strategies for Neurology Private Practices, Academic Centers, and the Future Revenue Cycle Management: How to Make Money in Your Practice and Be a Doctor Brad Klein Presentation Date: 4/24/2017 1:05:00 PM Session Title: How to Run a Practice: Business Strategies for Neurology Private Practices, Academic Centers, and the Future Acute Meningitis Jennifer Lyons Session Title: Infections of the Nervous System II: Neuro-ID Emergencies Refractory Neuropathic Pain-Mitigating First-line Treatment Failures and Implementing Multimodal Treatments James Watson Presentation Date: 4/26/2017 1:10:00 PM Session Title: Core Concepts in Pain Management I: Refractory Neuropathic Pain Practical Pharmacologics, Advances in Neuromodulation, and a Balanced Look at Cannabinoids Neuromodulation-Evolving Technologies, Targets, and Uses Jason Eldrige Presentation Date: 4/26/2017 1:10:00 PM Session Title: Core Concepts in Pain Management I: Refractory Neuropathic Pain Practical Pharmacologics, Advances in Neuromodulation, and a Balanced Look at Cannabinoids The Peripheral Nervous System Zachary London Presentation Date: 4/22/2017 8:05:00 AM Session Title: Resident Basic Science I: Neuroanatomy: All the Lesions Social Cognitive and Affective Function: Behavior and Brain Systems Bradford Dickerson Presentation Date: 4/22/2017 8:10:00 AM Session Title: The Neurology of Social Behavior Cannabinoids: Fact or Fiction-A Balanced Look at Cannabinoid Usage for Neuropathic Pain Jacob Strand Presentation Date: 4/26/2017 1:10:00 PM Session Title: Core Concepts in Pain Management I: Refractory Neuropathic Pain Practical Pharmacologics, Advances in Neuromodulation, and a Balanced Look at Cannabinoids Diagnosis of Chronic Migraine Morris Levin Presentation Date: 4/26/2017 1:15:00 PM Session Title: Comprehensive Migraine Education Program I: Diagnosis, Risk Factors, and Neurobiology Encephalitis Arun Venkatesan Session Title: Infections of the Nervous System II: Neuro-ID Emergencies Social Cognition and Behavior in Neuropsychiatric Disorders Elizabeth Finger Presentation Date: 4/22/2017 8:10:00 AM Session Title: The Neurology of Social Behavior NMOSD: Pathogenesis and Clinical Diagnosis Brian Weinshenker Presentation Date: 4/22/2017 10:30:00 AM Session Title: Neuromyelitis Optica Spectrum Disorders Risk Factors and Prognosis of Chronic Migraine Gretchen Tietjen Presentation Date: 4/26/2017 1:15:00 PM Session Title: Comprehensive Migraine Education Program I: Diagnosis, Risk Factors, and Neurobiology Neurobiology of Chronic Migraine Stewart Tepper Presentation Date: 4/26/2017 1:15:00 PM Session Title: Comprehensive Migraine Education Program I: Diagnosis, Risk Factors, and Neurobiology NMOSD: Current and Emerging Therapies and Strategies Dean Wingerchuk Presentation Date: 4/22/2017 10:30:00 AM Session Title: Neuromyelitis Optica Spectrum Disorders Concussion: From Biology to Biomarkers of Concussion and Recovery/Progression Christopher Giza Presentation Date: 4/22/2017 10:30:00 AM Session Title: Concussion: From Mechanisms to Management Pathophysiology and Management of Post-traumatic Headache David Dodick Presentation Date: 4/22/2017 10:30:00 AM Session Title: Concussion: From Mechanisms to Management The Risk of Bias Gary Gronseth Presentation Date: 4/26/2017 3:30:00 PM Session Title: Bedside Evidence-based Medicine: How to Find and Deconstruct Articles in Order to Take Care of Patients II Exploring knowledge and attitudes regarding autosomal dominant Alzheimer disease among an at-risk population in Mexico Mellissa Withers Presentation Date: 4/26/2017 3:30:00 PM Session Title: Global Health Presentation Date: 4/22/2017 10:30:00 AM Session Title: Neurologic Complications of Medical Disease Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Laboratory Studies-Lessons for the Practicing Neurologist Eli Miloslavsky Presentation Date: 4/24/2017 1:05:00 PM Session Title: Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease I Neurologic Complications of Cardiac and Aortic Disease James Klaas Presentation Date: 4/22/2017 10:30:00 AM Session Title: Neurologic Complications of Medical Disease Stroke Mortality Outcomes in Uganda Sam Olum Presentation Date: 4/26/2017 3:30:00 PM Session Title: Global Health Use of a tablet-based epilepsy diagnosis app by computer-na ve health workers: Our experience in a tribal Indian community Mamta Singh Presentation Date: 4/26/2017 3:30:00 PM Session Title: Global Health Systemic Lupus Erythematosus, Sjogren's Disease, Antiphospholipid Antibody Syndrome, Mixed Connective Tissue Disease, and Rheumatoid Arthritis-Neurological Manifestations Shamik Bhattacharyya Presentation Date: 4/24/2017 1:05:00 PM Session Title: Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease I CNS Vasculitis and Mimics Rula Hajj-Ali Presentation Date: 4/24/2017 1:05:00 PM Session Title: Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease I Drug-resistant Epilepsy: What Is It? Who Has It? How to Treat It? Ellen Bubrick Presentation Date: 4/26/2017 3:30:00 PM Session Title: Treatments for Drug-resistant Epilepsy: An Update Surgical Management of Drug-resistant Focal Epilepsy Gregory Cascino Presentation Date: 4/26/2017 3:30:00 PM Session Title: Treatments for Drug-resistant Epilepsy: An Update What's in the Diagnosis: Seropositive, MuSK, and Seronegative Myasthenia Gravis Janice Massey Presentation Date: 4/22/2017 10:35:00 AM Session Title: Neuromuscular Junction Disorders I: Myasthenia Gravis, Ocular, and MuSK Myasthenia Treatment of Autoimmune Myasthenia Gravis: Evidence-based and New Developments Jeff Guptill Presentation Date: 4/22/2017 10:35:00 AM Session Title: Neuromuscular Junction Disorders I: Myasthenia Gravis, Ocular, and MuSK Myasthenia Horizontal Canal BPPV and Atypical Positional Vertigo Terry Fife Presentation Date: 4/24/2017 3:30:00 PM Session Title: Neuro-otology II: Diagnosis and Treatment of Nuanced Causes of Dizziness Stroke and Dizziness Kevin Kerber Presentation Date: 4/24/2017 3:30:00 PM Session Title: Neuro-otology II: Diagnosis and Treatment of Nuanced Causes of Dizziness MACRA Overview and AAN Response Gregory Esper Presentation Date: 4/22/2017 10:35:00 AM Session Title: Making Sure You Get Paid Under the New Health Care Laws Strategies for MACRA: Documentation and Population Management Eric Cheng Presentation Date: 4/22/2017 10:35:00 AM Session Title: Making Sure You Get Paid Under the New Health Care Laws Case Studies in Surgical Epilepsy G.Rees Cosgrove Presentation Date: 4/26/2017 3:30:00 PM Session Title: Treatments for Drug-resistant Epilepsy: An Update Diagnostic Approach to the Patient with Dysautonomia William Cheshire Presentation Date: 4/26/2017 3:30:00 PM Session Title: Evaluation and Management of Autonomic Disorders II: Diagnostic Approach and Treatments for Dysautonomia Treatments for Autonomic Failure and Dysautonomia Amanda Peltier Presentation Date: 4/26/2017 3:30:00 PM Session Title: Evaluation and Management of Autonomic Disorders II: Diagnostic Approach and Treatments for Dysautonomia Vestibular Migraine Robert Baloh Session Title: Neuro-otology II: Diagnosis and Treatment of Nuanced Causes of Dizziness Neurosarcoidosis, Pachymeningitis, Behcet's Disease Jeffrey Gelfand Presentation Date: 4/24/2017 3:30:00 PM Session Title: Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease II Using Axon Registry for Quality Reporting Lyell Jones Presentation Date: 4/22/2017 10:35:00 AM Session Title: Making Sure You Get Paid Under the New Health Care Laws Increased Intracranial Pressure, Tumors, and Vascular Disease J.

Clay Goodman Presentation Date: 4/22/2017 1:00:00 PM Session Title: Resident Basic Science II: Neuropathology Neuropsychiatry and Encephalitis Josep Dalmau Presentation Date: 4/26/2017 3:30:00 PM Session Title: Autoimmune Neurology II Advanced: Autoimmune Encephalitis at the Frontiers of Neuroscience Demyelinating, Toxic/Metabolic, Traumatic, and Infectious Disorders J.Clay Goodman Presentation Date: 4/22/2017 1:00:00 PM Session Title: Resident Basic Science II: Neuropathology Neurodegenerative Disorders Matthew Cykowski Session Title: Resident Basic Science II: Neuropathology Epilepsy and Encephalitis Maarten Titulaer Presentation Date: 4/26/2017 3:30:00 PM Session Title: Autoimmune Neurology II Advanced: Autoimmune Encephalitis at the Frontiers of Neuroscience Peripheral Nervous System Manifestations of Rheumatological and Systemic Inflammatory Disease: Vasculitic Neuropathies, Small Fiber Neuropathies, Sensory Neuropathies Kelly Gwathmey Presentation Date: 4/24/2017 3:30:00 PM Session Title: Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease II Vascular Cognitive Impairment/Dementia: Setting the Stage Larry Goldstein Presentation Date: 4/22/2017 2:00:00 PM Session Title: Vascular Cognitive Impairment and Dementia: Current Status and Future Brainstem Encephalitis and Myelitis Andrew McKeon Presentation Date: 4/26/2017 3:30:00 PM Session Title: Autoimmune Neurology II Advanced: Autoimmune Encephalitis at the Frontiers of Neuroscience Episodic Migraine and Episodic Syndromes Associated with Migraine Amy Gelfand Presentation Date: 4/24/2017 3:30:00 PM Session Title: Child Neurology III: Headache, TBI/Post-concussion Chronic Migraine and Other Daily Headache Disorders Kenneth Mack Presentation Date: 4/24/2017 3:30:00 PM Session Title: Child Neurology III: Headache, TBI/Post-concussion Assessment and Diagnosis of Patients with Suspected VCI/Dementia David Knopman Presentation Date: 4/22/2017 2:00:00 PM Session Title: Vascular Cognitive Impairment and Dementia: Current Status and Future Traumatic Brain Injury and Concussion Christopher Giza Presentation Date: 4/24/2017 3:30:00 PM Session Title: Child Neurology III: Headache, TBI/Post-concussion Treatment of Common Spine Disorders J.Bartleson Presentation Date: 4/24/2017 3:30:00 PM Session Title: Common Spine Disorders II: Treatment Difficult Cases and Clinical Pearls Josep Dalmau Presentation Date: 4/26/2017 3:30:00 PM Session Title: Autoimmune Neurology II Advanced: Autoimmune Encephalitis at the Frontiers of Neuroscience Current and Future Management of Patients with VCI/Dementia Gregory Jicha Presentation Date: 4/22/2017 2:00:00 PM Session Title: Vascular Cognitive Impairment and Dementia: Current Status and Future Interventional Spine Procedures Timothy Maus Presentation Date: 4/24/2017 3:30:00 PM Session Title: Common Spine Disorders II: Treatment Imaging of Spinal Infections and Inflammation Shamik Bhattacharyya Presentation Date: 4/26/2017 3:30:00 PM Session Title: Neuroimaging for the General Neurologist II: Spine and Peripheral Nerve Imaging of Spinal Tumors Jorg Dietrich Presentation Date: 4/26/2017 3:30:00 PM Session Title: Neuroimaging for the General Neurologist II: Spine and Peripheral Nerve Concussion Evaluation and Management: Pre-season, Sideline, and Office Amaal Starling Presentation Date: 4/22/2017 2:00:00 PM Session Title: Concussion: Evaluation and Management in the Acute and Chronic Phases Drug-induced Disorders Seen in the ICU Sara Hocker Presentation Date: 4/24/2017 3:30:00 PM Session Title: Drug-induced Neurologic Emergencies Case 1 Valerie Biousse Session Title: Neuro-ophthalmology III: Diplopia, Ocular Motility Disorders, and Nystagmus Those Other Causes of Diplopia Nancy Newman Presentation Date: 4/26/2017 3:30:00 PM Session Title: Neuro-ophthalmology III: Diplopia, Ocular Motility Disorders, and Nystagmus Concussion: Vestibular Evaluation and Treatment Jamie Bogle Presentation Date: 4/22/2017 2:00:00 PM Session Title: Concussion: Evaluation and Management in the Acute and Chronic Phases Case 2 Valerie Biousse Session Title: Neuro-ophthalmology III: Diplopia, Ocular Motility Disorders, and Nystagmus Supranuclear and Internuclear Ocular Motility Disorders Steven Galetta Presentation Date: 4/26/2017 3:30:00 PM Session Title: Neuro-ophthalmology III: Diplopia, Ocular Motility Disorders, and Nystagmus Drug-induced Movement Disorder Emergencies Joseph Matsumoto Presentation Date: 4/24/2017 3:30:00 PM Session Title: Drug-induced Neurologic Emergencies Neurotoxicology and Neurologic Emergencies Michel Toledano Presentation Date: 4/24/2017 3:30:00 PM Session Title: Drug-induced Neurologic Emergencies Case 3 Valerie Biousse Session Title: Neuro-ophthalmology III: Diplopia, Ocular Motility Disorders, and Nystagmus Nystagmus Steven Galetta Session Title: Neuro-ophthalmology III: Diplopia, Ocular Motility Disorders, and Nystagmus Concussion: Cognitive Evaluation and Treatment Jennifer Wethe Presentation Date: 4/22/2017 2:00:00 PM Session Title: Concussion: Evaluation and Management in the Acute and Chronic Phases Congenital Anomalies of Pediatric Neuroimaging Jennifer McVige Presentation Date: 4/24/2017 3:30:00 PM Session Title: Neuroimaging for the General Neurologist II: Brain and Spine Imaging of Patients with Headache and Other Common Outpatient Complaints: When, Why, What? Dara Jamieson Presentation Date: 4/24/2017 3:30:00 PM Session Title: Neuroimaging for the General Neurologist II: Brain and Spine Case 4 Nancy Newman Session Title: Neuro-ophthalmology III: Diplopia, Ocular Motility Disorders, and Nystagmus Assorted Cases Valerie Biousse Session Title: Neuro-ophthalmology III: Diplopia, Ocular Motility Disorders, and Nystagmus How Is Your Patient Really Doing? Patient-Reported Scales and Tools Lisa Shulman Presentation Date: 4/22/2017 2:00:00 PM Session Title: How Is Your Patient Really Doing? Patient-Reported Scales, Tools, and Shared Decision Making Shared Decision-making Tools Anna Hohler Presentation Date: 4/22/2017 2:00:00 PM Session Title: How Is Your Patient Really Doing? Patient-Reported Scales, Tools, and Shared Decision Making Emergency and Critical Care Neuroimaging Joshua Klein Presentation Date: 4/24/2017 3:30:00 PM Session Title: Neuroimaging for the General Neurologist II: Brain and Spine The Early Development of Child Neurology at Boston City Hospital N.Paul Rosman Presentation Date: 4/24/2017 3:30:00 PM Session Title: Boston City Hospital: The Cradle of American Neurology Part II Presentation of Quality and Safety Award Anant Shenoy Presentation Date: 4/22/2017 2:00:00 PM Session Title: How Is Your Patient Really Doing? Patient-Reported Scales, Tools, and Shared Decision Making Neurologic Complications of Cardiac Surgeries and Procedures Sara Hocker Presentation Date: 4/22/2017 2:00:00 PM Session Title: Neurologic Complications of Medical and Surgical Therapies Neuro-oncology Amy Pruitt Session Title: Continuum Test Your Knowledge: A Multiple-choice Question Review II Multiple Sclerosis Stephen Krieger Session Title: Continuum Test Your Knowledge: A Multiple-choice Question Review II Norman Geschwind and the Rebirth of Behavioral Neurology Kenneth Heilman Presentation Date: 4/24/2017 3:30:00 PM Session Title: Boston City Hospital: The Cradle of American Neurology Part II What Makes a Headache a Neurologic Emergency? Calli Cook Presentation Date: 4/26/2017 3:30:00 PM Session Title: Clinical Neurology for Advanced Practice Providers II Neurologic Complications of Critical Care Christopher Kramer Presentation Date: 4/22/2017 2:00:00 PM Session Title: Neurologic Complications of Medical and Surgical Therapies Anatomy and Neuropathology at Boston City Hospital Jeremy Schmahmann Presentation Date: 4/24/2017 3:30:00 PM Session Title: Boston City Hospital: The Cradle of American Neurology Part II An Update in Multiple Sclerosis Bryan Walker Presentation Date: 4/26/2017 3:30:00 PM Session Title: Clinical Neurology for Advanced Practice Providers II Neurologic Complications of Drug Therapies Sara Hocker Presentation Date: 4/22/2017 2:00:00 PM Session Title: Neurologic Complications of Medical and Surgical Therapies The Cocoanut Grove Nightclub Disaster of 1942: Alexandra Adler's Seminal Work on Visual Agnosia and PTSD Steven Sparr Presentation Date: 4/24/2017 3:30:00 PM Session Title: Boston City Hospital: The Cradle of American Neurology Part II Clinical Features and Classification of the Dystonias Daniel Tarsy Presentation Date: 4/24/2017 3:30:00 PM Session Title: The Dystonias: Diagnosis, Treatment, and Update on Causes Specific human antisense oligonucleotide (ASO) targeting TGF- RII rescues proliferation of TGF- arrested human neuronal progenitor cells (ReNcell CX) Tim-Henrik Bruun Presentation Date: 4/26/2017 3:30:00 PM Session Title: Neuroscience in the Clinic: Functional Recovery in Neurology and Neuroscience Promoting network recovery after traumatic brain injury: exploring the targeted application of transcranial direct current stimulation Lucia M Li Presentation Date: 4/26/2017 3:30:00 PM Session Title: Neuroscience in the Clinic: Functional Recovery in Neurology and Neuroscience It's a Bird, It's a Plane, It's the Doctor Who Cured My Benign Paroxysmal Positional Vertigo Kevin Kerber Presentation Date: 4/22/2017 2:00:00 PM Session Title: It's a Bird, It's a Plane, It's the Doctor Who Cured My Benign Paroxysmal Positional Vertigo Application of Positional Testing and Treatment Kevin Kerber Presentation Date: 4/22/2017 2:00:00 PM Session Title: It's a Bird, It's a Plane, It's the Doctor Who Cured My Benign Paroxysmal Positional Vertigo The Medical and Surgical Treatment of Dystonia Samuel Frank Presentation Date: 4/24/2017 3:30:00 PM Session Title: The Dystonias: Diagnosis, Treatment, and Update on Causes Toxins and Disorders of Neuromuscular Transmission Laura Tormoehlen Presentation Date: 4/22/2017 2:05:00 PM Session Title: Neuromuscular Junction Disorders II: Toxins, Lambert-Eaton Syndrome and Less Common Disorders of Neuromuscular Transmission Lambert-Eaton Syndrome and the Less Common Disorders of Neuromuscular Transmission Robert Pascuzzi Presentation Date: 4/22/2017 2:05:00 PM Session Title: Neuromuscular Junction Disorders II: Toxins, Lambert-Eaton Syndrome and Less Common Disorders of Neuromuscular Transmission Retinal Nerve Fiber Layer Thickness defines Multiple Sclerosis Patients at Risk of Future Disease Progression Peter Calabresi Presentation Date: 4/26/2017 3:30:00 PM Session Title: Progressive MS Therapeutics Efficacy Results from the Phase 2b SYNERGY Study: Treatment of Disabling Multiple Sclerosis with the Anti-LINGO-1 Monoclonal Antibody Opicinumab Peter Calabresi Presentation Date: 4/26/2017 3:30:00 PM Session Title: Progressive MS Therapeutics Pathophysiology and Etiology of Dystonia Rachel Saunders-Pullman Presentation Date: 4/24/2017 3:30:00 PM Session Title: The Dystonias: Diagnosis, Treatment, and Update on Causes Development of a sensitive Outcome for Economical Drug Screening for Progressive Multiple Sclerosis Peter Kosa Presentation Date: 4/26/2017 3:30:00 PM Session Title: Progressive MS Therapeutics The Association Between Confirmed Disability Progression and Patient-Reported Fatigue in PPMS Patients in the ORATORIO study J.

Wollinsky Presentation Date: 4/26/2017 3:30:00 PM Session Title: Progressive MS Therapeutics Unicorns, Dragons, Polymyositis, and Other Mythological Beasts: The Truth About Polymyositis Tahseen Mozaffar Presentation Date: 4/24/2017 3:30:00 PM Session Title: Clinical Approach to Muscle Disease II: Inflammatory Myopathies and Muscle Pathology Lysosomal Proteins as a Therapeutic Target in Neurodegeneration Dimitri Krainc Presentation Date: 4/22/2017 5:00:00 PM Session Title: Hot Topics Plenary Session Antisense Oligonucleotide Treatment (ASO) and SMA: Results of Clinical Trials Claudia Chiriboga Presentation Date: 4/22/2017 5:00:00 PM Session Title: Hot Topics Plenary Session Role of Muscle Biopsy in Muscle Disorders Margherita Milone Presentation Date: 4/24/2017 3:30:00 PM Session Title: Clinical Approach to Muscle Disease II: Inflammatory Myopathies and Muscle Pathology Safety and Tolerability of Siponimod in Patients with Secondary Progressive Multiple Sclerosis: Robert Fox Presentation Date: 4/26/2017 3:30:00 PM Session Title: Progressive MS Therapeutics Long-term Outcomes in Patients with Progressive MS with Relapses: Analysis of TEMSO and TOWER Extension Data Flavia Nelson Presentation Date: 4/26/2017 3:30:00 PM Session Title: Progressive MS Therapeutics How to Cool in the ICU Neeraj Badjatia Presentation Date: 4/24/2017 3:30:00 PM Session Title: Therapeutic Temperature Modulation in the ICU Comparing the healthcare utilization and direct medical costs in newly diagnosed epilepsy patients and a comparator non-epilepsy population: a US database analysis Edward Faught Presentation Date: 4/26/2017 3:30:00 PM Session Title: Epilepsy and Clinical Neurophysiology (EEG) II Laser Interstitial Thermal Therapy (LITT) outcomes for intractable epilepsy Scheherazade Le Presentation Date: 4/26/2017 3:30:00 PM Session Title: Epilepsy and Clinical Neurophysiology (EEG) II TTM for Cardiac Arrest Stephan Mayer Presentation Date: 4/24/2017 3:30:00 PM Session Title: Therapeutic Temperature Modulation in the ICU The Role of CNS-draining Lymphatics in Neurological Diseases Jonathan Kipnis Presentation Date: 4/22/2017 5:00:00 PM Session Title: Hot Topics Plenary Session Population-based Comprehensive Epilepsy Care in Ontario, Canada: A Model Network O.Snead Presentation Date: 4/22/2017 5:00:00 PM Session Title: Hot Topics Plenary Session Use of sEMG to inform GTC seizure semiology Jose E.Cavazos Presentation Date: 4/26/2017 3:30:00 PM Session Title: Epilepsy and Clinical Neurophysiology (EEG) II High-resolution intracranial recordings provide direct electrophysiological evidence for music and speech-selective neural populations in human auditory cortex Jenelle Feather Presentation Date: 4/26/2017 3:30:00 PM Session Title: Epilepsy and Clinical Neurophysiology (EEG) II Introduction and the Importance of Lifestyle Larry Goldstein Presentation Date: 4/23/2017 7:00:00 AM Session Title: Cerebrovascular Disease I: Prevention Statins for Primary and Secondary Stroke Prevention Larry Goldstein Presentation Date: 4/23/2017 7:00:00 AM Session Title: Cerebrovascular Disease I: Prevention TTM for Fever Control David Greer Presentation Date: 4/24/2017 3:30:00 PM Session Title: Therapeutic Temperature Modulation in the ICU TTM for Trauma and ICP Neeraj Badjatia Presentation Date: 4/24/2017 3:30:00 PM Session Title: Therapeutic Temperature Modulation in the ICU Passive Functional Mapping of Language Areas Using Electrocorticographic Signals in Humans James Swift Presentation Date: 4/26/2017 3:30:00 PM Session Title: Epilepsy and Clinical Neurophysiology (EEG) II Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy Baibing Chen Presentation Date: 4/26/2017 3:30:00 PM Session Title: Epilepsy and Clinical Neurophysiology (EEG) II Emerging Indications: Stroke and Status David Greer Presentation Date: 4/24/2017 3:30:00 PM Session Title: Therapeutic Temperature Modulation in the ICU Carotid Revascularization for Stroke Prevention Seemant Chaturvedi Presentation Date: 4/23/2017 7:00:00 AM Session Title: Cerebrovascular Disease I: Prevention Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation Karen Furie Presentation Date: 4/23/2017 7:00:00 AM Session Title: Cerebrovascular Disease I: Prevention Association of Hippocampal CA3 Transcriptional Modules with Language Impairment in Mesial Temporal Lobe Epilepsy Joao Mansano-Oliveira Presentation Date: 4/26/2017 3:30:00 PM Session Title: Epilepsy and Clinical Neurophysiology (EEG) II PET Staging of Brain Amyloidosis Using Striatum Bernard Hanseeuw Presentation Date: 4/26/2017 3:30:00 PM Session Title: Aging and Dementia: Neuroimaging in Neurodegenerative Diseases Overview: Genetic Discoveries and Technological Advances Across Neurology Matthew Harms Presentation Date: 4/23/2017 7:00:00 AM Session Title: Advances in Neurogenetics Focus Topic I: Genetic Advances in Movement Disorders Christine Klein Presentation Date: 4/23/2017 7:00:00 AM Session Title: Advances in Neurogenetics Prognostication in the Era of TTM Stephan Mayer Presentation Date: 4/24/2017 3:30:00 PM Session Title: Therapeutic Temperature Modulation in the ICU 18F-AV-1451 in frontotemporal dementia spectrum disorders Richard Tsai Presentation Date: 4/26/2017 3:30:00 PM Session Title: Aging and Dementia: Neuroimaging in Neurodegenerative Diseases Brain tissue metabolites on baseline MRS are associated with greater-amyloid accumulation rate from serial PET in clinically normal older adults Zuzana Nedelska Presentation Date: 4/26/2017 3:30:00 PM Session Title: Aging and Dementia: Neuroimaging in Neurodegenerative Diseases Reduced emotional sensitivity and responsiveness measured by the Revised Self-Monitoring Scale is a behavioral marker of early salience network dysfunction in neurodegenerative disease Gianina Toller Presentation Date: 4/26/2017 3:30:00 PM Session Title: Aging and Dementia: Neuroimaging in Neurodegenerative Diseases Alzheimer′s Disease: 3-Dimensional MRI-texture for Prediction of Conversion from Mild Cognitive Impairment Collin Luk Presentation Date: 4/26/2017 3:30:00 PM Session Title: Aging and Dementia: Neuroimaging in Neurodegenerative Diseases Early Life Stress Increases Susceptibility to Cortical Spreading Depression and Anxiety in Rodents Stuart Collins Presentation Date: 4/24/2017 3:30:00 PM Session Title: Invited Science: Headache Posttraumatic Headache Five Years after Traumatic Brain Injury Sylvia Lucas Presentation Date: 4/24/2017 3:30:00 PM Session Title: Invited Science: Headache Focus Topic II: The Genetics of Inherited and Acquired Myopathy Namita Goyal Presentation Date: 4/23/2017 7:00:00 AM Session Title: Advances in Neurogenetics Introduction to Cases and Format Bradley Vaughn Presentation Date: 4/23/2017 7:00:00 AM Session Title: Using Sleep Medicine to Help Solve Difficult Neurologic Cases Case 2: Mimics and Variants Dean Wingerchuk Presentation Date: 4/28/2017 1:05:00 PM Session Title: Multiple Sclerosis: A Case-based Approach I Can't Sleep - Epilepsy and Daily Headache Bradley Vaughn Presentation Date: 4/23/2017 7:00:00 AM Session Title: Using Sleep Medicine to Help Solve Difficult Neurologic Cases Dementia Incidence and Predictors in Cerebral Amyloid Angiopathy Patients without Intracerebral Hemorrhage Li Xiong Presentation Date: 4/26/2017 3:30:00 PM Session Title: Aging and Dementia: Neuroimaging in Neurodegenerative Diseases Intracranial arterial blood flow in individuals with Mild Cognitive Impairment (MCI) is associated with cognitive performance and amyloid positivity Sara Berman Presentation Date: 4/26/2017 3:30:00 PM Session Title: Aging and Dementia: Neuroimaging in Neurodegenerative Diseases The Sleepy Patient with Neuromuscular Disease Michael Silber Presentation Date: 4/23/2017 7:00:00 AM Session Title: Using Sleep Medicine to Help Solve Difficult Neurologic Cases Epidemiology of Migraine in Men: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study Ann Scher Presentation Date: 4/24/2017 3:30:00 PM Session Title: Invited Science: Headache Perspectives of Adolescents on the Burden of their Parent’s Migraine: Results from the Chronic Migraine Epidemiology and Outcomes Study Richard Lipton Presentation Date: 4/24/2017 3:30:00 PM Session Title: Invited Science: Headache National Patterns of Carotid Revascularization in the Pre- and Post- Carotid Revascularization Endarterectomy vs.Awadh Kishor Pandit Presentation Date: 4/26/2017 3:30:00 PM Session Title: Cerebrovascular Disease and Interventional Neurology: Epidemiology Secular trends of ALS incidence in an Italian population-based register, 1995-2014: evidence for a cohort effect in women Adriano Chio Presentation Date: 4/24/2017 3:30:00 PM Session Title: Neuroepidemiology Presentation Date: 4/24/2017 3:30:00 PM Session Title: Neuroepidemiology Presentation Date: 4/23/2017 7:00:00 AM Session Title: Child Neurology: A Case-based Approach Encephalitis Avindra Nath Session Title: Differential Diagnosis of Neurologic Infections Critical Care Management of Acute Ischemic Stroke Wade Smith Presentation Date: 4/26/2017 3:35:00 PM Session Title: Neurological Intensive Care III: Vascular Diseases Neurocritical Care of Subarachanoid Hemorrhage Michael Diringer Presentation Date: 4/26/2017 3:35:00 PM Session Title: Neurological Intensive Care III: Vascular Diseases Chronic Meningitis Israel Steiner Session Title: Differential Diagnosis of Neurologic Infections Myelitis Marie Grill Session Title: Differential Diagnosis of Neurologic Infections Is Epilepsy the Diagnosis? Case Studies and Videos Tracey Milligan Presentation Date: 4/23/2017 7:00:00 AM Session Title: Clinical Epilepsy I: Basics Risk Factors for Pregnancy-Associated Stroke in Women with Preeclampsia: a Case-Control Study Eliza Miller Presentation Date: 4/24/2017 3:30:00 PM Session Title: Neuroepidemiology Presentation Date: 4/24/2017 3:30:00 PM Session Title: Neuroepidemiology Presentation Date: 4/26/2017 3:35:00 PM Session Title: Neurological Intensive Care III: Vascular Diseases Biomarkers in Alzheimer's Disease Beau Ances Presentation Date: 4/26/2017 3:35:00 PM Session Title: Biomarkers in Dementia Genetic descriptors of a multiple sclerosis cohort Noriko Isobe Presentation Date: 4/24/2017 3:30:00 PM Session Title: MS Characterizations and Tools for Measurement A Global Epidemiological Forecast of Multiple Sclerosis and Disease Subtypes Sunali Goonesekera Presentation Date: 4/24/2017 3:30:00 PM Session Title: MS Characterizations and Tools for Measurement Psychiatric Co-morbidities: What All Neurologists Need to Know in the Management of the Seizure Disorder Andres Kanner Presentation Date: 4/23/2017 7:00:00 AM Session Title: Clinical Epilepsy I: Basics Individualizing AED Choices Jacqueline French Presentation Date: 4/23/2017 7:00:00 AM Session Title: Clinical Epilepsy I: Basics Biomarkers in Frontotemporal Dementia and Dementia with Lewy Body Murray Grossman Presentation Date: 4/26/2017 3:35:00 PM Session Title: Biomarkers in Dementia Biomarkers in Rapidly Progressive Dementia Gregory Day Presentation Date: 4/26/2017 3:35:00 PM Session Title: Biomarkers in Dementia Progressive degeneration of RNFL and GCL is seen in pediatric MS in comparison to monophasic demyelination and controls Giulia Longoni Presentation Date: 4/24/2017 3:30:00 PM Session Title: MS Characterizations and Tools for Measurement Sample sizes and clinical relevance of MS-specific atrophy markers: A comprehensive, unbiased, simulation-based method accounting for normal aging Christina Azevedo Presentation Date: 4/24/2017 3:30:00 PM Session Title: MS Characterizations and Tools for Measurement Biomarkers in Vascular Dementia Rebecca Gottesman Presentation Date: 4/26/2017 3:35:00 PM Session Title: Biomarkers in Dementia Opioids: Pharmacology, Indications, Patient Selection, and Appropriate Use Jason Eldrige Presentation Date: 4/26/2017 3:40:00 PM Session Title: Core Concepts in Pain Management II: Safe Opioid Prescribing Practical Considerations, Unintended Consequences, and Legal Issues Mitigating Unintended Opioid Consequences-Safe Prescribing, Adverse Effects (Including Hypothalamic-Pituitary-Gonadal/Adrenal, Bone, and OIH), and Monitoring James Watson Presentation Date: 4/26/2017 3:40:00 PM Session Title: Core Concepts in Pain Management II: Safe Opioid Prescribing Practical Considerations, Unintended Consequences, and Legal Issues Legal Issues in Opioid Prescribing Joanne Martin Presentation Date: 4/26/2017 3:40:00 PM Session Title: Core Concepts in Pain Management II: Safe Opioid Prescribing Practical Considerations, Unintended Consequences, and Legal Issues Behavioral and Psychological Aspects of Migraine Dawn Buse Presentation Date: 4/26/2017 3:45:00 PM Session Title: Comprehensive Migraine Education Program II: Behavioral and Psychological Aspects, Preventative Pharmacology, and Treatment Advances Ofatumumab versus teriflunomide in relapsing MS: adaptive design of two Phase 3 studies (ASCLEPIOS I and ASCLEPIOS II) Stephen L Hauser Presentation Date: 4/24/2017 3:30:00 PM Session Title: MS Characterizations and Tools for Measurement Microstructural Deterioration in Multiple Sclerosis Patients Meeting Criteria for “no evidence of disease activity”: Correlations with Clinical Variables Asaff Harel Presentation Date: 4/24/2017 3:30:00 PM Session Title: MS Characterizations and Tools for Measurement Advanced Evaluation and Management (E&M) Coding Peter Donofrio Presentation Date: 4/23/2017 7:00:00 AM Session Title: Advanced Neurologic Coding Case 3: Treatment Options Robert Fox Presentation Date: 4/28/2017 1:05:00 PM Session Title: Multiple Sclerosis: A Case-based Approach Preventive Medications for Chronic Migraine Elizabeth Loder Presentation Date: 4/26/2017 3:45:00 PM Session Title: Comprehensive Migraine Education Program II: Behavioral and Psychological Aspects, Preventative Pharmacology, and Treatment Advances Advanced Coding for Neurophysiologic Testing Neil Busis Presentation Date: 4/23/2017 7:00:00 AM Session Title: Advanced Neurologic Coding Upper Cervical Cord Area Atrophy for Clinical Trials in Multiple Sclerosis Esha Datta Presentation Date: 4/24/2017 3:30:00 PM Session Title: MS Characterizations and Tools for Measurement Circulating microRNAs are associated with acute inflammation in patients with multiple sclerosis.

Maria Antonietta Mazzola Presentation Date: 4/24/2017 3:30:00 PM Session Title: MS Characterizations and Tools for Measurement Coding and Billing Guidlines for Infusion Services Christine Mann Presentation Date: 4/23/2017 7:00:00 AM Session Title: Advanced Neurologic Coding Advances in Acute Treatment of Migraine Gretchen Tietjen Presentation Date: 4/26/2017 3:45:00 PM Session Title: Comprehensive Migraine Education Program II: Behavioral and Psychological Aspects, Preventative Pharmacology, and Treatment Advances Approaching the Patient with Vision Loss Heather Moss Presentation Date: 4/23/2017 7:00:00 AM Session Title: Emergency Room Neuro-ophthalmology Examining the Ocular Fundus and Interpreting What You See Beau Bruce Presentation Date: 4/23/2017 7:00:00 AM Session Title: Emergency Room Neuro-ophthalmology MS Pathogenesis Olaf Stuve Session Title: Multiple Sclerosis Overview: Basic and Translational Science Mechanism of MS Therapies and Their Use Michael Racke Presentation Date: 4/27/2017 7:00:00 AM Session Title: Multiple Sclerosis Overview: Basic and Translational Science ATXN2 antisense therapy improves SCA2 mouse motor and Purkinje cell electrophysiological phenotypes.Xavier Guell Presentation Date: 4/24/2017 3:30:00 PM Session Title: Behavioral and Cognitive Neurology Cingulo-Insular Structural Alterations Associated with Psychogenic Symptoms, Childhood Abuse and PTSD in Functional Neurological Disorders David Perez Presentation Date: 4/24/2017 3:30:00 PM Session Title: Behavioral and Cognitive Neurology Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease Laurie Robak Presentation Date: 4/23/2017 8:00:00 AM Session Title: Best Of Session: Parkinson's Disease Neuropathic Gaucher’s Mutations: Shifting Parkinson’s Into High Gear Ganqiang Liu Presentation Date: 4/23/2017 8:00:00 AM Session Title: Best Of Session: Parkinson's Disease Secondary Paroxysmal Dyskinesias Kapil Sethi Presentation Date: 4/27/2017 7:00:00 AM Session Title: Paroxysmal Movement Disorders Peripheral Neuropathy-Overview of Anatomy and Pathology Steven Scherer Presentation Date: 4/27/2017 7:00:00 AM Session Title: Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies Discovery and systematic functional validation of Parkinson’s disease genes from exome sequencing Joshua Shulman Presentation Date: 4/23/2017 8:00:00 AM Session Title: Best Of Session: Parkinson's Disease The role of habenula and amygdala in Parkinson’s disease patients with punding Elisa Canu Presentation Date: 4/23/2017 8:00:00 AM Session Title: Best Of Session: Parkinson's Disease Negotiating with Payers Brad Klein Presentation Date: 4/24/2017 3:35:00 PM Session Title: Business Strategies for Payer Negotiations and/or How to Go off the Grid Transitioning Without Payers-Where to Begin Daryl Story Presentation Date: 4/24/2017 3:35:00 PM Session Title: Business Strategies for Payer Negotiations and/or How to Go off the Grid Diagnosis and Treatment of Acquired Demyelinating Neuropathies Richard Lewis Presentation Date: 4/27/2017 7:00:00 AM Session Title: Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies Questions and Answers/Case Presentations Richard Lewis Presentation Date: 4/27/2017 7:00:00 AM Session Title: Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies Growing a Successful Practice without Payers Peter McAllister Presentation Date: 4/24/2017 3:35:00 PM Session Title: Business Strategies for Payer Negotiations and/or How to Go off the Grid Memory: Systems, Abilities, and Deficits Bradford Dickerson Presentation Date: 4/24/2017 3:35:00 PM Session Title: Behavioral Neurology II: Memory and Praxis Presidential Lecture Terrence Cascino Session Title: Presidential Plenary Session H.Houston Merritt Lecture: Ophthalmoscopy in the 21st Century Nancy Newman Presentation Date: 4/23/2017 9:30:00 AM Session Title: Presidential Plenary Session Two Routes to Skilled Action in the Healthy and Damaged Brain Laurel Buxbaum Presentation Date: 4/24/2017 3:35:00 PM Session Title: Behavioral Neurology II: Memory and Praxis Infectious Causes of Stroke Kiran Thakur Presentation Date: 4/24/2017 3:35:00 PM Session Title: Infections of the Nervous System III: Advanced Topics in Infectious Neurology Sleep Apnea Assessment: Tools, Tricks, and Tips Douglas Kirsch Presentation Date: 4/27/2017 7:05:00 AM Session Title: Interpreting Sleep Study Procedure(s), Data, and Reports: What the Non-sleep Specialist Needs to Know Central Hypersomnia and REM Behavioral Sleep Disorder: Making Sense of the Sleep Study Reports Rachel Marie Salas Presentation Date: 4/27/2017 7:05:00 AM Session Title: Interpreting Sleep Study Procedure(s), Data, and Reports: What the Non-sleep Specialist Needs to Know Nervous System Lyme Disease - What It Is, What It Isn't John Halperin Presentation Date: 4/24/2017 3:35:00 PM Session Title: Infections of the Nervous System III: Advanced Topics in Infectious Neurology Sidney Carter Award in Child Neurology: Improving Outcomes in Childhood Epilepsy J.Helen Cross Presentation Date: 4/23/2017 9:30:00 AM Session Title: Presidential Plenary Session Robert Wartenberg Lecture: How Early Can We Diagnose Alzheimer's Disease? Ronald Petersen Presentation Date: 4/23/2017 9:30:00 AM Session Title: Presidential Plenary Session Your Sleepless Patient: Making Sense of the Procedural and Wearable Options Charlene Gamaldo Presentation Date: 4/27/2017 7:05:00 AM Session Title: Interpreting Sleep Study Procedure(s), Data, and Reports: What the Non-sleep Specialist Needs to Know Frontiers of Mechanical Thrombectomy in Acute Stroke Hesham Masoud Presentation Date: 4/27/2017 7:05:00 AM Session Title: Stroke Team Action Therapy (STAT): Current State of the Art and New Frontiers Therapeutic Management of Recurrent Stroke in Patients with PFO and Additional Vascular Risk Factors Steven Messe Presentation Date: 4/27/2017 7:05:00 AM Session Title: Stroke Team Action Therapy (STAT): Current State of the Art and New Frontiers Update in Epilepsy Gregory Bergey Presentation Date: 4/23/2017 1:00:00 PM Session Title: Neurology Update I: Epilepsy, Headache, and Neurologic Infections Program Director Breakout Session I B: Career Development for Program Directors Zachary London Presentation Date: 4/24/2017 4:00:00 PM Session Title: Clerkship and Program Directors Conference: Wellness and Burnout During Training Program Director Breakout Session II B: Barriers to Effective Implementation of a Residency Curriculum David Gordon Presentation Date: 4/24/2017 4:00:00 PM Session Title: Clerkship and Program Directors Conference: Wellness and Burnout During Training Neuromuscular Case: Errors in Diagnosis-What, Why, and How? Pushpa Narayanaswami Presentation Date: 4/27/2017 7:10:00 AM Session Title: Cognitive Psychology of Neurologic Errors: Why Do Neurologists Make Errors? Update in Headache Christopher Boes Presentation Date: 4/23/2017 1:00:00 PM Session Title: Neurology Update I: Epilepsy, Headache, and Neurologic Infections Cognitive-behavioral Case and Discussion Daniel Press Presentation Date: 4/27/2017 7:10:00 AM Session Title: Cognitive Psychology of Neurologic Errors: Why Do Neurologists Make Errors? Cerebrovascular Case: System of Diagnosis and Discussion Louis Caplan Presentation Date: 4/27/2017 7:10:00 AM Session Title: Cognitive Psychology of Neurologic Errors: Why Do Neurologists Make Errors? Clerkship Directors: Introduction to ReBoot Camp Joseph Safdieh Presentation Date: 4/24/2017 4:00:00 PM Session Title: Clerkship and Program Directors Conference: Wellness and Burnout During Training Clerkship Director Breakout Session I B: Blended Learning Joseph Safdieh Presentation Date: 4/24/2017 4:00:00 PM Session Title: Clerkship and Program Directors Conference: Wellness and Burnout During Training Update in Neurologic Infections Kenneth Tyler Presentation Date: 4/23/2017 1:00:00 PM Session Title: Neurology Update I: Epilepsy, Headache, and Neurologic Infections Clerkship Director Breakout Session II B: Faculty Development Charlene Gamaldo Presentation Date: 4/24/2017 4:00:00 PM Session Title: Clerkship and Program Directors Conference: Wellness and Burnout During Training Clerkship Directors: Debrief Joseph Safdieh Presentation Date: 4/24/2017 4:00:00 PM Session Title: Clerkship and Program Directors Conference: Wellness and Burnout During Training Mitochondrial Biology Eric Schon Session Title: Mitochondrial Disorders in Neurology Mitochondrial Diseases Michio Hirano Session Title: Mitochondrial Disorders in Neurology Treatment of Mitochondrial Diseases Salvatore DiMauro Presentation Date: 4/27/2017 7:10:00 AM Session Title: Mitochondrial Disorders in Neurology Migraine Headache Lawrence Newman Presentation Date: 4/23/2017 1:00:00 PM Session Title: Introduction to Primary Headache Disorders I: Migraine and Other Primary Headaches Including Tension-type, Hypnic, Primary Stabbing, and Nummular Headache Syndromes Clerkship Director Breakout Session I A: Curriculum Development Ralph Jozefowicz Presentation Date: 4/24/2017 4:05:00 PM Session Title: Clerkship and Program Directors Conference: Wellness and Burnout During Training Clerkship Director Breakout Session II A: Assessment of Student Clinical Skills Ann Poncelet Presentation Date: 4/24/2017 4:05:00 PM Session Title: Clerkship and Program Directors Conference: Wellness and Burnout During Training 2016 WHO CNS Tumor Classification Updates and Genetic Syndromes Pearls John Henson Presentation Date: 4/27/2017 7:10:00 AM Session Title: Basic Principles of Brain Tumors: For Practice and for Certification Neurosurgical and Radiation-oncology Management Jeffrey Weinberg Presentation Date: 4/27/2017 7:10:00 AM Session Title: Basic Principles of Brain Tumors: For Practice and for Certification Other Primary Headache Syndromes Deborah Friedman Presentation Date: 4/23/2017 1:00:00 PM Session Title: Introduction to Primary Headache Disorders I: Migraine and Other Primary Headaches Including Tension-type, Hypnic, Primary Stabbing, and Nummular Headache Syndromes Neuro-oncology and Symptom Management Erin Dunbar Presentation Date: 4/27/2017 7:10:00 AM Session Title: Basic Principles of Brain Tumors: For Practice and for Certification In vivo two-photon calcium imaging of excitatory pyramidal neurons and inhibitory fast-spiking parvalbumin-positive interneurons during temperature-induced seizures in a mouse model of Dravet syndrome Conny Tran Presentation Date: 4/27/2017 8:00:00 AM Session Title: Best Of Session: Epilepsy Cases Enrique Alvarez Session Title: Case Studies: Multiple Sclerosis Neuroimaging Cases I Joseph Masdeu Presentation Date: 4/24/2017 6:00:00 PM Session Title: Test Your Knowledge: A Case-based Approach to Neuroimaging Frontotemporal Dementia and Primary Progressive Aphasia Gil Rabinovici Presentation Date: 4/23/2017 1:00:00 PM Session Title: Non-Alzheimer's Dementia I: Frontotemporal Dementias and Chronic Traumatic Encephalopathy A Checklist for Neuroimaging James Smirniotopoulos Presentation Date: 4/24/2017 6:00:00 PM Session Title: Test Your Knowledge: A Case-based Approach to Neuroimaging Chronic Traumatic Encephalopathy Andrew Budson Presentation Date: 4/23/2017 1:00:00 PM Session Title: Non-Alzheimer's Dementia I: Frontotemporal Dementias and Chronic Traumatic Encephalopathy Neuroimaging Cases II Joshua Klein Presentation Date: 4/24/2017 6:00:00 PM Session Title: Test Your Knowledge: A Case-based Approach to Neuroimaging Neuroimaging Cases III Joseph Masdeu Presentation Date: 4/24/2017 6:00:00 PM Session Title: Test Your Knowledge: A Case-based Approach to Neuroimaging Electrodiagnostic Approach to Neuromuscular Junction Testing Vern Juel Presentation Date: 4/23/2017 1:00:00 PM Session Title: Clinical EMG II: Neuromuscular Junction Testing and Quantitative EMG Seizure triggers in epilepsy patients: a national perspective Anjie Ge Presentation Date: 4/27/2017 8:00:00 AM Session Title: Best Of Session: Epilepsy The Importance of Family Planning as a Determinant of Spontaneous Fetal Loss in Women with Epilepsy: Findings of the Epilepsy Birth Control Registry Andrew Herzog Presentation Date: 4/27/2017 8:00:00 AM Session Title: Best Of Session: Epilepsy Neuroimaging Cases IV James Smirniotopoulos Presentation Date: 4/24/2017 6:00:00 PM Session Title: Test Your Knowledge: A Case-based Approach to Neuroimaging Quantitative EMG Mark Bromberg Session Title: Clinical EMG II: Neuromuscular Junction Testing and Quantitative EMG Video Cases Alberto Espay Session Title: Case Studies: Unusual Movement Disorders Unusual Case Studies in Neuromuscular Disorders Muhammad Al-Lozi Presentation Date: 4/24/2017 6:00:00 PM Session Title: Case Studies: Unusual Diagnostic and Management of Cases in Neuromuscular Disease Extrapolation of efficacy data from adults with primary generalized tonic-clonic seizures (PGTC) to pediatric patients: a meta-analysis of published clinical trials Douglas Nordli Presentation Date: 4/27/2017 8:00:00 AM Session Title: Best Of Session: Epilepsy No: Is Focused Ultrasound Better Than Deep Brain Stimulation? Michael Okun Presentation Date: 4/27/2017 9:15:00 AM Session Title: Controversies in Neurology Plenary Session Introduction to Study Design/Case-Control Studies Deborah Hall Presentation Date: 4/23/2017 1:00:00 PM Session Title: Introduction to Clinical Research and Methods Case Studies in Coma and Brain Death David Greer Presentation Date: 4/24/2017 6:00:00 PM Session Title: Case Studies in the ICU Case Studies in Epilepsy and Status Epilepticus Julie Roth Presentation Date: 4/24/2017 6:00:00 PM Session Title: Case Studies in the ICU Yes: Is Focused Ultrasound Better Than Deep Brain Stimulation? Paul Fishman Presentation Date: 4/27/2017 9:15:00 AM Session Title: Controversies in Neurology Plenary Session No: Should Disease-modifying Therapies Be Stopped in Progressive MS? Robert Naismith Presentation Date: 4/27/2017 9:15:00 AM Session Title: Controversies in Neurology Plenary Session Cohort Studies Alexander Pantelyat Session Title: Introduction to Clinical Research and Methods Case Studies in Neuromuscular Disorders in the ICU Nicholas Silvestri Presentation Date: 4/24/2017 6:00:00 PM Session Title: Case Studies in the ICU Cases for Discussion Kathleen Digre Presentation Date: 4/24/2017 6:05:00 PM Session Title: Case Studies: Challenging Headache Cases Clinical Trial Design Gary Gronseth Presentation Date: 4/23/2017 1:00:00 PM Session Title: Introduction to Clinical Research and Methods Yes: Should Disease-modifying Therapies Be Stopped in Progressive MS? John Corboy Presentation Date: 4/27/2017 9:15:00 AM Session Title: Controversies in Neurology Plenary Session No: Does Removal of Amyloid Improve Cognition in Alzheimer's Disease? George Perry Presentation Date: 4/27/2017 9:15:00 AM Session Title: Controversies in Neurology Plenary Session Yes: Does Removal of Amyloid Improve Cognition in Alzheimer's Disease? Reisa Sperling Presentation Date: 4/27/2017 9:15:00 AM Session Title: Controversies in Neurology Plenary Session Excitatory CXCR4/SDF-1 signaling and calcium overload in Nav1.

Best website to buy a custom communication strategies presentation 58 pages / 15950 words one hour premium us letter size

8 nociceptors are responsible for small fiber degeneration in Painful Diabetic Neuropathy Nirupa Jayaraj Presentation Date: 4/27/2017 1:00:00 PM Session Title: Pain and Palliative Care Introduction to Biostatistics Jordan Elm Presentation Date: 4/23/2017 1:00:00 PM Session Title: Introduction to Clinical Research and Methods Numbness, Memory Loss, and Hearing Loss Neill Graff-Radford Presentation Date: 4/24/2017 6:05:00 PM Session Title: Case Studies: Dementia A Treatable Cause of MCI Ronald Petersen Presentation Date: 4/24/2017 6:05:00 PM Session Title: Case Studies: Dementia Memory Loss and Abnormal Movements Jody Corey-Bloom Presentation Date: 4/24/2017 6:05:00 PM Session Title: Case Studies: Dementia Hippocampal atrophy in older adults with chronic pain is associated with higher levels of depressive symptoms Ali Ezzati Presentation Date: 4/27/2017 1:00:00 PM Session Title: Pain and Palliative Care Mexiletine for the treatment of muscle cramps in ALS: a randomized double-blind crossover trial Bjorn Oskarsson Presentation Date: 4/27/2017 1:00:00 PM Session Title: Pain and Palliative Care Immunomodulation Versus Immunosuppression: Mechanism of Action of Multiple Sclerosis Drugs Scott Zamvil Presentation Date: 4/23/2017 1:00:00 PM Session Title: Multiple Sclerosis Therapy: Disease-modifying Treatment I Considering DMT: Escalation, Induction, Sequencing and Exit Strategy Timothy West Presentation Date: 4/23/2017 1:00:00 PM Session Title: Multiple Sclerosis Therapy: Disease-modifying Treatment I Walking and Memory Difficulty Neill Graff-Radford Presentation Date: 4/24/2017 6:05:00 PM Session Title: Case Studies: Dementia Behavioral and Gait Changes Jody Corey-Bloom Presentation Date: 4/24/2017 6:05:00 PM Session Title: Case Studies: Dementia An Unusual Case Ronald Petersen Presentation Date: 4/24/2017 6:05:00 PM Session Title: Case Studies: Dementia An Approach to Functional Movement Disorders Anthony Lang Presentation Date: 4/27/2017 1:00:00 PM Session Title: Functional Neurologic Disorders I: Movement, Non-epileptic Seizures, and MS-like Disorders An Approach to Functional (Psychogenic Nonepileptic) Seizures W.LaFrance Presentation Date: 4/27/2017 1:00:00 PM Session Title: Functional Neurologic Disorders I: Movement, Non-epileptic Seizures, and MS-like Disorders Audience Cases and Other Faculty Cases Jody Corey-Bloom Presentation Date: 4/24/2017 6:05:00 PM Session Title: Case Studies: Dementia Seizure Semiology Andreas Alexopoulos Session Title: Case Studies: How to Analyze Spells by Video-EEG Evidence-based Diagnosis and Management of Intraparenchymal Hemorrhage Venkatesh Aiyagari Presentation Date: 4/23/2017 1:00:00 PM Session Title: Cerebrovascular Disease II: Hemorrhagic Stroke An Approach to Functional Disorders Misdiagnosed as Multiple Sclerosis Andrew Solomon Presentation Date: 4/27/2017 1:00:00 PM Session Title: Functional Neurologic Disorders I: Movement, Non-epileptic Seizures, and MS-like Disorders Multiple Sclerosis and Related Autoimmune CNS Disorders Dean Wingerchuk Presentation Date: 4/27/2017 1:00:00 PM Session Title: Therapy in Neurology I: Multiple Sclerosis and Headache Headache David Dodick Session Title: Therapy in Neurology I: Multiple Sclerosis and Headache Evaluation of Pediatric Spells in the EMU Tobias Loddenkemper Presentation Date: 4/24/2017 6:15:00 PM Session Title: Case Studies: How to Analyze Spells by Video-EEG Evaluation of Adult Spells in the EMU Amy Crepeau Presentation Date: 4/24/2017 6:15:00 PM Session Title: Case Studies: How to Analyze Spells by Video-EEG Evidence-based Diagnosis and Management of Aneurysmal Subarachnoid Hemorrhage Sean Ruland Presentation Date: 4/23/2017 1:00:00 PM Session Title: Cerebrovascular Disease II: Hemorrhagic Stroke Management of Fatigue, Sleep Disorders, and Spasticity in MS Jonathan Carter Presentation Date: 4/25/2017 7:00:00 AM Session Title: Multiple Sclerosis Therapy: Symptom Management Management of Ambulatory Dysfunction in MS Michelle Cameron Presentation Date: 4/25/2017 7:00:00 AM Session Title: Multiple Sclerosis Therapy: Symptom Management Aspirin: Benefits and Bleeding Risks Philip Gorelick Presentation Date: 4/23/2017 1:00:00 PM Session Title: Cerebrovascular Disease II: Hemorrhagic Stroke MS Diagnosis and Classification Myla Goldman Presentation Date: 4/27/2017 1:00:00 PM Session Title: Multiple Sclerosis Overview I: Clinical Pearls MRI and MS: Is a Picture Worth a Thousand Words? Scott Newsome Presentation Date: 4/27/2017 1:00:00 PM Session Title: Multiple Sclerosis Overview I: Clinical Pearls Medical Problems Arising During the Course of Tumor Treatment Jaishri Blakeley Presentation Date: 4/23/2017 1:00:00 PM Session Title: Case Studies: Neurologic Consultations in Cancer Patients I Diagnostic Dilemmas David Schiff Session Title: Case Studies: Neurologic Consultations in Cancer Patients I Management of GU Dysfunction: When MS Hits Below the Belt Barbara Giesser Presentation Date: 4/25/2017 7:00:00 AM Session Title: Multiple Sclerosis Therapy: Symptom Management Introduction to Nystagmus and Saccadic Intrusions Janet Rucker Presentation Date: 4/25/2017 7:00:00 AM Session Title: Nystagmus and Saccadic Intrusions Made Simple Introduction to Cortical Visual Disorders Sashank Prasad Presentation Date: 4/27/2017 1:00:00 PM Session Title: Higher Cortical Visual Disorders: Case-based Review Summary Marc Dinkin Session Title: Higher Cortical Visual Disorders: Case-based Review Nystagmus Marc Dinkin Session Title: Nystagmus and Saccadic Intrusions Made Simple Saccadic Intrusions Janet Rucker Session Title: Nystagmus and Saccadic Intrusions Made Simple Self-test and Cases Steven Galetta Presentation Date: 4/25/2017 7:00:00 AM Session Title: Nystagmus and Saccadic Intrusions Made Simple Tumor Board: Eight Important Diagnoses for the Consulting Neurologist Amy Pruitt Presentation Date: 4/23/2017 1:00:00 PM Session Title: Case Studies: Neurologic Consultations in Cancer Patients I Navigating the World of Mobile Health Eric Anderson Presentation Date: 4/23/2017 1:00:00 PM Session Title: Navigating the World of Mobile Health Chorea Steven Frucht Session Title: Hyperkinetic Movement Disorders: Videodiagnosis and Treatment Dystonia Steven Frucht Session Title: Hyperkinetic Movement Disorders: Videodiagnosis and Treatment Anatomical Network Degeneration in Primary Progressive Aphasia John Medaglia Presentation Date: 4/23/2017 1:00:00 PM Session Title: Neuroscience in the Clinic: Neurobiology and Treatment of Disorders of Language and Action Characterization of Primary Progressive Aphasia and Prediction of Naming Decline by Multi-Modality MRI Andreia Faria Presentation Date: 4/23/2017 1:00:00 PM Session Title: Neuroscience in the Clinic: Neurobiology and Treatment of Disorders of Language and Action Myoclonus Steven Frucht Session Title: Hyperkinetic Movement Disorders: Videodiagnosis and Treatment Unusual Movement Disorders Steven Frucht Presentation Date: 4/27/2017 1:00:00 PM Session Title: Hyperkinetic Movement Disorders: Videodiagnosis and Treatment Comparison of MRI Dissemination in Space Criteria for Predicting a First Clinical Event in Children with the Radiologically Isolated Syndrome Naila Makhani Presentation Date: 4/23/2017 1:00:00 PM Session Title: Neuroimaging in MS Longitudinal Assessment of Cervical Cord Atrophy Across MS Clinical Phenotypes: A Multicenter Study Maria A.Rocca Presentation Date: 4/23/2017 1:00:00 PM Session Title: Neuroimaging in MS The Use of Clinical Exome Sequencing in the Diagnosis of Neurologic Disease Brent Fogel Presentation Date: 4/25/2017 7:00:00 AM Session Title: Principles of Genomic Medicine: Clinical Exome Sequencing in Neurologic Disease Atrophy of spinal cord gray matter is detectable at an early stage of multiple sclerosis Regina Schlaeger Presentation Date: 4/23/2017 1:00:00 PM Session Title: Neuroimaging in MS Thalamic MRI and histopathologic correlations in advanced multiple sclerosis Kedar Mahajan Presentation Date: 4/23/2017 1:00:00 PM Session Title: Neuroimaging in MS Case 1: Stroke in Pregnancy Steven Feske Presentation Date: 4/27/2017 1:00:00 PM Session Title: Neurologic Case Studies in Pregnancy I: Stroke and Headache In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis Tobias Granberg Presentation Date: 4/23/2017 1:00:00 PM Session Title: Neuroimaging in MS Structural Connectivity Shapes Patterns of Cortical Atrophy in Multiple Sclerosis Kevin Patel Presentation Date: 4/23/2017 1:00:00 PM Session Title: Neuroimaging in MS Medicolegal and Ethical Issues in Clinical Exome Sequencing Wayne Grody Presentation Date: 4/25/2017 7:00:00 AM Session Title: Principles of Genomic Medicine: Clinical Exome Sequencing in Neurologic Disease Discussion - Case 1: Stroke in Pregnancy Aneesh Singhal Presentation Date: 4/27/2017 1:00:00 PM Session Title: Neurologic Case Studies in Pregnancy I: Stroke and Headache Case Presentations and Examples of Clinical Interpretation of Exome Sequencing Results Brent Fogel Presentation Date: 4/25/2017 7:00:00 AM Session Title: Principles of Genomic Medicine: Clinical Exome Sequencing in Neurologic Disease Prevalence of Leptomeningeal Contract Enhancement in Multiple Sclerosis Versus Other Chronic Neuroinflammatory Diseases Martina Absinta Presentation Date: 4/23/2017 1:00:00 PM Session Title: Neuroimaging in MS Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Post-Contrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis Deepa Ramasamy Presentation Date: 4/23/2017 1:00:00 PM Session Title: Neuroimaging in MS Introduction and Epidemiology Aneesh Singhal Presentation Date: 4/25/2017 7:00:00 AM Session Title: Stroke in Young Adults and Women Case 2: Stroke in Pregnancy Aneesh Singhal Presentation Date: 4/27/2017 1:00:00 PM Session Title: Neurologic Case Studies in Pregnancy I: Stroke and Headache Postnatal CRISPR-mediated genome editing prolongs survival in a mouse model of amyotrophic lateral sclerosis Zachary Kennedy Presentation Date: 4/23/2017 1:00:00 PM Session Title: ALS: Disease Mechanism and Therapeutics Plasma Neurofilament Heavy Chain Levels correlate with disease severity and progression on multiple clinical outcomes in Amyotrophic Lateral Sclerosis (ALS) Steve Han Presentation Date: 4/23/2017 1:00:00 PM Session Title: ALS: Disease Mechanism and Therapeutics Cerebral Arteriopathies Aneesh Singhal Session Title: Stroke in Young Adults and Women Discussion - Case 2: Stroke in Pregnancy Steven Feske Presentation Date: 4/27/2017 1:00:00 PM Session Title: Neurologic Case Studies in Pregnancy I: Stroke and Headache Case 1: Headache in Pregnancy Paul Mathew Presentation Date: 4/27/2017 1:00:00 PM Session Title: Neurologic Case Studies in Pregnancy I: Stroke and Headache Distinct patterns of disease progression in SOD1-associated familial ALS: A study of 25 mutations 9 Dec 2017 - Help me with an case study social media high quality cbe graduate academic american; 9 formatting tactics that will double your readers average time on nbsp   turabian proofreading standard; Best website to purchase a college social media case study single spaced apa a4 (british/european) american  .Rocca Presentation Date: 4/23/2017 1:00:00 PM Session Title: Neuroimaging in MS The Use of Clinical Exome Sequencing in the Diagnosis of Neurologic Disease Brent Fogel Presentation Date: 4/25/2017 7:00:00 AM Session Title: Principles of Genomic Medicine: Clinical Exome Sequencing in Neurologic Disease Atrophy of spinal cord gray matter is detectable at an early stage of multiple sclerosis Regina Schlaeger Presentation Date: 4/23/2017 1:00:00 PM Session Title: Neuroimaging in MS Thalamic MRI and histopathologic correlations in advanced multiple sclerosis Kedar Mahajan Presentation Date: 4/23/2017 1:00:00 PM Session Title: Neuroimaging in MS Case 1: Stroke in Pregnancy Steven Feske Presentation Date: 4/27/2017 1:00:00 PM Session Title: Neurologic Case Studies in Pregnancy I: Stroke and Headache In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis Tobias Granberg Presentation Date: 4/23/2017 1:00:00 PM Session Title: Neuroimaging in MS Structural Connectivity Shapes Patterns of Cortical Atrophy in Multiple Sclerosis Kevin Patel Presentation Date: 4/23/2017 1:00:00 PM Session Title: Neuroimaging in MS Medicolegal and Ethical Issues in Clinical Exome Sequencing Wayne Grody Presentation Date: 4/25/2017 7:00:00 AM Session Title: Principles of Genomic Medicine: Clinical Exome Sequencing in Neurologic Disease Discussion - Case 1: Stroke in Pregnancy Aneesh Singhal Presentation Date: 4/27/2017 1:00:00 PM Session Title: Neurologic Case Studies in Pregnancy I: Stroke and Headache Case Presentations and Examples of Clinical Interpretation of Exome Sequencing Results Brent Fogel Presentation Date: 4/25/2017 7:00:00 AM Session Title: Principles of Genomic Medicine: Clinical Exome Sequencing in Neurologic Disease Prevalence of Leptomeningeal Contract Enhancement in Multiple Sclerosis Versus Other Chronic Neuroinflammatory Diseases Martina Absinta Presentation Date: 4/23/2017 1:00:00 PM Session Title: Neuroimaging in MS Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Post-Contrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis Deepa Ramasamy Presentation Date: 4/23/2017 1:00:00 PM Session Title: Neuroimaging in MS Introduction and Epidemiology Aneesh Singhal Presentation Date: 4/25/2017 7:00:00 AM Session Title: Stroke in Young Adults and Women Case 2: Stroke in Pregnancy Aneesh Singhal Presentation Date: 4/27/2017 1:00:00 PM Session Title: Neurologic Case Studies in Pregnancy I: Stroke and Headache Postnatal CRISPR-mediated genome editing prolongs survival in a mouse model of amyotrophic lateral sclerosis Zachary Kennedy Presentation Date: 4/23/2017 1:00:00 PM Session Title: ALS: Disease Mechanism and Therapeutics Plasma Neurofilament Heavy Chain Levels correlate with disease severity and progression on multiple clinical outcomes in Amyotrophic Lateral Sclerosis (ALS) Steve Han Presentation Date: 4/23/2017 1:00:00 PM Session Title: ALS: Disease Mechanism and Therapeutics Cerebral Arteriopathies Aneesh Singhal Session Title: Stroke in Young Adults and Women Discussion - Case 2: Stroke in Pregnancy Steven Feske Presentation Date: 4/27/2017 1:00:00 PM Session Title: Neurologic Case Studies in Pregnancy I: Stroke and Headache Case 1: Headache in Pregnancy Paul Mathew Presentation Date: 4/27/2017 1:00:00 PM Session Title: Neurologic Case Studies in Pregnancy I: Stroke and Headache Distinct patterns of disease progression in SOD1-associated familial ALS: A study of 25 mutations.

Pooled analysis of two trials of pyrimethamine in familial ALS.Pavlakis Presentation Date: 4/23/2017 1:00:00 PM Session Title: ALS: Disease Mechanism and Therapeutics Immuno-modulation in Amyotrophic Lateral Sclerosis- A Phase II Study of Safety and Activity of Low Dose Interleukin-2 (IMODALS study) Gilbert Bensimon Presentation Date: 4/23/2017 1:00:00 PM Session Title: ALS: Disease Mechanism and Therapeutics Hormones and Hypercoagulable States Cheryl Bushnell Presentation Date: 4/25/2017 7:00:00 AM Session Title: Stroke in Young Adults and Women Discussion - Case 1: Headache in Pregnancy Mary O'Neal Presentation Date: 4/27/2017 1:00:00 PM Session Title: Neurologic Case Studies in Pregnancy I: Stroke and Headache Updates on the Clinical and Research Use of Magnetic Resonance Imaging in Neurodegenerative Disorders Liana Apostolova Presentation Date: 4/25/2017 7:00:00 AM Session Title: Neuroimaging Biomarkers Across the Dementia Spectrum The Role of Functional Neuroimaging in the Evaluation of Patients with Cognitive/Behavioral Impairment or Dementia Bradford Dickerson Presentation Date: 4/25/2017 7:00:00 AM Session Title: Neuroimaging Biomarkers Across the Dementia Spectrum Case 2: Headache in Pregnancy Mary O'Neal Presentation Date: 4/27/2017 1:00:00 PM Session Title: Neurologic Case Studies in Pregnancy I: Stroke and Headache The NEALS Randomized, Placebo Controlled Trial of Diaphragm Pacing in Patients with ALS Jonathan Katz Presentation Date: 4/23/2017 1:00:00 PM Session Title: ALS: Disease Mechanism and Therapeutics The polymorphisms of CX3CR1 gene influence ALS survival in an Italian population-based study Cristina Moglia Presentation Date: 4/23/2017 1:00:00 PM Session Title: ALS: Disease Mechanism and Therapeutics Discussion - Case 2: Headache in Pregnancy Paul Mathew Presentation Date: 4/27/2017 1:00:00 PM Session Title: Neurologic Case Studies in Pregnancy I: Stroke and Headache Global long-term registry on efficacy and safety of levodopa-carbidopa intestinal gel in advanced Parkinson’s disease patients (GLORIA) – final results in a subgroup of patients with dyskinesia at baseline Werner Poewe Presentation Date: 4/23/2017 1:00:00 PM Session Title: Movement Disorders: Beyond Oral Levodopa in Parkinson's Disease ND0612, a novel liquid formulation of levodopa/carbidopa for subcutaneous infusion in patients with Parkinson’s disease achieves stable levodopa plasma levels when administered in low and high doses S Purdue OWL Formatting in Sociology ASA Style.Pavlakis Presentation Date: 4/23/2017 1:00:00 PM Session Title: ALS: Disease Mechanism and Therapeutics Immuno-modulation in Amyotrophic Lateral Sclerosis- A Phase II Study of Safety and Activity of Low Dose Interleukin-2 (IMODALS study) Gilbert Bensimon Presentation Date: 4/23/2017 1:00:00 PM Session Title: ALS: Disease Mechanism and Therapeutics Hormones and Hypercoagulable States Cheryl Bushnell Presentation Date: 4/25/2017 7:00:00 AM Session Title: Stroke in Young Adults and Women Discussion - Case 1: Headache in Pregnancy Mary O'Neal Presentation Date: 4/27/2017 1:00:00 PM Session Title: Neurologic Case Studies in Pregnancy I: Stroke and Headache Updates on the Clinical and Research Use of Magnetic Resonance Imaging in Neurodegenerative Disorders Liana Apostolova Presentation Date: 4/25/2017 7:00:00 AM Session Title: Neuroimaging Biomarkers Across the Dementia Spectrum The Role of Functional Neuroimaging in the Evaluation of Patients with Cognitive/Behavioral Impairment or Dementia Bradford Dickerson Presentation Date: 4/25/2017 7:00:00 AM Session Title: Neuroimaging Biomarkers Across the Dementia Spectrum Case 2: Headache in Pregnancy Mary O'Neal Presentation Date: 4/27/2017 1:00:00 PM Session Title: Neurologic Case Studies in Pregnancy I: Stroke and Headache The NEALS Randomized, Placebo Controlled Trial of Diaphragm Pacing in Patients with ALS Jonathan Katz Presentation Date: 4/23/2017 1:00:00 PM Session Title: ALS: Disease Mechanism and Therapeutics The polymorphisms of CX3CR1 gene influence ALS survival in an Italian population-based study Cristina Moglia Presentation Date: 4/23/2017 1:00:00 PM Session Title: ALS: Disease Mechanism and Therapeutics Discussion - Case 2: Headache in Pregnancy Paul Mathew Presentation Date: 4/27/2017 1:00:00 PM Session Title: Neurologic Case Studies in Pregnancy I: Stroke and Headache Global long-term registry on efficacy and safety of levodopa-carbidopa intestinal gel in advanced Parkinson’s disease patients (GLORIA) – final results in a subgroup of patients with dyskinesia at baseline Werner Poewe Presentation Date: 4/23/2017 1:00:00 PM Session Title: Movement Disorders: Beyond Oral Levodopa in Parkinson's Disease ND0612, a novel liquid formulation of levodopa/carbidopa for subcutaneous infusion in patients with Parkinson’s disease achieves stable levodopa plasma levels when administered in low and high doses S.Oren Presentation Date: 4/23/2017 1:00:00 PM Session Title: Movement Disorders: Beyond Oral Levodopa in Parkinson's Disease Towards Molecular Diagnosis: Clinical Applications of Amyloid and Tau PET Imaging Gil Rabinovici Presentation Date: 4/25/2017 7:00:00 AM Session Title: Neuroimaging Biomarkers Across the Dementia Spectrum You Make the Call! Interactive Audience Quiz of Unknown EMG Waveforms Devon Rubin Presentation Date: 4/25/2017 7:00:00 AM Session Title: Mastering EMG Waveform Recognition Skills in Just Two Hours! Preliminary Results of the Phase I Clinical Study Evaluating Neural Stem Cell Based Therapy for Parkinson's Disease Ibon Garitaonandia Presentation Date: 4/23/2017 1:00:00 PM Session Title: Movement Disorders: Beyond Oral Levodopa in Parkinson's Disease Quality of Life in Homebound People with Advanced Parkinson′s Disease: Feasibility and Outcomes of an Interdisciplinary Home Visit Program Jori Fleisher Presentation Date: 4/23/2017 1:00:00 PM Session Title: Movement Disorders: Beyond Oral Levodopa in Parkinson's Disease Diabetic Neuropathies A.Gordon Smith Presentation Date: 4/27/2017 1:00:00 PM Session Title: Peripheral Neuropathy II: Diabetic and Inherited Neuropathies Inherited Neuropathies Michael Shy Session Title: Peripheral Neuropathy II: Diabetic and Inherited Neuropathies Therapy of Neuromuscular Disease Anthony Amato Presentation Date: 4/28/2017 1:05:00 PM Session Title: Therapy in Neurology III: Neuromuscular Disease and Neurological Infectious Diseases Therapy of Neurological Infectious Diseases Karen Roos Presentation Date: 4/28/2017 1:05:00 PM Session Title: Therapy in Neurology III: Neuromuscular Disease and Neurological Infectious Diseases 5 Case Presentations & Discussion Alberto Espay Presentation Date: 4/25/2017 7:05:00 AM Session Title: Therapy of Movement Disorders: A Case-based Approach Questions and Answers/Case Presentations A.Gordon Smith Presentation Date: 4/27/2017 1:00:00 PM Session Title: Peripheral Neuropathy II: Diabetic and Inherited Neuropathies Managing Severe TBI in the ICU Holly Hinson Presentation Date: 4/27/2017 1:00:00 PM Session Title: Severe TBI: From ICU to Rehabilitation Effects of a Parkinson-Specific, Interdisciplinary Approach, To Inpatient Rehabilitation Christian Benedict Presentation Date: 4/23/2017 1:00:00 PM Session Title: Movement Disorders: Beyond Oral Levodopa in Parkinson's Disease Motor retraining (MoRe) for functional movement disorders: Outcomes from a one-week multidisciplinary rehabilitation program Alexandra Jacob Presentation Date: 4/23/2017 1:00:00 PM Session Title: Movement Disorders: Beyond Oral Levodopa in Parkinson's Disease Epidemiology of the Psychiatric Comorbidities Associated with Migraine Mia Minen Presentation Date: 4/25/2017 7:05:00 AM Session Title: Management of Migraine and Psychiatric Comorbidities Potential Mechanisms Linking Migraine and Psychiatric Comorbidities and Treatment Implications Gretchen Tietjen Presentation Date: 4/25/2017 7:05:00 AM Session Title: Management of Migraine and Psychiatric Comorbidities Screening Tools for Psychiatric Comorbidity Elizabeth Seng Presentation Date: 4/25/2017 7:05:00 AM Session Title: Management of Migraine and Psychiatric Comorbidities Outcomes of a Prospective, Multicenter International Registry of Deep Brain Stimulation for Parkinson's Disease G nther Deuschl Presentation Date: 4/23/2017 1:00:00 PM Session Title: Movement Disorders: Beyond Oral Levodopa in Parkinson's Disease Impact of NEOD001 on Neuropathy in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction: Results From the Expansion Phase of a Phase 1/2 Study Raymond Comenzo Presentation Date: 4/23/2017 1:00:00 PM Session Title: General Neurology: Pathogenesis, Modulation, and Biomarkers of Complex Neurological Disorders Imaging in Severe TBI Brian Edlow Presentation Date: 4/27/2017 1:00:00 PM Session Title: Severe TBI: From ICU to Rehabilitation Pharmacological and Rehabilitative Approaches to Neurological Sequelae of TBI David Brody Presentation Date: 4/27/2017 1:00:00 PM Session Title: Severe TBI: From ICU to Rehabilitation Behavioral Treatment Options for Psychiatric Comorbidity in Migraine Elizabeth Seng Presentation Date: 4/25/2017 7:05:00 AM Session Title: Management of Migraine and Psychiatric Comorbidities Pharmacologic Treatment Options for the Psychiatric Comorbidities Noah Rosen Presentation Date: 4/25/2017 7:05:00 AM Session Title: Management of Migraine and Psychiatric Comorbidities Volumetric analysis of limbic structures in patients with functional movement disorders Carine Maurer Presentation Date: 4/27/2017 1:00:00 PM Session Title: Movement Disorders: Functional and Structural Imaging in Parkinson's Disease Inferior parietal cortex as a hub of loss of inhibition and maladaptive plasticity Kristina Simonyan Presentation Date: 4/27/2017 1:00:00 PM Session Title: Movement Disorders: Functional and Structural Imaging in Parkinson's Disease Corticokinematic coherence is decreased in patients with Friedreich Ataxia and correlates with GAA1 expansion Gilles Naeije Presentation Date: 4/23/2017 1:00:00 PM Session Title: General Neurology: Pathogenesis, Modulation, and Biomarkers of Complex Neurological Disorders Long-Term Risk of Seizures in Survivors of Sepsis Michael Reznik Presentation Date: 4/23/2017 1:00:00 PM Session Title: General Neurology: Pathogenesis, Modulation, and Biomarkers of Complex Neurological Disorders Cases Noah Rosen Session Title: Management of Migraine and Psychiatric Comorbidities Impact of Neurological Magnetic Resonance Imaging in Non-Approved Cardiac Devices Lina Ya'qoub Presentation Date: 4/23/2017 1:00:00 PM Session Title: General Neurology: Pathogenesis, Modulation, and Biomarkers of Complex Neurological Disorders Resting cerebral perfusion impairment in Type 2 Diabetes Freddy Alfaro Presentation Date: 4/23/2017 1:00:00 PM Session Title: General Neurology: Pathogenesis, Modulation, and Biomarkers of Complex Neurological Disorders Distinct Mesocorticolimbic blood flow response to dopamine therapy in patients with Parkinson′s disease and compulsive reward-driven behaviors Cam Bermudez Presentation Date: 4/27/2017 1:00:00 PM Session Title: Movement Disorders: Functional and Structural Imaging in Parkinson's Disease Hippocampal and entorhinal cortex atrophy across the Parkinson′s disease cognitive impairment spectrum Roshni Patel Presentation Date: 4/27/2017 1:00:00 PM Session Title: Movement Disorders: Functional and Structural Imaging in Parkinson's Disease Clinical features of post-vaccination Guillain-Barr Syndrome (GBS) in the Republic of Korea Bum Chun Suh Presentation Date: 4/23/2017 1:00:00 PM Session Title: General Neurology: Pathogenesis, Modulation, and Biomarkers of Complex Neurological Disorders Specific human antisense oligonucleotide (ASO) targeting TGF- RII rescues proliferation of TGF- arrested human neuronal progenitor cells (ReNcell CX) Ultrich Bogdahn Presentation Date: 4/23/2017 1:00:00 PM Session Title: General Neurology: Pathogenesis, Modulation, and Biomarkers of Complex Neurological Disorders Palliative Care and Neurology: Why Does it Matter, How Does It Affect Our Patients and Their Families, and Why Should We Care? What Is the Role of Advance Care Planning in Neurology? Tobias Walbert Presentation Date: 4/25/2017 7:10:00 AM Session Title: The Palliative Care Guide in Neurology: Best Practice Guidelines in Communication, Symptom Management, and End of Life Care of Patients with Brain Tumors and Other Life Limiting Neurological Disorders The effects of different modalities of gait training on brain activation in patients with Parkinson′s disease: an fMRI study Inbal Maidan Presentation Date: 4/27/2017 1:00:00 PM Session Title: Movement Disorders: Functional and Structural Imaging in Parkinson's Disease Effects of Subthalamic Stimulation in Elderly patients with Parkinson′s Disease Vibhash Sharma Presentation Date: 4/27/2017 1:00:00 PM Session Title: Movement Disorders: Functional and Structural Imaging in Parkinson's Disease Identification of Usp8 as a toxicity modifying Deubiquitinase for -synuclein Zoi Alexopoulou Presentation Date: 4/27/2017 1:00:00 PM Session Title: Movement Disorders: Functional and Structural Imaging in Parkinson's Disease Glucose-regulated protein 78 (GRP78) in plasma and CSF is associated with Parkinson′s disease statistics.Gordon Smith Presentation Date: 4/27/2017 1:00:00 PM Session Title: Peripheral Neuropathy II: Diabetic and Inherited Neuropathies Managing Severe TBI in the ICU Holly Hinson Presentation Date: 4/27/2017 1:00:00 PM Session Title: Severe TBI: From ICU to Rehabilitation Effects of a Parkinson-Specific, Interdisciplinary Approach, To Inpatient Rehabilitation Christian Benedict Presentation Date: 4/23/2017 1:00:00 PM Session Title: Movement Disorders: Beyond Oral Levodopa in Parkinson's Disease Motor retraining (MoRe) for functional movement disorders: Outcomes from a one-week multidisciplinary rehabilitation program Alexandra Jacob Presentation Date: 4/23/2017 1:00:00 PM Session Title: Movement Disorders: Beyond Oral Levodopa in Parkinson's Disease Epidemiology of the Psychiatric Comorbidities Associated with Migraine Mia Minen Presentation Date: 4/25/2017 7:05:00 AM Session Title: Management of Migraine and Psychiatric Comorbidities Potential Mechanisms Linking Migraine and Psychiatric Comorbidities and Treatment Implications Gretchen Tietjen Presentation Date: 4/25/2017 7:05:00 AM Session Title: Management of Migraine and Psychiatric Comorbidities Screening Tools for Psychiatric Comorbidity Elizabeth Seng Presentation Date: 4/25/2017 7:05:00 AM Session Title: Management of Migraine and Psychiatric Comorbidities Outcomes of a Prospective, Multicenter International Registry of Deep Brain Stimulation for Parkinson's Disease G nther Deuschl Presentation Date: 4/23/2017 1:00:00 PM Session Title: Movement Disorders: Beyond Oral Levodopa in Parkinson's Disease Impact of NEOD001 on Neuropathy in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction: Results From the Expansion Phase of a Phase 1/2 Study Raymond Comenzo Presentation Date: 4/23/2017 1:00:00 PM Session Title: General Neurology: Pathogenesis, Modulation, and Biomarkers of Complex Neurological Disorders Imaging in Severe TBI Brian Edlow Presentation Date: 4/27/2017 1:00:00 PM Session Title: Severe TBI: From ICU to Rehabilitation Pharmacological and Rehabilitative Approaches to Neurological Sequelae of TBI David Brody Presentation Date: 4/27/2017 1:00:00 PM Session Title: Severe TBI: From ICU to Rehabilitation Behavioral Treatment Options for Psychiatric Comorbidity in Migraine Elizabeth Seng Presentation Date: 4/25/2017 7:05:00 AM Session Title: Management of Migraine and Psychiatric Comorbidities Pharmacologic Treatment Options for the Psychiatric Comorbidities Noah Rosen Presentation Date: 4/25/2017 7:05:00 AM Session Title: Management of Migraine and Psychiatric Comorbidities Volumetric analysis of limbic structures in patients with functional movement disorders Carine Maurer Presentation Date: 4/27/2017 1:00:00 PM Session Title: Movement Disorders: Functional and Structural Imaging in Parkinson's Disease Inferior parietal cortex as a hub of loss of inhibition and maladaptive plasticity Kristina Simonyan Presentation Date: 4/27/2017 1:00:00 PM Session Title: Movement Disorders: Functional and Structural Imaging in Parkinson's Disease Corticokinematic coherence is decreased in patients with Friedreich Ataxia and correlates with GAA1 expansion Gilles Naeije Presentation Date: 4/23/2017 1:00:00 PM Session Title: General Neurology: Pathogenesis, Modulation, and Biomarkers of Complex Neurological Disorders Long-Term Risk of Seizures in Survivors of Sepsis Michael Reznik Presentation Date: 4/23/2017 1:00:00 PM Session Title: General Neurology: Pathogenesis, Modulation, and Biomarkers of Complex Neurological Disorders Cases Noah Rosen Session Title: Management of Migraine and Psychiatric Comorbidities Impact of Neurological Magnetic Resonance Imaging in Non-Approved Cardiac Devices Lina Ya'qoub Presentation Date: 4/23/2017 1:00:00 PM Session Title: General Neurology: Pathogenesis, Modulation, and Biomarkers of Complex Neurological Disorders Resting cerebral perfusion impairment in Type 2 Diabetes Freddy Alfaro Presentation Date: 4/23/2017 1:00:00 PM Session Title: General Neurology: Pathogenesis, Modulation, and Biomarkers of Complex Neurological Disorders Distinct Mesocorticolimbic blood flow response to dopamine therapy in patients with Parkinson′s disease and compulsive reward-driven behaviors Cam Bermudez Presentation Date: 4/27/2017 1:00:00 PM Session Title: Movement Disorders: Functional and Structural Imaging in Parkinson's Disease Hippocampal and entorhinal cortex atrophy across the Parkinson′s disease cognitive impairment spectrum Roshni Patel Presentation Date: 4/27/2017 1:00:00 PM Session Title: Movement Disorders: Functional and Structural Imaging in Parkinson's Disease Clinical features of post-vaccination Guillain-Barr Syndrome (GBS) in the Republic of Korea Bum Chun Suh Presentation Date: 4/23/2017 1:00:00 PM Session Title: General Neurology: Pathogenesis, Modulation, and Biomarkers of Complex Neurological Disorders Specific human antisense oligonucleotide (ASO) targeting TGF- RII rescues proliferation of TGF- arrested human neuronal progenitor cells (ReNcell CX) Ultrich Bogdahn Presentation Date: 4/23/2017 1:00:00 PM Session Title: General Neurology: Pathogenesis, Modulation, and Biomarkers of Complex Neurological Disorders Palliative Care and Neurology: Why Does it Matter, How Does It Affect Our Patients and Their Families, and Why Should We Care? What Is the Role of Advance Care Planning in Neurology? Tobias Walbert Presentation Date: 4/25/2017 7:10:00 AM Session Title: The Palliative Care Guide in Neurology: Best Practice Guidelines in Communication, Symptom Management, and End of Life Care of Patients with Brain Tumors and Other Life Limiting Neurological Disorders The effects of different modalities of gait training on brain activation in patients with Parkinson′s disease: an fMRI study Inbal Maidan Presentation Date: 4/27/2017 1:00:00 PM Session Title: Movement Disorders: Functional and Structural Imaging in Parkinson's Disease Effects of Subthalamic Stimulation in Elderly patients with Parkinson′s Disease Vibhash Sharma Presentation Date: 4/27/2017 1:00:00 PM Session Title: Movement Disorders: Functional and Structural Imaging in Parkinson's Disease Identification of Usp8 as a toxicity modifying Deubiquitinase for -synuclein Zoi Alexopoulou Presentation Date: 4/27/2017 1:00:00 PM Session Title: Movement Disorders: Functional and Structural Imaging in Parkinson's Disease Glucose-regulated protein 78 (GRP78) in plasma and CSF is associated with Parkinson′s disease.Deepak Gupta Presentation Date: 4/27/2017 1:00:00 PM Session Title: Movement Disorders: Functional and Structural Imaging in Parkinson's Disease Know How: Symptom Management and Communication Skills for the Neurologist Alan Carver Presentation Date: 4/25/2017 7:10:00 AM Session Title: The Palliative Care Guide in Neurology: Best Practice Guidelines in Communication, Symptom Management, and End of Life Care of Patients with Brain Tumors and Other Life Limiting Neurological Disorders Glia maturation factor inhibits mitochondrial biogenesis, increase oxidative stress and apoptotic cell death in dopaminergic neurons Govindhasamy Pushpavathi Selvakumar Presentation Date: 4/23/2017 1:00:00 PM Session Title: General Neurology: Pathogenesis, Modulation, and Biomarkers of Complex Neurological Disorders Case 1 David Boulware Presentation Date: 4/23/2017 1:05:00 PM Session Title: So You've Diagnosed Your Patient with a Neuroinfectious Disease, Now What? Practical Pearls in the Treatment and Management of Neuroinfectious Diseases A Human MiniBrain as a model to study Zika virus associated neurological disease.

Paula Barreras Presentation Date: 4/27/2017 1:00:00 PM Session Title: Infectious Disease: The Neurology of Zika, Chikungunya, and Acute Flaccid Myelitis Neuroviruses Emerging in the Americas Study (NEAS): The Colombian experience during the 2016 outbreak of Zika virus infection Laura S.Mu oz Presentation Date: 4/27/2017 1:00:00 PM Session Title: Infectious Disease: The Neurology of Zika, Chikungunya, and Acute Flaccid Myelitis Case 2 Felicia Chow Presentation Date: 4/23/2017 1:05:00 PM Session Title: So You've Diagnosed Your Patient with a Neuroinfectious Disease, Now What? Practical Pearls in the Treatment and Management of Neuroinfectious Diseases Case 3 Christina Marra Presentation Date: 4/23/2017 1:05:00 PM Session Title: So You've Diagnosed Your Patient with a Neuroinfectious Disease, Now What? Practical Pearls in the Treatment and Management of Neuroinfectious Diseases Adverse Effects of Antiepileptic Drug Medication Terence O'Brien Presentation Date: 4/25/2017 7:20:00 AM Session Title: The Burden of Epilepsy: Managing Comorbidities and Quality of Life Mortality in Newborns with Microcephaly Due to Maternal Zika Virus Infection in Rio Grande Do Norte State- Northeast Brazil: A Cross-Sectional Study Nilson Mendes Presentation Date: 4/27/2017 1:00:00 PM Session Title: Infectious Disease: The Neurology of Zika, Chikungunya, and Acute Flaccid Myelitis Indirect Immunoflourescence assay for the screening of Zika antibodies in serum and cerebrospinal fluid Anupama Kumar Presentation Date: 4/27/2017 1:00:00 PM Session Title: Infectious Disease: The Neurology of Zika, Chikungunya, and Acute Flaccid Myelitis Diagnosis and Treatment of Pediatric Epilepsy Lily Wong-Kisiel Presentation Date: 4/23/2017 1:05:00 PM Session Title: Clinical Epilepsy II: Considerations Across the Age Span Pediatrics, Pregnancy, and Elderly Cognitive and Psychiatric Issues Associated with Seizure Disorders Kimford Meador Presentation Date: 4/25/2017 7:20:00 AM Session Title: The Burden of Epilepsy: Managing Comorbidities and Quality of Life Zika-associated Atypical Guillain–Barre Variants in rural Haiti Francois Roosevelt Presentation Date: 4/27/2017 1:00:00 PM Session Title: Infectious Disease: The Neurology of Zika, Chikungunya, and Acute Flaccid Myelitis Zika-V outbreak and Guillain–Barre syndrome in Jamaica Amza Ali Presentation Date: 4/27/2017 1:00:00 PM Session Title: Infectious Disease: The Neurology of Zika, Chikungunya, and Acute Flaccid Myelitis Pregnancy and Reproductive Health in Patients with Epilepsy Page Pennell Presentation Date: 4/23/2017 1:05:00 PM Session Title: Clinical Epilepsy II: Considerations Across the Age Span Pediatrics, Pregnancy, and Elderly SUDEP and Medical Issues Related to Seizures Jeffrey Buchhalter Presentation Date: 4/25/2017 7:20:00 AM Session Title: The Burden of Epilepsy: Managing Comorbidities and Quality of Life Epilepsy in the Elderly: Special Considerations Barbara Jobst Presentation Date: 4/23/2017 1:05:00 PM Session Title: Clinical Epilepsy II: Considerations Across the Age Span Pediatrics, Pregnancy, and Elderly Fully automated pipeline for white matter hyperintensity segmentation using clinical scans in patients with acute ischemic stroke Markus D Schirmer Presentation Date: 4/25/2017 8:00:00 AM Session Title: Best Of Session: Cerebrovascular Disease and Interventional Neurology Recanalization Therapy is Associated with Lower Odds of 30-Day Readmission: An Analysis of the Nationwide Readmission Database Farhaan Vahidy Presentation Date: 4/25/2017 8:00:00 AM Session Title: Best Of Session: Cerebrovascular Disease and Interventional Neurology Neurological involvement in Chikangunya Virus infection Rajiv Anand Presentation Date: 4/27/2017 1:00:00 PM Session Title: Infectious Disease: The Neurology of Zika, Chikungunya, and Acute Flaccid Myelitis Acute Flaccid Myelitis: Characteristics and Outcomes in 2014 and 2016 Clusters Sarah Hopkins Presentation Date: 4/27/2017 1:00:00 PM Session Title: Infectious Disease: The Neurology of Zika, Chikungunya, and Acute Flaccid Myelitis Overview of Neuropharmacology James Owens Presentation Date: 4/23/2017 1:05:00 PM Session Title: Resident Basic Science III: Neuropharmacology Disparities in Delivery of Endovascular Therapy: The Florida Puerto Rico Collaboration to Reduce Stroke Disparities Study (CReSD) Negar Asdaghi Presentation Date: 4/25/2017 8:00:00 AM Session Title: Best Of Session: Cerebrovascular Disease and Interventional Neurology Time-course of functional recovery after acute ischaemic stroke and its relationship to cause-specific mortality: Implications for follow-up of stroke trials Aravind Ganesh Presentation Date: 4/25/2017 8:00:00 AM Session Title: Best Of Session: Cerebrovascular Disease and Interventional Neurology Clinical and molecular characteristics of glioneuronal tumors Julie Miller Presentation Date: 4/27/2017 1:00:00 PM Session Title: Neuro-oncology Presentation Date: 4/27/2017 1:00:00 PM Session Title: Neuro-oncology Effect of Intensive Systolic Blood Pressure Lowering on Hematoma Expansion in Patients with Intracerebral Hemorrhage: Analysis of Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II Trial Joshua Goldstein Presentation Date: 4/25/2017 9:15:00 AM Session Title: Clinical Trials Plenary Session Exon Skipping: Development and Approval of Eteplirsen for DMD Jerry Mendell Presentation Date: 4/25/2017 9:15:00 AM Session Title: Clinical Trials Plenary Session Treatment of Parkinson's Disease Joohi Jimenez Shahed Presentation Date: 4/23/2017 1:05:00 PM Session Title: Resident Basic Science III: Neuropharmacology Treatment of Epilepsy Atul Maheshwari Presentation Date: 4/23/2017 1:05:00 PM Session Title: Resident Basic Science III: Neuropharmacology Targeting carcinoma–astrocyte gap junctions in brain metastasis Adrienne Boire Presentation Date: 4/27/2017 1:00:00 PM Session Title: Neuro-oncology Presentation Date: 4/27/2017 1:00:00 PM Session Title: Neuro-oncology Presentation Date: 4/23/2017 1:05:00 PM Session Title: Resident Basic Science III: Neuropharmacology The Childhood and Adolescent Migraine Prevention Trial Scott Powers Presentation Date: 4/25/2017 9:15:00 AM Session Title: Clinical Trials Plenary Session Efficacy of Siponimod in Secondary Progressive Multiple Sclerosis: Results of the Phase 3 Study Ludwig Kappos Presentation Date: 4/25/2017 9:15:00 AM Session Title: Clinical Trials Plenary Session Microtubule Associated Protein (MAP) 1B: Antigen of PCA-2 IgG, Biomarker of Small-Cell Lung Carcinoma-related Paraneoplastic Neurological Autoimmunity Avi Gadoth Presentation Date: 4/27/2017 1:00:00 PM Session Title: Neuro-oncology Germline genetic mutations contribute to the development of primary brain tumors: a review of a multigene panel testing cohort Amanda Bergner Presentation Date: 4/27/2017 1:00:00 PM Session Title: Neuro-oncology Presentation Date: 4/23/2017 1:10:00 PM Session Title: Deep Brain Stimulation I: Basic Principles and Programming in Movement Disorders The Art and Science of Basic DBS Stimulation Programming (Focus PD and ET) Michael Pourfar Presentation Date: 4/23/2017 1:10:00 PM Session Title: Deep Brain Stimulation I: Basic Principles and Programming in Movement Disorders A 2-year Multidomain Intervention of Diet, Exercise, Cognitive Training, and Vascular Risk Monitoring Versus Control to Prevent Cognitive Decline in At-risk Elderly People (FINGER): A Randomized Controlled Trial Miia Kivipelto Presentation Date: 4/25/2017 9:15:00 AM Session Title: Clinical Trials Plenary Session AVXS-101 Phase 1 Gene Therapy Clinical Trial in SMA Type 1: Event Free Survival and Achievement of Developmental Milestones Jerry Mendell Presentation Date: 4/25/2017 9:15:00 AM Session Title: Clinical Trials Plenary Session Eteplirsen for the Treatment of Duchenne Muscular Dystrophy (DMD) JS Charleston Presentation Date: 4/27/2017 1:00:00 PM Session Title: Update in Muscular Dystrophy Genetic landscape of Limb-Girdle Muscular Dystrophies from a Large Cohort of Neuromuscular Disease Patients Samya Chakravorty Presentation Date: 4/27/2017 1:00:00 PM Session Title: Update in Muscular Dystrophy Team Teaching Exercises Richard Haspel Presentation Date: 4/23/2017 1:15:00 PM Session Title: Genomic Neurology Workshop: Developing Practical Knowledge of Tools and Concepts Through Case Studies I Update in Movement Disorders Claire Henchcliffe Presentation Date: 4/23/2017 3:30:00 PM Session Title: Neurology Update II: Movement, Spine, and Autonomic Neurology Therapeutic Effect of KPT-350 in a Preclinical Model of Duchenne Muscular Dystrophy Matthew Alexander Presentation Date: 4/27/2017 1:00:00 PM Session Title: Update in Muscular Dystrophy Eteplirsen, a Phosphorodiamidate Morpholino Oligomer (PMO) for Duchenne Muscular Dystrophy (DMD): Longitudinal Comparison to External Controls on Six-Minute Walk Test (6MWT) and Loss of Ambulation (LOA) Linda Lowes Presentation Date: 4/27/2017 1:00:00 PM Session Title: Update in Muscular Dystrophy Cannabidiol (CBD) Reduces Convulsive Seizure Frequency in Dravet Syndrome: Results of a Multi-Center, Randomized, Controlled Trial (GWPCARE1) J.Bartleson Presentation Date: 4/23/2017 3:30:00 PM Session Title: Neurology Update II: Movement, Spine, and Autonomic Neurology Stroke Scott Silverman Session Title: Neurology Update III: Neuromuscular, Dementia, and Stroke Update in Autonomic Neurology Roy Freeman Presentation Date: 4/23/2017 3:30:00 PM Session Title: Neurology Update II: Movement, Spine, and Autonomic Neurology Respiratory muscle unloading (RMU) to treat dyspnea on exertion (DOE) in ambulatory patients with Amyotrophic Lateral Sclerosis (ambALS).

Mohammed Sanjak Presentation Date: 4/27/2017 3:30:00 PM Session Title: Exciting New Results in Neuro-rehabilitation Incidence, History, and Differential Diagnosis of BPPV Kristen Steenerson Presentation Date: 4/27/2017 3:30:00 PM Session Title: Canalith Repositioning for Benign Paroxysmal Positional Vertigo Extranigral Pathology and Premotor Detection of Parkinson's Disease Charles Adler Presentation Date: 4/25/2017 1:00:00 PM Session Title: Nonmotor Manifestations of Parkinson's Disease I Mechanisms of BPPV Kamala Saha Presentation Date: 4/27/2017 3:30:00 PM Session Title: Canalith Repositioning for Benign Paroxysmal Positional Vertigo Diagnosis and Impact of Nonmotor Complications of Parkinson's Disease Janis Miyasaki Presentation Date: 4/25/2017 1:00:00 PM Session Title: Nonmotor Manifestations of Parkinson's Disease I Other Primary Headache Syndromes Todd Rozen Presentation Date: 4/23/2017 3:30:00 PM Session Title: Introduction to Primary Headache Disorders II: Trigeminal Autonomic Cephalalgias and Other Primary Headaches Including New Daily Persistent Headache, Cough, Exercise, and Primary Thunderclap Headaches Examination Manuevers and Nystagmus of BPPV Terry Fife Presentation Date: 4/27/2017 3:30:00 PM Session Title: Canalith Repositioning for Benign Paroxysmal Positional Vertigo The Pediatric Neuro-ophthalmic Examination Christopher Glisson Presentation Date: 4/25/2017 1:00:00 PM Session Title: Pediatric Neuro-ophthalmology Update Welcome and Introduction Michael Howell Presentation Date: 4/28/2017 3:30:00 PM Session Title: Sleep for the Practicing Neurologist II: Night Fighting: Sleep Related Hypermotor Epilepsy, Sleepwalking, and Dream Enactment Trigeminal Autonomic Cephalalgias Christopher Boes Presentation Date: 4/23/2017 3:30:00 PM Session Title: Introduction to Primary Headache Disorders II: Trigeminal Autonomic Cephalalgias and Other Primary Headaches Including New Daily Persistent Headache, Cough, Exercise, and Primary Thunderclap Headaches Optic Disc Swelling in Childhood Melissa Ko Presentation Date: 4/25/2017 1:00:00 PM Session Title: Pediatric Neuro-ophthalmology Update The First Step in the Management of Functional Neurologic Disorders: Diagnostic Debriefing Alberto Espay Presentation Date: 4/27/2017 3:30:00 PM Session Title: Functional Neurologic Disorders II: Management, CBT, and Inpatient Therapeutic Strategies Cognitive Behavioral Therapy (CBT) for Patients with Functional Neurologic Disorders Scott Ries Presentation Date: 4/27/2017 3:30:00 PM Session Title: Functional Neurologic Disorders II: Management, CBT, and Inpatient Therapeutic Strategies Alpha-synucleinopathies: Parkinson's, Lewy Body, and Multiple System Atrophy Bradley Boeve Presentation Date: 4/23/2017 3:30:00 PM Session Title: Non-Alzheimer's Dementia II: Lewy Body Dementias and Other Parkinsonian Dementias Tauopathies: Progressive Supranuclear Palsy and Corticobasal Degeneration Anthony Lang Presentation Date: 4/23/2017 3:30:00 PM Session Title: Non-Alzheimer's Dementia II: Lewy Body Dementias and Other Parkinsonian Dementias Pediatric Optic Neuritis (KEYNOTE) Grant Liu Presentation Date: 4/25/2017 1:00:00 PM Session Title: Pediatric Neuro-ophthalmology Update Nerve Conduction Criteria for AIDP/CIDP Mark Bromberg Presentation Date: 4/23/2017 3:30:00 PM Session Title: Clinical EMG III: Nerve Conduction Criteria and Electrodiagnostic Approaches Nystagmus and Nystagmoid Eye Movements Robert Avery Presentation Date: 4/25/2017 1:00:00 PM Session Title: Pediatric Neuro-ophthalmology Update Inpatient Therapeutic Strategies for Patients with Functional Neurologic Disorders Kathrin LaFaver Presentation Date: 4/27/2017 3:30:00 PM Session Title: Functional Neurologic Disorders II: Management, CBT, and Inpatient Therapeutic Strategies Pediatric 3rd, 4th, and 6th Nerve Palsies Grant Liu Presentation Date: 4/25/2017 1:00:00 PM Session Title: Pediatric Neuro-ophthalmology Update Differential Diagnosis of Episodic Memory Failures: Case Presentations Andrew Budson Presentation Date: 4/27/2017 3:30:00 PM Session Title: Memory Disorders: A Case-based Approach Neuro-ophthalmic Manifestations of Systemic Disease Robert Avery Presentation Date: 4/25/2017 1:00:00 PM Session Title: Pediatric Neuro-ophthalmology Update Electrodiagnostic Approach to Diagnosing ALS/MMN Mark Bromberg Presentation Date: 4/23/2017 3:30:00 PM Session Title: Clinical EMG III: Nerve Conduction Criteria and Electrodiagnostic Approaches Clinical Assessment of Memory Loss: Case Presentations David Wolk Presentation Date: 4/27/2017 3:30:00 PM Session Title: Memory Disorders: A Case-based Approach The Mary Walker Effect: Mary Broadfoot Walker Christopher Boes Presentation Date: 4/25/2017 1:00:00 PM Session Title: Eponymous Women in Neurology I Myopathies: Diagnostic Guidance and Correlations from EMG/NCS Laurie Gutmann Presentation Date: 4/23/2017 3:30:00 PM Session Title: Clinical EMG III: Nerve Conduction Criteria and Electrodiagnostic Approaches Use of of Intravenous Alteplase in Acute Ischemic Stroke Louis Caplan Presentation Date: 4/23/2017 3:30:00 PM Session Title: Cerebrovascular Disease III: Acute Ischemic Stroke Epilepsy Joseph Drazkowski Session Title: Therapy in Neurology II: Epilepsy and Neuro-oncology Neuro-oncology Alyx Porter Session Title: Therapy in Neurology II: Epilepsy and Neuro-oncology Case 1: Epilepsy and Pregnancy Kimford Meador Presentation Date: 4/27/2017 3:30:00 PM Session Title: Neurologic Case Studies in Pregnancy II: Epilepsy and Neuro-ophthalmology D jerine-Klumpke Syndrome: Augusta D jerine-Klumpke Jennifer McKinney Presentation Date: 4/25/2017 1:00:00 PM Session Title: Eponymous Women in Neurology I Case Examples of Evidence-based Application of Endovascular Therapy in Acute Ischemic Stroke Tudor Jovin Presentation Date: 4/23/2017 3:30:00 PM Session Title: Cerebrovascular Disease III: Acute Ischemic Stroke Discussion - Case 1: Epilepsy and Pregnancy Page Pennell Presentation Date: 4/27/2017 3:30:00 PM Session Title: Neurologic Case Studies in Pregnancy II: Epilepsy and Neuro-ophthalmology The Roussy-L vy Syndrome: Gabrielle L vy Peter Koehler Presentation Date: 4/25/2017 1:00:00 PM Session Title: Eponymous Women in Neurology I Risk Stratification and Mitigation Bruce Cree Presentation Date: 4/23/2017 3:30:00 PM Session Title: Multiple Sclerosis Therapy: Disease-modifying Treatment II Emerging Therapies in MS: Slowing Progressive MS, Remyelination, Neural Protection, Neural Repair Gavin Giovannoni Presentation Date: 4/23/2017 3:30:00 PM Session Title: Multiple Sclerosis Therapy: Disease-modifying Treatment II Take Home Points - Case 1: Epilepsy and Pregnancy Page Pennell Presentation Date: 4/27/2017 3:30:00 PM Session Title: Neurologic Case Studies in Pregnancy II: Epilepsy and Neuro-ophthalmology Louis-Bar Syndrome (Ataxia Telangiectasia): Denise Louis-Bar Elizabeth Coon Presentation Date: 4/25/2017 1:00:00 PM Session Title: Eponymous Women in Neurology I Update on WHO Classification and Treatment of Gliomas Patrick Wen Presentation Date: 4/23/2017 3:30:00 PM Session Title: Case Studies: Neurologic Consultations in Cancer Patients II Diagnosis and Management of Metastatic Complications of Cancer David Schiff Presentation Date: 4/23/2017 3:30:00 PM Session Title: Case Studies: Neurologic Consultations in Cancer Patients II Case 2: Epilepsy and Pregnancy Page Pennell Presentation Date: 4/27/2017 3:30:00 PM Session Title: Neurologic Case Studies in Pregnancy II: Epilepsy and Neuro-ophthalmology Discussion - Case 2: Epilepsy and Pregnancy Kimford Meador Presentation Date: 4/27/2017 3:30:00 PM Session Title: Neurologic Case Studies in Pregnancy II: Epilepsy and Neuro-ophthalmology Diagnosis and Management of Paraneoplastic Syndromes Josep Dalmau Presentation Date: 4/23/2017 3:30:00 PM Session Title: Case Studies: Neurologic Consultations in Cancer Patients II Tumor Board Case Studies Amy Pruitt Presentation Date: 4/23/2017 3:30:00 PM Session Title: Case Studies: Neurologic Consultations in Cancer Patients II Migraine Pathophysiology: What's New? Andrew Charles Presentation Date: 4/25/2017 1:00:00 PM Session Title: Hot Topics in Headaches and Related Disorders I: Migraine Pathophysiology, Brain Imaging, and Therapeutic Advances Brain Imaging in Migraine: An Update Todd Schwedt Presentation Date: 4/25/2017 1:00:00 PM Session Title: Hot Topics in Headaches and Related Disorders I: Migraine Pathophysiology, Brain Imaging, and Therapeutic Advances Take Home Points - Case 2: Epilepsy and Pregnancy Kimford Meador Presentation Date: 4/27/2017 3:30:00 PM Session Title: Neurologic Case Studies in Pregnancy II: Epilepsy and Neuro-ophthalmology Risks of psychiatric disorders in children and young adults with demyelinating diseases of the central nervous system: a national record-linkage study Julia Pakpoor Presentation Date: 4/23/2017 3:30:00 PM Session Title: Neuroscience in the Clinic: Child Neurology: Neurologic Disorder Through a Lifespan- A Focus on MS Structural Connectivity Abnormalities Underlying Cognitive Impairment in Pediatric Multiple Sclerosis Ermelinda De Meo Presentation Date: 4/23/2017 3:30:00 PM Session Title: Neuroscience in the Clinic: Child Neurology: Neurologic Disorder Through a Lifespan- A Focus on MS Therapeutic Advances in Migraine: What Can We Expect? Denise Chou Presentation Date: 4/25/2017 1:00:00 PM Session Title: Hot Topics in Headaches and Related Disorders I: Migraine Pathophysiology, Brain Imaging, and Therapeutic Advances Expanding Spectrum of Neurologic manifestations with Zika Virus Infection Laura Surillo Dahdah Presentation Date: 4/25/2017 1:00:00 PM Session Title: Neuroscience in the Clinic: Zika Virus: The Global Outbreak of a Neurotropic Virus A Randomized Education Research Trial of Fundoscopy Training Methods in Neurology Residency.Deepak Gupta Presentation Date: 4/23/2017 3:30:00 PM Session Title: Research Methodology and Education: Education Research The Effect of a Clerkship Didactic Curriculum on Medical Student Career Choice in Neurology David Lee Gordon Presentation Date: 4/23/2017 3:30:00 PM Session Title: Research Methodology and Education: Education Research Case 1: Neuro-ophthalmology in Pregnancy Sashank Prasad Presentation Date: 4/27/2017 3:30:00 PM Session Title: Neurologic Case Studies in Pregnancy II: Epilepsy and Neuro-ophthalmology Discussion - Case 1: Neuro-ophthalmology in Pregnancy Steven Galetta Presentation Date: 4/27/2017 3:30:00 PM Session Title: Neurologic Case Studies in Pregnancy II: Epilepsy and Neuro-ophthalmology Effectiveness of on recruitment for an Alzheimer′s disease prevention clinical trial Emily Caesar Presentation Date: 4/23/2017 3:30:00 PM Session Title: Research Methodology and Education: Education Research Developing a Mobile Application for Stroke Caregivers Jonathan Singer Presentation Date: 4/23/2017 3:30:00 PM Session Title: Research Methodology and Education: Education Research Neuroviruses Emerging in the Americas Study (NEAS): The Colombian experience during the 2016 outbreak of Zika virus infection Laura S.Mu oz Presentation Date: 4/25/2017 1:00:00 PM Session Title: Neuroscience in the Clinic: Zika Virus: The Global Outbreak of a Neurotropic Virus ACT IV: An International, Double-blind, Phase 3 Trial of Rindopepimut in Newly Diagnosed, EGFRvIII-expressing Glioblastoma Michael Weller Presentation Date: 4/25/2017 1:00:00 PM Session Title: Invited Science: Neuro-oncology Sleep-related Hypermotor Epilepsy-Not Just a New Name: Novel Insights for a Fascinating Disorder Milena Pavlova Presentation Date: 4/28/2017 3:30:00 PM Session Title: Sleep for the Practicing Neurologist II: Night Fighting: Sleep Related Hypermotor Epilepsy, Sleepwalking, and Dream Enactment Take Home Points - Case 1: Neuro-ophthalmology in Pregnancy Steven Galetta Presentation Date: 4/27/2017 3:30:00 PM Session Title: Neurologic Case Studies in Pregnancy II: Epilepsy and Neuro-ophthalmology Case 2: Neuro-ophthalmology in Pregnancy Steven Galetta Presentation Date: 4/27/2017 3:30:00 PM Session Title: Neurologic Case Studies in Pregnancy II: Epilepsy and Neuro-ophthalmology Targeting Carcinoma–astrocyte Gap Junctions in Brain Metastasis Adrienne Boire Presentation Date: 4/25/2017 1:00:00 PM Session Title: Invited Science: Neuro-oncology Single-cell Profiling of Glioblastoma Biopsies Identifies a Family of Activating PDGF-receptor Deletions Soeren Mueller Presentation Date: 4/25/2017 1:00:00 PM Session Title: Invited Science: Neuro-oncology Discussion - Case 2: Neuro-ophthalmology in Pregnancy Steven Galetta Presentation Date: 4/27/2017 3:30:00 PM Session Title: Neurologic Case Studies in Pregnancy II: Epilepsy and Neuro-ophthalmology Take Home Points - Case 2: Neuro-ophthalmology in Pregnancy Sashank Prasad Presentation Date: 4/27/2017 3:30:00 PM Session Title: Neurologic Case Studies in Pregnancy II: Epilepsy and Neuro-ophthalmology Transformation of Tumor Endothelial Cells to Mesenchymal Stem Cell-like Cells Induces Therapy Resistance in Glioblastoma Menggui Huang Presentation Date: 4/25/2017 1:00:00 PM Session Title: Invited Science: Neuro-oncology Phase 2 Study to Evaluate the Clinical Efficacy and Safety of MEDI4736 (Durvalumab DUR ) in Patients with Glioblastoma (GBM): Results For Cohort B (DUR Monotherapy), Bevacizumab (BEV) Na ve Patients with Recurrent GBM David Reardon Presentation Date: 4/25/2017 1:00:00 PM Session Title: Invited Science: Neuro-oncology The Expanding Armamentarium of Multiple Sclerosis Therapeutics Scott Newsome Presentation Date: 4/27/2017 3:30:00 PM Session Title: Multiple Sclerosis Overview II: Clinical Advances Case-based Considerations in Clinical Practice for Multiple Sclerosis Myla Goldman Presentation Date: 4/27/2017 3:30:00 PM Session Title: Multiple Sclerosis Overview II: Clinical Advances Timing of curriculum affects medical student career choice.Vicki Ramsey-Williams Presentation Date: 4/23/2017 3:30:00 PM Session Title: Research Methodology and Education: Education Research Engaging Neurology Residents in Learner-Centered Medical Student Education: A Novel Resident-Led, Video-Based Pilot Curriculum Jeffrey Dewey M.Presentation Date: 4/23/2017 3:30:00 PM Session Title: Research Methodology and Education: Education Research Redefining the Cellular Architecture of Adult and Pediatric Glioblastomas Through Large-scale Single-cell Analyses Mariella Filbin Presentation Date: 4/25/2017 1:00:00 PM Session Title: Invited Science: Neuro-oncology Justification for New Diagnostic Criteria for Susac Syndrome: Evolving Beyond the Triad Gillian Paton Presentation Date: 4/25/2017 1:00:00 PM Session Title: Neuromyelitis Optica and Other Autoimmune Disorders Improving Stroke Clinical Trial Enrollment via the Use of Telemedicine Jared Noroozi Presentation Date: 4/23/2017 3:30:00 PM Session Title: Research Methodology and Education: Education Research The State of Diversity and Cultural Diversity Training in Neurology Residency Programs Nicole Rosendale Presentation Date: 4/23/2017 3:30:00 PM Session Title: Research Methodology and Education: Education Research Clinical Assessment of Gait and Balance Disorders Bastiaan Bloem Presentation Date: 4/27/2017 3:30:00 PM Session Title: Balance and Gait Disorders Interpreting Genetic Testing Results in Patients with Inherited Neuropathies Shawna Feely Presentation Date: 4/27/2017 3:30:00 PM Session Title: Peripheral Neuropathy III: Genetic Testing and Next Generation Sequencing Titration dosing of aducanumab: Results of a 12-month interim analysis from a randomized, double-blind, placebo-controlled Phase 1b study (PRIME) in patients with prodromal or mild Alzheimer's Disease Ahmed Enayetallah Presentation Date: 4/23/2017 3:30:00 PM Session Title: Aging and Dementia: Clinical and Translational Studies in Neurodegenerative Diseases An Investigation on Repetitive Head Impact Exposure and Plasma Total Tau Concentrations in Former National Football League Players Michael Alosco Presentation Date: 4/23/2017 3:30:00 PM Session Title: Aging and Dementia: Clinical and Translational Studies in Neurodegenerative Diseases Specificity of glial fibrillary acidic protein IgG autoantibody (GFAP-IgG) for Autoimmune Meningoencephalomyelitis Diagnosis Eoin Flanagan Presentation Date: 4/25/2017 1:00:00 PM Session Title: Neuromyelitis Optica and Other Autoimmune Disorders Pathophysiological impact of anti-AMPA receptor antibodies in autoimmune encephalitis Christian Geis Presentation Date: 4/25/2017 1:00:00 PM Session Title: Neuromyelitis Optica and Other Autoimmune Disorders Advances and Limits of Next Generation Sequencing Beyond Clinical Testing Stephan Zuchner Presentation Date: 4/27/2017 3:30:00 PM Session Title: Peripheral Neuropathy III: Genetic Testing and Next Generation Sequencing Questions and Answers/Case Presentations Shawna Feely Presentation Date: 4/27/2017 3:30:00 PM Session Title: Peripheral Neuropathy III: Genetic Testing and Next Generation Sequencing Crenezumab′s Preferential Binding Of Oligomeric Amyloid-Beta Species Underlies Its Unique Mechanism Of Action Jasvinder Atwal Presentation Date: 4/23/2017 3:30:00 PM Session Title: Aging and Dementia: Clinical and Translational Studies in Neurodegenerative Diseases Comparison of detergent-insoluble proteome changes in autosomal dominant Alzheimer′s disease brain to late onset AD and transgenic rodents Chad Hales Presentation Date: 4/23/2017 3:30:00 PM Session Title: Aging and Dementia: Clinical and Translational Studies in Neurodegenerative Diseases Association between Leukocyte Count and Perihematomal Edema Growth After Primary Intracerebral Hemorrhage Aaron Gusdon Presentation Date: 4/27/2017 3:30:00 PM Session Title: Neuroscience in the Clinic: Novel Therapeutic Targets in Critical Care Neurology: Intracerebral and Intraventricular Hemorrhage Role Of Sulfonylureas In Perihematomal Edema In Spontaneous Intracerebral Hemorrhage Shailesh Male Presentation Date: 4/27/2017 3:30:00 PM Session Title: Neuroscience in the Clinic: Novel Therapeutic Targets in Critical Care Neurology: Intracerebral and Intraventricular Hemorrhage IgLON5 Autoimmunity: Serological Findings, Neurological Disorders & Outcomes in 16 patients Josephe Archie Honorat Presentation Date: 4/25/2017 1:00:00 PM Session Title: Neuromyelitis Optica and Other Autoimmune Disorders Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders Maureen Mealy Presentation Date: 4/25/2017 1:00:00 PM Session Title: Neuromyelitis Optica and Other Autoimmune Disorders Sporadic FTLD TDP type C is a distinct clinicopathological entity from FTLD types A/B G Michael Baer Presentation Date: 4/23/2017 3:30:00 PM Session Title: Aging and Dementia: Clinical and Translational Studies in Neurodegenerative Diseases Mortality and risk of dementia in normal pressure hydrocephalus: 25-year follow-up of a population-based cohort Daniel Jaraj Presentation Date: 4/23/2017 3:30:00 PM Session Title: Aging and Dementia: Clinical and Translational Studies in Neurodegenerative Diseases The effect of hospitalization on subsequent disability in multiple sclerosis Ruth-Ann Marrie Presentation Date: 4/27/2017 3:30:00 PM Session Title: MS Risk Factors and Modifications A survey of current dietary habits within a large population of people with multiple sclerosis Kathryn C.Fitzgerald Presentation Date: 4/27/2017 3:30:00 PM Session Title: MS Risk Factors and Modifications Placental transmission of AQP4-IgG to neonate from mothers with neuromyelitis optica spectrum disorder (NMOSD) Jessica Sagen Presentation Date: 4/25/2017 1:00:00 PM Session Title: Neuromyelitis Optica and Other Autoimmune Disorders Aquaporin-4 antibody titration in NMO patients treated with Rituximab: a retrospective study.Antonio Bertolotto Presentation Date: 4/25/2017 1:00:00 PM Session Title: Neuromyelitis Optica and Other Autoimmune Disorders Impact of hyperglycemia according to collateral status on reperfusion and outcomes in acute ischemic stroke after mechanical thrombectomy Joon-Tae Kim Presentation Date: 4/23/2017 3:30:00 PM Session Title: Cerebrovascular Disease and Interventional Neurology: Acute Stroke Treatment Ultra-short door-to-needle times of 10 minutes or less in stroke thrombolysis – experience from 63 cases Raffi Topakian Presentation Date: 4/23/2017 3:30:00 PM Session Title: Cerebrovascular Disease and Interventional Neurology: Acute Stroke Treatment Environmental risk factors associated with pediatric MS: The role of remote viral infections and vitamin D revisited.Shayandokht Taleb Presentation Date: 4/27/2017 3:30:00 PM Session Title: MS Risk Factors and Modifications Cholecalciferol supplementation in Relapsing Multiple Sclerosis patients treated with subcutaneous interferon beta-1a: a Randomized Controlled Trial.William Camu Presentation Date: 4/27/2017 3:30:00 PM Session Title: MS Risk Factors and Modifications Disorders of Arousal and Dream Enactment: Exploring the World of NREM and REM Parasomnias Michael Howell Presentation Date: 4/28/2017 3:30:00 PM Session Title: Sleep for the Practicing Neurologist II: Night Fighting: Sleep Related Hypermotor Epilepsy, Sleepwalking, and Dream Enactment Central Dysregulation of Heart Rate and Blood Pressure in Autoimmune AQP4 Channelopathy: Expanding the neuromyelitis optica spectrum disorder (NMOSD).

Masoud Majed Presentation Date: 4/25/2017 1:00:00 PM Session Title: Neuromyelitis Optica and Other Autoimmune Disorders Cannabidiol (CBD) significantly reduces drop seizure frequency in Lennox–Gastaut syndrome (LGS): results of a multi-center, randomized, double–blind, placebo controlled trial (GWPCARE4) Jacqueline French Presentation Date: 4/25/2017 1:00:00 PM Session Title: Epilepsy and Clinical Neurophysiology (EEG) I High dose cholecalciferol (vitamin D3) oil as add-on therapy in subjects with relapsing-remitting multiple sclerosis (RRMS) receiving subcutaneous interferon 1a (scIFN?-1a) J.Smolders Presentation Date: 4/27/2017 3:30:00 PM Session Title: MS Risk Factors and Modifications Maternal levels of Epstein-Barr virus IgG antibodies and risk of multiple sclerosis in offspring in the Finnish Maternity Cohort A.Ascherio Presentation Date: 4/27/2017 3:30:00 PM Session Title: MS Risk Factors and Modifications Neurological Autoantibody Prevalence in Epilepsy of Unknown Etiology - APE Study Divyanshu Dubey Presentation Date: 4/25/2017 1:00:00 PM Session Title: Epilepsy and Clinical Neurophysiology (EEG) I Relationship between Cognitive Performance and Subjective Symptoms in Patients with Newly Diagnosed Focal Epilepsy Kimford Meador Presentation Date: 4/25/2017 1:00:00 PM Session Title: Epilepsy and Clinical Neurophysiology (EEG) I Impact of Neurologist In-Hospital 24/7 on stroke patients arriving to the Emergency Department activated as a Code Stroke Alexander Schneider Presentation Date: 4/23/2017 3:30:00 PM Session Title: Cerebrovascular Disease and Interventional Neurology: Acute Stroke Treatment An analysis of fixed dose IV recombinant tissue plasminogen activator (rtPA) and clinical outcomes in acute ischemic stroke patients with body weight 100 kilograms: pooled data from three randomized clinical trials Shahram Majidi Presentation Date: 4/23/2017 3:30:00 PM Session Title: Cerebrovascular Disease and Interventional Neurology: Acute Stroke Treatment Epstein-Barr virus, Cytomegalovirus, the Hygeine Hypothesis and Multiple Sclerosis Susceptibility: A Multi-Ethnic Study Annette Langer-Gould Presentation Date: 4/27/2017 3:30:00 PM Session Title: MS Risk Factors and Modifications Familial Transverse Myelitis Associated with Mutation in VPS37A Gene Michael Levy Presentation Date: 4/27/2017 3:30:00 PM Session Title: MS Risk Factors and Modifications Long-term safety and efficacy of responsive brain stimulation in adults with medically intractable partial onset seizures Dileep Nair Presentation Date: 4/25/2017 1:00:00 PM Session Title: Epilepsy and Clinical Neurophysiology (EEG) I Post-Diagnosis Neurological Care for Patients with Psychogenic Nonepileptic Spells (PNES) Chloe Hill Presentation Date: 4/25/2017 1:00:00 PM Session Title: Epilepsy and Clinical Neurophysiology (EEG) I To Reveal or Conceal? Adult Patient Perspectives on SUDEP Disclosure.Lucretia Long Presentation Date: 4/25/2017 1:00:00 PM Session Title: Epilepsy and Clinical Neurophysiology (EEG) I Antibodies to neuronal surface antigens in possible autoimmune encephalitis and new-onset refractory status epilepticus (NORSE) Takahiro Iizuka Presentation Date: 4/25/2017 1:00:00 PM Session Title: Epilepsy and Clinical Neurophysiology (EEG) I The effect of baseline blood pressure on the benefit and safety of intra-arterial treatment in MR CLEAN.Biller Presentation Date: 4/27/2017 3:30:00 PM Session Title: Peripheral Nerve Disorders Neuroendocrine Axes: Hypothalamus, Pituitary, and Beyond Karen Klahr Miller Presentation Date: 4/25/2017 1:05:00 PM Session Title: Neuroendocrine Update: Nuts and Bolts of What You Need to Know Environmental Enrichment Mitigates Deficits after Repetitive Mild TBI Jianhua Qiu Presentation Date: 4/23/2017 3:30:00 PM Session Title: Neuro Trauma and Sports Neurology Near point convergence and other measures of vestibulo-ocular dysfunction are associated with protracted neurological recovery after sports concussion Andrew Russman Presentation Date: 4/23/2017 3:30:00 PM Session Title: Neuro Trauma and Sports Neurology Epilepsy, Antiepileptic Drugs, and Neuroendocrine Effects Alison Pack Presentation Date: 4/25/2017 1:05:00 PM Session Title: Neuroendocrine Update: Nuts and Bolts of What You Need to Know Microcephaly proteins Wdr62 and Aspm define a mother centriole complex regulating centriole biogenesis, apical complex and cell fate Divya Jayaraman Presentation Date: 4/27/2017 3:30:00 PM Session Title: Child Neurology: Molecular Biology to Clinical Trials Outcome following hemicraniectomy in children with acute stroke in the International Pediatric Stroke Study Laura Lehman Presentation Date: 4/27/2017 3:30:00 PM Session Title: Child Neurology: Molecular Biology to Clinical Trials 18F AV-1451 positron emission tomography reveals tau pathology in long-term survivors of traumatic brain injury Nikos Gorgoraptis Presentation Date: 4/23/2017 3:30:00 PM Session Title: Neuro Trauma and Sports Neurology Disruption to the dopaminergic system following traumatic brain injury Peter Jenkins Presentation Date: 4/23/2017 3:30:00 PM Session Title: Neuro Trauma and Sports Neurology Neuroendocrine Effects on Multiple Sclerosis Riley Bove Presentation Date: 4/25/2017 1:05:00 PM Session Title: Neuroendocrine Update: Nuts and Bolts of What You Need to Know Neuroendocrine Effects on Headache Michael Rogawski Presentation Date: 4/25/2017 1:05:00 PM Session Title: Neuroendocrine Update: Nuts and Bolts of What You Need to Know Advanced Management of PD, ET, Dystonia, and Troubleshooting Joohi Jimenez Shahed Presentation Date: 4/23/2017 3:35:00 PM Session Title: Deep Brain Stimulation II: Advanced Management in Movement Disorders and Applications Beyond Movement Disorders Interim Efficacy and Safety Results from the Phase 2 NURTURE Study Evaluating Nusinersen in Presymptomatic Infants with Spinal Muscular Atrophy Darryl C.De Vivo Presentation Date: 4/27/2017 3:30:00 PM Session Title: Child Neurology: Molecular Biology to Clinical Trials Motor mapping by transcranial magnetic stimulation reveals a pathologically preserved immature motor lateralization in patients with intractable focal epilepsy Harper Kaye Presentation Date: 4/27/2017 3:30:00 PM Session Title: Child Neurology: Molecular Biology to Clinical Trials Neuroendocrine Effects of Traumatic Brain Injury Gary Abrams Presentation Date: 4/25/2017 1:05:00 PM Session Title: Neuroendocrine Update: Nuts and Bolts of What You Need to Know Novel and Emerging Uses of DBS: OCD, Tourette Syndrome, Depression, Alzheimer's, and Epilepsy Michael Okun Presentation Date: 4/23/2017 3:35:00 PM Session Title: Deep Brain Stimulation II: Advanced Management in Movement Disorders and Applications Beyond Movement Disorders ICU EEG Monitoring: Why, When, and for Whom Aatif Husain Presentation Date: 4/25/2017 1:05:00 PM Session Title: Critical Care EEG Monitoring Acute Repetitive Seizures and Status Epilepticus Tobias Loddenkemper Presentation Date: 4/23/2017 3:35:00 PM Session Title: Clinical Epilepsy III: Advanced (Status, Beyond AED, Video EEG) Beyond AEDs—Surgery, Devices, Diet, or Marijuana? Elson So Presentation Date: 4/23/2017 3:35:00 PM Session Title: Clinical Epilepsy III: Advanced (Status, Beyond AED, Video EEG) A Randomized Double-blind, Placebo-controlled, Cross-over Trial of Ganaxolone in Children and Adolescents with Fragile X Syndrome Julia Tsai Presentation Date: 4/27/2017 3:30:00 PM Session Title: Child Neurology: Molecular Biology to Clinical Trials Long Term Outcomes and Risk Factors for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors Tejaswi Kandula Presentation Date: 4/27/2017 3:30:00 PM Session Title: Child Neurology: Molecular Biology to Clinical Trials EEG Patterns in the ICU Suzette LaRoche Presentation Date: 4/25/2017 1:05:00 PM Session Title: Critical Care EEG Monitoring Quantitative EEG for Seizure Identification Nicholas Abend Presentation Date: 4/25/2017 1:05:00 PM Session Title: Critical Care EEG Monitoring Physician- and Patient-Reported Outcomes in X-linked Adrenoleukodystrophy: Accelerated Roadmap from Patients′ Insights to Clinical Trials Alexander Sherman Presentation Date: 4/27/2017 3:30:00 PM Session Title: Child Neurology: Molecular Biology to Clinical Trials PREPL deficiency: delineation of the phenotype and development of a functional blood assay Luc Regal Presentation Date: 4/27/2017 3:30:00 PM Session Title: Child Neurology: Molecular Biology to Clinical Trials Neglect Kenneth Heilman Session Title: Unilateral Neglect and Anosognosia: Chalk Talk Anosognosia Kenneth Heilman Session Title: Unilateral Neglect and Anosognosia: Chalk Talk Cortical spreading depression closes the paravascular space and impairs glymphatic flow: Implications for migraine headache.Aaron Schain Presentation Date: 4/27/2017 3:30:00 PM Session Title: Headache: Basic and Clinical Science Upregulation of inflammatory gene transcripts in periosteum of chronic migraineurs: implications to extracranial origin of headache Rami Burstein Presentation Date: 4/27/2017 3:30:00 PM Session Title: Headache: Basic and Clinical Science In vivo imaging of CSD-induced activation of resident meningeal immune cells: implications for activation of meningeal nociceptors Aaron Schain Presentation Date: 4/27/2017 3:30:00 PM Session Title: Headache: Basic and Clinical Science Increased cortical network activity in a migraine mutant mouse following traumatic brain injury C.Austin Service Presentation Date: 4/27/2017 3:30:00 PM Session Title: Headache: Basic and Clinical Science Transverse Myelitis Benjamin Greenberg Session Title: Myelopathies I: Inflammatory and Vascular Etiologies Vascular Myelopathies Philippe Gailloud Session Title: Myelopathies I: Inflammatory and Vascular Etiologies Name that Seizure: Video Case Presentations William Tatum Presentation Date: 4/23/2017 3:35:00 PM Session Title: Clinical Epilepsy III: Advanced (Status, Beyond AED, Video EEG) What REVEAL and MedSeq Tell Us About the Future of Precision Medicine Kurt Christensen Presentation Date: 4/23/2017 3:35:00 PM Session Title: Precision Neurology: The Promise and Perils of Personalized Medicine in the Genomic Era RNA-seq for the diagnosis of inherited myopathies: a pilot study Stefan Nicolau Presentation Date: 4/28/2017 3:30:00 PM Session Title: Motor Neuron Disease and Myopathies Spread of pathogenic and non-pathogenic cytosolic proteins between motor neurons in chimeric mice Eleanor Thomas Presentation Date: 4/28/2017 3:30:00 PM Session Title: Motor Neuron Disease and Myopathies Genetic Variance and Risk in Complex Neurological Disorders David Goldstein Presentation Date: 4/23/2017 3:35:00 PM Session Title: Precision Neurology: The Promise and Perils of Personalized Medicine in the Genomic Era Green light alleviates migraine photophobia Rodrigo Noseda Presentation Date: 4/27/2017 3:30:00 PM Session Title: Headache: Basic and Clinical Science Migraine is comorbid with Attention Deficit Hyperactivity Disorder in childhood: a nationwide populational study Renato Arruda Presentation Date: 4/27/2017 3:30:00 PM Session Title: Headache: Basic and Clinical Science Hereditary Myelopathies John Fink Session Title: Myelopathies I: Inflammatory and Vascular Etiologies Closing Remarks Benjamin Greenberg Session Title: Myelopathies I: Inflammatory and Vascular Etiologies Introduction: Clinical Trials in the Drug Development Pipeline Wendy Galpern Presentation Date: 4/25/2017 3:30:00 PM Session Title: Developing the Treatments of Tomorrow II: Clinical Trials in Neurology We Are the 99%: How Non-exonic Sequences and Repeats Cause Neurological Disease Peter Todd Presentation Date: 4/23/2017 3:35:00 PM Session Title: Precision Neurology: The Promise and Perils of Personalized Medicine in the Genomic Era Considerations for Early and Late Stage Trials Gilmore O'Neill Presentation Date: 4/25/2017 3:30:00 PM Session Title: Developing the Treatments of Tomorrow II: Clinical Trials in Neurology Epidemiology of Migraine in Men: Disease Presentation and Comorbidities from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study Ann Scher Presentation Date: 4/27/2017 3:30:00 PM Session Title: Headache: Basic and Clinical Science Exploring the Role of the Hippocampus in Migraine Catherine Chong Presentation Date: 4/27/2017 3:30:00 PM Session Title: Headache: Basic and Clinical Science One Brain, Many Genomes: Somatic Mutations in Neural Development and Neurological Disease Christopher Walsh Presentation Date: 4/23/2017 3:35:00 PM Session Title: Precision Neurology: The Promise and Perils of Personalized Medicine in the Genomic Era Implementation of an on-line communication interface (“Ask-a-doc”) in a neurology department Muhammad Taimur Malik Presentation Date: 4/27/2017 3:30:00 PM Session Title: Practice, Policy, and Ethics MyChart Enrollment and other Factors that Affect No Show Rates in the Neurology Resident Clinic Kavit Shah Presentation Date: 4/27/2017 3:30:00 PM Session Title: Practice, Policy, and Ethics Statistical Considerations for Designing and Interpreting Clinical Trials Christopher Coffey Presentation Date: 4/25/2017 3:30:00 PM Session Title: Developing the Treatments of Tomorrow II: Clinical Trials in Neurology Regulatory Considerations for Clinical Trials in Neurology Lei Xu Presentation Date: 4/25/2017 3:30:00 PM Session Title: Developing the Treatments of Tomorrow II: Clinical Trials in Neurology Factors affecting post-discharge outcomes in hospital patients with non-surgical neurological diseases Krishna Mourya Galla Presentation Date: 4/27/2017 3:30:00 PM Session Title: Practice, Policy, and Ethics Reducing delays to imaging and thombolysis in acute stroke care Tracie Caller Presentation Date: 4/27/2017 3:30:00 PM Session Title: Practice, Policy, and Ethics Team Teaching Exercises Richard Haspel Presentation Date: 4/23/2017 3:45:00 PM Session Title: Genomic Neurology Workshop: Developing Practical Knowledge of Tools and Concepts Through Case Studies II ICD-10-CM Basics: Value-based Purchasing and Case Presentations Jeffrey Buchhalter Presentation Date: 4/24/2017 7:00:00 AM Session Title: ICD-10-CM: How to Optimize for Accurate Diagnosis and Reimbursement Innovations in Clinical Trial Design and Implementation Jeffrey Gelfand Presentation Date: 4/25/2017 3:30:00 PM Session Title: Developing the Treatments of Tomorrow II: Clinical Trials in Neurology Optimal ICD-10 Coding of Common Neurological Disorders Korwyn Williams Presentation Date: 4/24/2017 7:00:00 AM Session Title: ICD-10-CM: How to Optimize for Accurate Diagnosis and Reimbursement Introducing the Idea of Palliative Care from the Time of Diagnosis Maisha Robinson Presentation Date: 4/25/2017 3:30:00 PM Session Title: Non-Neuro-oncology: Case-based Palliative Care Throughout the Continuum of Disease How to Avoid and Respond to Denials David Evans Presentation Date: 4/24/2017 7:00:00 AM Session Title: ICD-10-CM: How to Optimize for Accurate Diagnosis and Reimbursement A multimodal quality improvement program for delirium in stroke Sophia Ryan Presentation Date: 4/27/2017 3:30:00 PM Session Title: Practice, Policy, and Ethics Enhancing Efficiency of the Epilepsy Center King Faisal-Specialist Hospital and Research Center-Jeddah (KFSH&RC – Jeddah) Youssef Al Said Presentation Date: 4/27/2017 3:30:00 PM Session Title: Practice, Policy, and Ethics Putting Palliative Care into Practice: Symptom Assessment and Management from Day One Alan Carver Presentation Date: 4/25/2017 3:30:00 PM Session Title: Non-Neuro-oncology: Case-based Palliative Care Throughout the Continuum of Disease Discussing Prognosis at the Time of Diagnosis Janis Miyasaki Presentation Date: 4/25/2017 3:30:00 PM Session Title: Non-Neuro-oncology: Case-based Palliative Care Throughout the Continuum of Disease Factors in Unplanned Readmission or ED Visit within 30 Days of Discharge from an Inpatient Neurology Service Faisal Ahmed Presentation Date: 4/27/2017 3:30:00 PM Session Title: Practice, Policy, and Ethics Validation of i1 Biometrics Vector MouthGuard: Measuring Head Impact Frequency in Sport Geoffrey McKendry Presentation Date: 4/27/2017 3:30:00 PM Session Title: Practice, Policy, and Ethics Using Cases to Put it in to Practice Alan Carver Presentation Date: 4/25/2017 3:30:00 PM Session Title: Non-Neuro-oncology: Case-based Palliative Care Throughout the Continuum of Disease Approach to Unruptured Aneurysms and AVMs Roberta Novakovic Presentation Date: 4/24/2017 7:00:00 AM Session Title: Current Management of Incidental and Asymptomatic Cerebrovascular Lesions Approach to Asymptomatic Carotid Stenosis Seemant Chaturvedi Presentation Date: 4/24/2017 7:00:00 AM Session Title: Current Management of Incidental and Asymptomatic Cerebrovascular Lesions Normal and Abnormal EEG in Neonates and Children Tammy Tsuchida Presentation Date: 4/27/2017 3:35:00 PM Session Title: Clinical EEG III: Pediatric and Neonatal Case Studies in Peripheral Neuropathy Christopher Gibbons Presentation Date: 4/25/2017 3:30:00 PM Session Title: Small Fiber Neuropathies: Sensory, Autonomic, and Both II: Focus on Sensory Nervous System Neuropathic Pain—Mechanisms Guide Treatment Ralf Baron Presentation Date: 4/25/2017 3:30:00 PM Session Title: Small Fiber Neuropathies: Sensory, Autonomic, and Both II: Focus on Sensory Nervous System Overview of Mild Cognitive Impairment Ronald Petersen Presentation Date: 4/24/2017 7:00:00 AM Session Title: Mild Cognitive Impairment: Implications for Clinicians Mild Cognitive Impairment: Prediction of Progression and Treatment David Gill Presentation Date: 4/24/2017 7:00:00 AM Session Title: Mild Cognitive Impairment: Implications for Clinicians Multiple Sclerosis Daniel Harrison Session Title: Neurology Update IV: Multiple Sclerosis, Dizziness, and Autoimmune Encephalopathies Dizziness Daniel Gold Session Title: Neurology Update IV: Multiple Sclerosis, Dizziness, and Autoimmune Encephalopathies Interictal and Ictal EEG in Neonates and Children Tobias Loddenkemper Presentation Date: 4/27/2017 3:35:00 PM Session Title: Clinical EEG III: Pediatric and Neonatal EEG Unknowns Tobias Loddenkemper Session Title: Clinical EEG III: Pediatric and Neonatal Introduction in the Clinical and Diagnostic Approach to Tremor Vicki Shanker Presentation Date: 4/24/2017 7:00:00 AM Session Title: Approach to the Shaky Patient Autoimmune Encephalopathies David Benavides Session Title: Neurology Update IV: Multiple Sclerosis, Dizziness, and Autoimmune Encephalopathies Mild Cognitive Impairment, Dementia, and Psychiatric Jennifer Goldman Presentation Date: 4/25/2017 3:30:00 PM Session Title: Nonmotor Manifestations of Parkinson's Disease II Evolving New Therapies in Neuro-oncology-What a Neurologist Should Know Maciej Mrugala Presentation Date: 4/27/2017 3:35:00 PM Session Title: Cutting Edge Neuro-oncology Understanding Current Trends Tremor in Parkinson's Disease Andres Deik Acosta Madiedo Presentation Date: 4/24/2017 7:00:00 AM Session Title: Approach to the Shaky Patient Understanding Molecular Testing in Brain Tumors-How Clinically Useful Is It? Seema Nagpal Presentation Date: 4/27/2017 3:35:00 PM Session Title: Cutting Edge Neuro-oncology Understanding Current Trends Tremor in Dystonia Andres Deik Acosta Madiedo Presentation Date: 4/24/2017 7:00:00 AM Session Title: Approach to the Shaky Patient Sleep and Autonomic Complications in Parkinson's Disease Stewart Factor Presentation Date: 4/25/2017 3:30:00 PM Session Title: Nonmotor Manifestations of Parkinson's Disease II The Dix-Hallpike Maneuver: Margaret Dix Douglas Lanska Presentation Date: 4/25/2017 3:30:00 PM Session Title: Eponymous Women in Neurology II Deciphering Technical Novelties in Surgical Therapy for Brain Tumors-What Is Coming and How to Advise the Patients? Bernard Bendok Presentation Date: 4/27/2017 3:35:00 PM Session Title: Cutting Edge Neuro-oncology Understanding Current Trends Tremor in Essential Tremor Vicki Shanker Presentation Date: 4/24/2017 7:00:00 AM Session Title: Approach to the Shaky Patient Canavan Disease: Myrtelle May Canavan Lenora Lehwald Presentation Date: 4/25/2017 3:30:00 PM Session Title: Eponymous Women in Neurology II Uncommon Tremors: Psychogenic and Beyond Vicki Shanker Presentation Date: 4/24/2017 7:00:00 AM Session Title: Approach to the Shaky Patient Hurler Syndrome: Gertrud Hurler Margie Ream Presentation Date: 4/25/2017 3:30:00 PM Session Title: Eponymous Women in Neurology II Digital Biomarkers for Neurology E.Ray Dorsey Presentation Date: 4/27/2017 3:35:00 PM Session Title: Emerging Approaches to Biosensing for the Diagnosis and Management of Neurological Disease Childhood Arterial Ischemic Stroke: Risk Factors, Management and Outcomes Catherine Amlie-Lefond Presentation Date: 4/24/2017 7:00:00 AM Session Title: Child Neurology I: Pediatric Stroke, MS/Autoimmune Biosensing and Wearables in MS Jennifer Graves Presentation Date: 4/27/2017 3:35:00 PM Session Title: Emerging Approaches to Biosensing for the Diagnosis and Management of Neurological Disease Frey Syndrome (Gustatory Sweating): Lucja Frey Stephen Reich Presentation Date: 4/25/2017 3:30:00 PM Session Title: Eponymous Women in Neurology II New Approaches to Biosensing in the Management of Epilepsy John Hixson Presentation Date: 4/27/2017 3:35:00 PM Session Title: Emerging Approaches to Biosensing for the Diagnosis and Management of Neurological Disease Childhood Headache: A Growing Problem Amy Gelfand Presentation Date: 4/25/2017 3:30:00 PM Session Title: Hot Topics in Headaches and Related Disorders II: Unusual Headaches, Childhood Headaches, and Head Trauma Post-traumatic Headache: What is New? Bert Vargas Presentation Date: 4/25/2017 3:30:00 PM Session Title: Hot Topics in Headaches and Related Disorders II: Unusual Headaches, Childhood Headaches, and Head Trauma Pediatric MS Jan-Mendelt Tillema Session Title: Child Neurology I: Pediatric Stroke, MS/Autoimmune Metabolic Mimics of Stroke and Immune-mediated Disorders Marc Patterson Presentation Date: 4/24/2017 7:00:00 AM Session Title: Child Neurology I: Pediatric Stroke, MS/Autoimmune Exam Skills Marc Dinkin Session Title: Eye Movement Disorders: A Systematic Approach to the Evaluation of Diplopia Supranuclear Causes of Diplopia Janet Rucker Presentation Date: 4/28/2017 7:00:00 AM Session Title: Eye Movement Disorders: A Systematic Approach to the Evaluation of Diplopia An Update on Trigeminal Autonomic Cephalalgias and Other Unusual Headaches Peter Goadsby Presentation Date: 4/25/2017 3:30:00 PM Session Title: Hot Topics in Headaches and Related Disorders II: Unusual Headaches, Childhood Headaches, and Head Trauma Argon treatment provides short and long-term neuroprotection in a mouse model of traumatic brain injury Jennifer Creed Presentation Date: 4/25/2017 3:30:00 PM Session Title: Neurocritical Care: Neurological Intensive Care Cranial Nerve Dysfunction Marc Dinkin Presentation Date: 4/28/2017 7:00:00 AM Session Title: Eye Movement Disorders: A Systematic Approach to the Evaluation of Diplopia Neuromuscular Junction Janet Rucker Session Title: Eye Movement Disorders: A Systematic Approach to the Evaluation of Diplopia Treatment of Amyotrophic Lateral Sclerosis Michael Weiss Presentation Date: 4/24/2017 7:00:00 AM Session Title: Therapy of Neuromuscular Disease: ALS, Inflammatory Neuropathies and Myopathies, and Myasthenia Gravis Treatment of Inflammatory Neuropathies Michael Weiss Presentation Date: 4/24/2017 7:00:00 AM Session Title: Therapy of Neuromuscular Disease: ALS, Inflammatory Neuropathies and Myopathies, and Myasthenia Gravis Orbital Causes of Diplopia Marc Dinkin Presentation Date: 4/28/2017 7:00:00 AM Session Title: Eye Movement Disorders: A Systematic Approach to the Evaluation of Diplopia Update on Medical Management of Stroke Natalia Rost Presentation Date: 4/28/2017 7:00:00 AM Session Title: Update on Medical Management of Stroke Safety of Thrombolysis for Acute Ischemic Stroke in Patients with Recent Stroke Setareh Salehi Omran Presentation Date: 4/25/2017 3:30:00 PM Session Title: Neurocritical Care: Neurological Intensive Care Analysis of adjudicated edema endpoints in the Glyburide Advantage in Malignant Edema and Stroke (GAMES-RP) Trial W.

Taylor Kimberly Presentation Date: 4/25/2017 3:30:00 PM Session Title: Neurocritical Care: Neurological Intensive Care Treatment of Myasthenia Gravis Anthony Amato Presentation Date: 4/24/2017 7:00:00 AM Session Title: Therapy of Neuromuscular Disease: ALS, Inflammatory Neuropathies and Myopathies, and Myasthenia Gravis Treatment of Inflammatory Myopathies Anthony Amato Presentation Date: 4/24/2017 7:00:00 AM Session Title: Therapy of Neuromuscular Disease: ALS, Inflammatory Neuropathies and Myopathies, and Myasthenia Gravis Machine Learning Approach to Automate Detection of Cerebral Vasospasm Using Transcranial Doppler Monitoring Gyanendra Kumar Presentation Date: 4/25/2017 3:30:00 PM Session Title: Neurocritical Care: Neurological Intensive Care Predictors of family satisfaction with support during shared decision making in neuroscience intensive care units Derek Ou Presentation Date: 4/25/2017 3:30:00 PM Session Title: Neurocritical Care: Neurological Intensive Care The Hyperacute Stroke: All That On-call Neurologists Need to Know Natalia Rost Presentation Date: 4/28/2017 7:00:00 AM Session Title: Update on Medical Management of Stroke Beyond Thrombolytics: Medical Management of Acute Stroke and Its Early Complications Jose Biller Presentation Date: 4/28/2017 7:00:00 AM Session Title: Update on Medical Management of Stroke Caring for the Whole Person: Resilience, Spirituality and Religious Coping in the Neurocritical Care Environment Barbara Gordon Presentation Date: 4/25/2017 3:30:00 PM Session Title: Neurocritical Care: Neurological Intensive Care Ominous EEG patterns do not preclude recovery in post-arrest patients treated with neurostimulants Alexis Steinberg Presentation Date: 4/25/2017 3:30:00 PM Session Title: Neurocritical Care: Neurological Intensive Care Pharmaceuticals Eoin Flanagan Session Title: CNS Toxicities Presentation Date: 4/28/2017 7:00:00 AM Session Title: Update on Medical Management of Stroke Special Cases in Acute Stroke: Challenging the Norm Jose Biller Presentation Date: 4/28/2017 7:00:00 AM Session Title: Update on Medical Management of Stroke Structural organization of the brain connectome in patients with primary lateral sclerosis Silvia Basaia Presentation Date: 4/28/2017 3:30:00 PM Session Title: Motor Neuron Disease and Myopathies Connexin 43 affects disease progression and motor neuron toxicity in Amyotrophic Lateral Sclerosis Akshata Almad Presentation Date: 4/28/2017 3:30:00 PM Session Title: Motor Neuron Disease and Myopathies Neurologic Consultation and Use of Therapeutic Hypothermia for Cardiac Arrest Elan L.Guterman Presentation Date: 4/25/2017 3:30:00 PM Session Title: Neurocritical Care: Neurological Intensive Care Dimethyl fumarate treatment produces alterations in lipid metabolism that are linked to occurrence of lymphopenia Pavan Bhargava Presentation Date: 4/25/2017 3:30:00 PM Session Title: MS Therapeutics and Clinical Research I All Patients with CIS and RIS Should Start MS Therapy Riley Bove Presentation Date: 4/28/2017 7:00:00 AM Session Title: Controversies in Multiple Sclerosis Therapy All JCV Positive MS Patients Should Discontinue Natalizumab Therapy Bruce Cree Presentation Date: 4/28/2017 7:00:00 AM Session Title: Controversies in Multiple Sclerosis Therapy Drugs of Abuse Neeraj Kumar Presentation Date: 4/24/2017 7:00:00 AM Session Title: CNS Toxicities Depletion of CD8+ cells in patients with multiple sclerosis on dimethyl fumarate and its association with shingles Ursela Siddiqui Presentation Date: 4/25/2017 3:30:00 PM Session Title: MS Therapeutics and Clinical Research I Ofatumumab Differs from Rituximab by Effectively Targeting Lymph Node B cells and Achieving Faster Post-treatment Repletion David Leppert Presentation Date: 4/25/2017 3:30:00 PM Session Title: MS Therapeutics and Clinical Research I All Patients with MS Should Be Treated with Vitamin D Supplementation Ellen Mowry Presentation Date: 4/28/2017 7:00:00 AM Session Title: Controversies in Multiple Sclerosis Therapy Once Started, MS Therapies Should Be Continued for Life Ellen Mowry Presentation Date: 4/28/2017 7:00:00 AM Session Title: Controversies in Multiple Sclerosis Therapy Syndromes Eoin Flanagan Session Title: CNS Toxicities Presentation Date: 4/28/2017 7:00:00 AM Session Title: The Global Burden of Neurologic Diseases Ambulation Assistive Device Training Prevents Falls, Increases Device Satisfaction and May Decrease Sitting and Increase Walking in MS: A Randomized-Controlled Pilot Study Andrea Hildebrand Presentation Date: 4/25/2017 3:30:00 PM Session Title: MS Therapeutics and Clinical Research I Improvements in Clinical Outcomes With Alemtuzumab in Treatment-Naive Patients With Active Relapsing-Remitting Multiple Sclerosis Are Durable Over 6 Years in the Absence of Continuous Treatment (CARE-MS I) Barry Singer Presentation Date: 4/25/2017 3:30:00 PM Session Title: MS Therapeutics and Clinical Research I Metals Neeraj Kumar Session Title: CNS Toxicities Alemtuzumab Provides Durable Efficacy Over 6 Years in Patients With Active Relapsing-Remitting Multiple Sclerosis and an Inadequate Response to Prior Therapy in the Absence of Continuous Treatment (CARE-MS II) Edward J Fox Presentation Date: 4/25/2017 3:30:00 PM Session Title: MS Therapeutics and Clinical Research I Fitness to drive in persons with MS and cognitive impairment: a pilot study Sarah Anne Morrow Presentation Date: 4/25/2017 3:30:00 PM Session Title: MS Therapeutics and Clinical Research I Neurologic Infections: A Global Update Kiran Thakur Presentation Date: 4/28/2017 7:00:00 AM Session Title: The Global Burden of Neurologic Diseases REM Sleep Behavior Disorder: Recent Advances in Diagnosis and Treatment Erik St.Louis Presentation Date: 4/24/2017 7:00:00 AM Session Title: Hot Topics in Sleep Neurology Efficacy and Safety of Ozanimod: Results From the 2-Year Blinded Extension of RADIANCE, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial in Relapsing Multiple Sclerosis Jeffrey Cohen Presentation Date: 4/25/2017 3:30:00 PM Session Title: MS Therapeutics and Clinical Research I Emergency Medical Services Survey Of A Low-cost, Ambulance-based System For Mobile Neurological Assessment: The iTREAT Study Nicole Chiota-McCollum Presentation Date: 4/25/2017 3:30:00 PM Session Title: Cerebrovascular Disease and Interventional Neurology: Prehospital and Emergency Department Ischemic Stroke Care Sleep and Neurodegeneration: A State of the Art Review Yo-El Ju Presentation Date: 4/24/2017 7:00:00 AM Session Title: Hot Topics in Sleep Neurology Global Epidemiology of Stroke Jerome Chin Presentation Date: 4/28/2017 7:00:00 AM Session Title: The Global Burden of Neurologic Diseases Results of Successful Tiered Stroke Triage Process Angela Hawkins Presentation Date: 4/25/2017 3:30:00 PM Session Title: Cerebrovascular Disease and Interventional Neurology: Prehospital and Emergency Department Ischemic Stroke Care External Validation of the TeleStroke Mimic (TM) Score for Predicting Stroke Mimics Evaluated during Telestroke Syed Ali Presentation Date: 4/25/2017 3:30:00 PM Session Title: Cerebrovascular Disease and Interventional Neurology: Prehospital and Emergency Department Ischemic Stroke Care Dreaming of Somnolence: An Update in Insomnia Management Michael Howell Presentation Date: 4/24/2017 7:00:00 AM Session Title: Hot Topics in Sleep Neurology Modeling the Impact of Interhospital Transfer Protocol Design on Mechanical Thrombectomy Eligibility and Outcomes in a Large Metropolitan Area Neal Parikh Presentation Date: 4/25/2017 3:30:00 PM Session Title: Cerebrovascular Disease and Interventional Neurology: Prehospital and Emergency Department Ischemic Stroke Care Developing a Family of Visual Decision Aids for Intravenous and Endovascular Reperfusion Therapies for Acute Ischemic Stroke Ivie Tokunboh Presentation Date: 4/25/2017 3:30:00 PM Session Title: Cerebrovascular Disease and Interventional Neurology: Prehospital and Emergency Department Ischemic Stroke Care Restless Legs Syndrome: Evolving Understanding and Treatments LynnMarie Trotti Presentation Date: 4/24/2017 7:00:00 AM Session Title: Hot Topics in Sleep Neurology Clinical and Sleep Laboratory Assessment Suresh Kotagal Presentation Date: 4/28/2017 7:00:00 AM Session Title: How to Integrate Sleep Medicine into Your Child Neurology Practice Research and Clinical Practice: Sleep in Neurodevelopmental Disabilities Kiran Maski Presentation Date: 4/28/2017 7:00:00 AM Session Title: How to Integrate Sleep Medicine into Your Child Neurology Practice Professionalism Pedagogy and the Conspicuous Curriculum William Cheshire Presentation Date: 4/24/2017 7:05:00 AM Session Title: Annual A.Baker Program: Focus on Professionalism Characteristics and Outcomes among Patients Transferred to Regional Stroke Centers across the United States for Specialized Stroke Care Syed Ali Presentation Date: 4/25/2017 3:30:00 PM Session Title: Cerebrovascular Disease and Interventional Neurology: Prehospital and Emergency Department Ischemic Stroke Care Effect of Prestroke Aspirin on Infarct Volume in Ischemic Stroke Soo-Hyun Park Presentation Date: 4/25/2017 3:30:00 PM Session Title: Cerebrovascular Disease and Interventional Neurology: Prehospital and Emergency Department Ischemic Stroke Care Epilepsy and Sleep-Common Bedfellows Sanjeev Kothare Presentation Date: 4/28/2017 7:00:00 AM Session Title: How to Integrate Sleep Medicine into Your Child Neurology Practice Overdiagnosis of optic neuritis.

Leanne Stunkel Presentation Date: 4/25/2017 3:30:00 PM Session Title: Neuro-opthalmology/Neuro-otology Presentation Date: 4/25/2017 3:30:00 PM Session Title: Neuro-opthalmology/Neuro-otology Presentation Date: 4/28/2017 7:00:00 AM Session Title: How to Integrate Sleep Medicine into Your Child Neurology Practice Ischemic Optic Neuropathy in Cardiac Surgery: Incidence and Risk Factors in the United States from the Nationwide Inpatient Sample 1998-2013 Heather Moss Presentation Date: 4/25/2017 3:30:00 PM Session Title: Neuro-opthalmology/Neuro-otology Presentation Date: 4/25/2017 3:30:00 PM Session Title: Neuro-opthalmology/Neuro-otology Presentation Date: 4/24/2017 7:05:00 AM Session Title: Annual A.Baker Program: Focus on Professionalism Closing Remarks Suresh Kotagal Session Title: How to Integrate Sleep Medicine into Your Child Neurology Practice Presentation of the 2017 A.Baker Award for Lifetime Achievement in Neurologic Education to Harold P.

, MD, FAAN Laurie Gutmann Presentation Date: 4/24/2017 7:05:00 AM Session Title: Annual A.Baker Program: Focus on Professionalism Borderlands of Neurology and Internal Medicine Martin Samuels Presentation Date: 4/28/2017 7:00:00 AM Session Title: Borderlands of Neurology and Internal Medicine: Chalk Talk Phenomenology, Classification, and Assessment Daniel Kaufer Presentation Date: 4/28/2017 7:00:00 AM Session Title: Assessment and Management of Neuropsychiatric Symptoms in Neurocognitive Disorders Intravitreal rAAV2/2-ND4 (GS010): A gene therapy for vision loss in Leber′s Hereditary Optic Neuropathy (LHON) caused by the G11778A ND4 mitochondrial mutation Jose-Alain Sahel Presentation Date: 4/25/2017 3:30:00 PM Session Title: Neuro-opthalmology/Neuro-otology Jun and Ddit3 (CHOP) deficiency provides additive protection for retinal ganglion cell death after optic nerve injury Stephanie Syc Presentation Date: 4/25/2017 3:30:00 PM Session Title: Neuro-opthalmology/Neuro-otology Presentation Date: 4/24/2017 7:05:00 AM Session Title: Annual A.Baker Program: Focus on Professionalism Pharmacological and Non-Pharmacological Management Douglas Scharre Presentation Date: 4/28/2017 7:00:00 AM Session Title: Assessment and Management of Neuropsychiatric Symptoms in Neurocognitive Disorders Clinical Cases Daniel Kaufer Session Title: Assessment and Management of Neuropsychiatric Symptoms in Neurocognitive Disorders Does the Combination of Acute Hearing Loss and Vertigo Increase Stroke Risk? Tzu-Pu Chang Presentation Date: 4/25/2017 3:30:00 PM Session Title: Neuro-opthalmology/Neuro-otology Presentation Date: 4/25/2017 3:30:00 PM Session Title: Neuro-opthalmology/Neuro-otology